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Summary 
The microvasculature of the liver is specialised in that it facilitates a relatively 
unimpeded bi-directional exchange of substances between the blood and parenchyma. 
Liver sinusoidal endothelial cells (LSECs) line the liver sinusoids and are perforated 
with thousands of transcellular fenestrations (open pores of approximately 100 nm in 
diameter devoid of diaphragms) and are underlined by a very sparse extracellular 
matrix. Thus, a virtually unimpeded passage of substances smaller than fenestrations 
to and from hepatocytes (the primary liver parenchymal cells) is facilitated. Direct 
contact between hepatocytes and circulating leukocytes is also facilitated through 
fenestrations, having implications for immune tolerance or activation. The diameter 
and number of fenestrations in the LSEC cytoplasm is modulated by both endogenous 
and exogenous substances such as drugs, hormones, and toxins, also pathological 
states and ageing. Modulation of fenestrations can have serious implications for drug 
and lipid metabolism as the liver is main site of drug and lipid metabolism in the 
body. Xenobiotics and chylomicron remnants smaller than fenestrations pass from the 
sinusoid lumen to the perisinusoidal space and hepatocytes for metabolism. As the 
diameter and number of fenestrations change, alterations in drug and lipid uptake 
follow that may alter the clearance of a drug or contribute to hyperlipidemia. 
 
Pathological states and oxidative stress in the sinusoids contribute to the 
capillarisation of LSECs. Capillarisation describes the alteration of LSEC phenotype 
to that of a defenestrated and thickened endothelial cell, similar to a typical capillary 
endothelial cell with underlying basement membrane. Capillarisation impedes the bi-
directional exchange of substances and decreases hepatocyte oxygenation, having 
severe consequences for liver functioning and perpetuation of disease states including 
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fibrosis and cirrhosis. Pseudocapillarisation is a less severe form of capillarisation 
associated with ageing. During pseudocapillarisation, LSECs lose about 50 % of their 
fenestrations, experience mild thickening and an increase of perisinusoidal extra 
cellular matrix. Ageing is associated with alterations in drug metabolism, postprandial 
hyperlipidemia, atherosclerosis, and an increased incidence of immune-related 
disorders, all of which are linked to pseudocapillarisation and defenestration. As such, 
modulation of fenestrations and maintenance of the fenestrated LSEC phenotype are 
important therapeutic targets. 
 
Chapter 3 of this thesis investigated the effect of fasting on the number and diameter 
of fenestrations in LSECs. In this study I found that fenestration diameter was 
significantly increased by approximately 10 % in fasted compared to ad libitum fed 
rats. However, a concomitant significant decrease in the number of fenestrations 
rendered the overall porosity of the LSECs unchanged. Increase in fenestration 
diameter during fasting has implications for the transfer of substrates and fluid 
between blood and hepatocytes, and allows increased passage of chylomicron 
remnants and nutrients through to the perisinusoidal space and hepatocytes. This is the 
first in vivo demonstration that fenestrations alter with physiological stimuli, in this 
case, the fasting or fed state. Increased fenestration diameter during fasting should 
therefore be considered in studies utilising fasted animals. 
 
Drug induced liver injury (DILI) is a major cause of mortality and fulminant hepatic 
failure. Acetaminophen (APAP) toxicity is one of the leading causes of DILI and liver 
failure in humans. In APAP toxicity, early injury to the LSEC initiates a cascade of 
events that exacerbate and sometimes initiate hepatocyte necrosis. Studies have shown 
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that protection of the liver microvasculature during APAP toxicity markedly reduces 
liver injury however the process of LSEC injury in APAP toxicity is not fully 
understood. Some studies suggest that early injury to the LSEC may be repaired 
during the course of APAP toxicity although the mechanisms are unknown. In 
Chapter 4 a thorough ultrastructural investigation on the liver sinusoids after an 
overdose of APAP in fed and fasted rats was performed. The morphology of the 
LSEC was observed on both SEM and TEM soon after overdose at 6 hours and again 
after the progression of hepatocyte centrilobular necrosis at 24 hours. There was 
injury to the LSEC at 6 hours after APAP in the form of gap formation, 
defenestration, and swelling. Gaps enabled RBCs to pass through and accumulate in 
the perisinusoidal space, decreasing sinusoid lumen size and promoting congestion 
and hypoxia. At 24 hours, LSEC injury was variable. Some LSECs were dead 
however some were viable and fenestrated in areas of severe hepatocyte necrosis. 
There were more viable LSECs observed in fed than fasted rats. Viable LSECs in 
necrotic zones were tethered to HSCs with some basement membrane formation 
between the cells, and both LSECs and HSCs were attached to degenerate 
hepatocytes. Retaining the sinusoid wall structure in at least some areas of the liver 
with hepatocyte necrosis may be vital to the restoration of hepatic microvasculature 
and subsequent regeneration of parenchyma in APAP toxicity. 
 
In Chapter 5 the therapeutic potential of a substance known to modulate fenestrations, 
poloxamer 407 (P407), was studied in the setting of APAP toxicity in fed and fasted 
rats. P407 has been shown in previous studies to defenestrate the LSEC by up to 80 % 
however the mechanism is unknown. In this study it was hypothesised that P407 
micelles may coat the LSEC, offering some protection from toxic insult and oxidative 
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stress. Defenestration by P407 may also decrease the amount of drug available to 
hepatocytes thus reduce the metabolism of APAP and production of toxic metabolites. 
It may also prevent gap formation in LSECs and subsequent hemorrhage leading to 
hepatocyte hypoxia. Rats were pre-treated with P407 via an intraperitoneal injection 
18 hours prior to an APAP overdose. Pre-treatment was not protective at 6 or 24 hours 
after APAP, and appeared to increase toxicity in some rats. This may have been due to 
an increase of inflammation stimulated by P407.  
 
Another cohort of rats was given an intraperitoneal injection of P407 one hour after 
APAP overdose. P407 post-treatment appeared to have a protective effect on the fed 
APAP group. At 24 hours after APAP only one of the rats had some very mild 
centrilobular necrosis, and no necrosis was observed in the other rats. In the fasted 
P407 post-treated rats at 24 hours after APAP the effect of P407 was unclear as there 
was extreme variability of toxicity throughout the group. In addition, at 6 hours after 
APAP in fasted P407 post-treated rats, gap formation in LSECs was not prevented. 
The mechanism of protection of P407 post-treatment in the fed group is unclear. The 
LSECs in the fed P407 post-treated group displayed some degree of defenestration 
which may have reduced the amount of APAP delivered to hepatocytes, whereas in 
the fasted post-treated group there was less defenestration and more gap formation, 
increasing hepatocyte vulnerability to toxic insult. 
 
In Chapter 6, LSEC isolation from old and young rats was performed to observe 
whether the pseudocapillarisation of LSECs associated with ageing is maintained in 
vitro. We found no change in the overall porosity in the isolated LSECs of young and 
old rats, however there was a significant decrease in the diameter of fenestrations 
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from 194 ± 1 nm in young to 185 ± 1 nm in old isolated LSECs. Thus LSECs from 
old livers maintained some, but not all, of their reported in vivo ultrastructural 
changes. The results of this study suggest that reduced fenestration diameter in old 
age is intrinsic to the LSEC. 
 
The work in this thesis supports the vital role of the fenestrated LSEC phenotype in 
maintaining healthy functioning of the liver, and the integral role of the LSEC in liver 
injury and repair. In addition, fenestration modulation appears to be an important 
therapeutic target in ageing, disease, and toxicity. 
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1.1    The liver  
1.1.1    Liver function and anatomy 
The liver is a complex organ with many vital functions (Cattley, 2002, Kmiec, 2001). 
It has a major role in drug and pathogen detoxification, immunity, lipoprotein 
synthesis and metabolism, bile formation and secretion, and nutrient storage and 
processing, and is considered the primary “metabolic clearing house” for both 
endogenous chemicals (steroid hormones, fatty acids, proteins, and cholesterol) and 
xenobiotics. The liver is located in the upper right quadrant of the abdominal cavity 
consisting of four main lobes (left, right, median or quadrate, and caudate) surrounded 
by a fibrous capsule of connective tissue (Glisson’s capsule) and is the largest internal 
organ. The histological lobular architecture of the liver is similar in all species 
(Malarkey, 2005).  
 
The liver is the first organ exposed to ingested pathogens and toxins, receiving blood 
directly from the gastrointestinal tract. As such it is the primary site of drug and toxin 
(xenobiotic) metabolism in the body (Neal, 1992). About 70 % of blood is supplied to 
the liver via the hepatic portal vein carrying blood from the abdominal organs via the 
mesenteric (intestines), gastric (stomach), splenic (spleen), and pancreatic (pancreas) 
veins. This deoxygenated blood delivers a mixture of micro and macro nutrients for 
processing and storage, and pathogens, drugs, and toxins for metabolism and/or 
elimination. The other 30 % of blood flow is supplied by the hepatic artery, branching 
from the celiac trunk and delivering oxygenated blood to the liver. These blood 
supplies enter the liver at a hilum, the porta hepatis (otherwise known as the portal 
tract or portal triad (fig 1.1)), mixing together as they empty into the liver sinusoids 
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(through terminal hepatic arterioles and terminal portal venules) such that the cells of 
the liver are never exposed to fully oxygenated blood. Blood leaves the sinusoids via 
the central venules (otherwise known as terminal hepatic venules or central veins (fig 
1.2)) and empties into the hepatic veins before the inferior vena cava (Cattley, 2002, 
Malarkey, 2005). The length from each portal tract to central venule is approximately 
250 µm in the rat (Oda, 2006). 
  
 
Figure 1.1 A portal tract from the liver of an F344 rat 
A) A portal tract consisting of a portal vein (PV) and branches (open arrows) of the 
hepatic artery and arterioles (HA), bile ducts (B) and lymphatic vessels (L). The thin 
arrow points to a smaller branch of the portal venule, possibly a terminal venule. Bar 
= 100 µm.  
B) Magnified view of a branch of vessels in the portal tract. Arrows point to smaller 
branches of hepatic arterioles. Bar = 20 µm  
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Figure 1.2 Light and electron micrographs of the central vein, portal tract, and liver 
sinusoids from an F344 rat 
A) Histological and B) scanning electron micrographs of the portal tract (PT), central 
vein (CV), and sinusoids. Blood enters and exits the sinusoids in the direction of the 
arrow. The sinusoids are noticeably more tortuous around the portal tract, and run 
more parallel as they reach the central venule. Both bars = 100 µm. 
 
 
 
 
Lymph and bile exit the liver through lymphatic vessels and bile ducts respectively 
which are part of the portal tracts, flowing in the opposite direction to the blood. 
Together with unmyelinated nerve endings (Oda, 2006), bile ducts and lymphatic 
vessels are adjoined with the portal venule and hepatic artery in a connective tissue 
matrix primarily made from type 1 collagen (MacSween, 2002, Ohtani, 2003) (fig 
1.2). 
 
The internal histological structure of the liver appears homogenous. It consists of a 
repetitive lobule, known as the “classic lobule” (Kiernan, 1833), that is roughly 
hexagonal in shape containing a central venule surrounded by repeating branches of 
portal tracts (figs 1.3 and 1.4). Within each lobule, the anatomical zones are classified 
as centrilobular (or central zone), containing the sinusoids and hepatocytes 
surrounding the central venules, periportal (or portal zone), containing the sinusoids 
and hepatocytes surrounding the portal tracts, and midzonal or midlobular, containing 
B 
CV PT CV 
A 
PT
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the sinusoids and hepatocytes between these two (fig 1.3). Lobules are easily 
identified in the pig liver as each lobule is surrounded by connective tissue, and 
vascular septa (septal branches of portal veins and hepatic arterioles) are present in 
human and pig livers (fig 1.3), however these are not present in the rat (fig 1.4) 
(Teutsch, 1999). 
 
Despite structural homogeneity, functional zones of the liver are heterogeneous within 
each lobule, across regions of each individual lobe, and between individual lobes. The 
metabolic zones or functional units of the liver, known as the acinus (first described in 
(Rappaport, 1954)), are defined according to the level of oxygenation and nutrient 
exposure of the cells (fig 1.3). Zone 1 contains the cells receiving the most 
oxygenated and nutrient rich blood lying closest to the portal venules and hepatic 
arterioles of the portal tracts and vascular septa. These cells are the first exposed to 
portal blood and are thus the first exposed to pathogens and toxins. Zones 2 and 3 
respectively contain cells that are exposed to less oxygenated and less nutrient rich 
blood as they lie further and furthest away from the arteriolar blood. Rats lack the 
vascular septa present in humans and pigs (that more clearly outline the lobular 
pattern) and instead have a polyhedral portal unit that terminates in all branches of the 
central vein (Bhunchet, 1998). As such it has been suggested that the concept of the 
liver acinus may not be directly applied to the rat (Saxena, 1999, Teutsch, 1999). One 
method proposed to visualise a primary parenchymal functional unit in the rat is by 
immunohistochemical analysis of liver enzyme activity (Teutsch, 1992, Teutsch, 
1999). Hepatocyte function (and enzyme activity) differs depending on cell location 
along the sinusoidal axis and the origin of the sinusoids (or sinusoidal blood). This 
serves to compartmentalise opposing metabolic functions. Using histochemical 
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analysis it is easy to visualise that the activity of the gluconeogenic enzyme glucose-
6-phosphatase is highest in hepatocytes around portal tracts and has a decreasing 
gradient of activity along sinusoids towards the central venules (Teutsch, 1999). 
Whereas the activities of the glycolytic enzyme glucokinase (Teutsch, 1988) and the 
ketogenic enzyme 3-hydroxybutyrate dehydrogenase (Teutsch, 1992) are distributed 
reciprocally to glucose-6-phosphatase, being lowest in hepatocytes around the portal 
tracts and having a gradient of increasing activity along the sinusoids towards the 
central venules. Results from these studies suggest that the angioarchitecture and 
arrangement of hepatocytes into functional units in the rat are very similar to that 
described in the anatomical “classic” lobule (fig 1.3) in humans (Teutsch, 1988). 
Although the most widely accepted and used models are the (classic) lobule to 
describe the liver anatomical unit, and the acinus to describe the liver functional unit, 
many other alternative models of the functional and anatomical units of the liver have 
been proposed such as the “portal lobule” defined by the central venules with a portal 
tract at the centre, and the “primary lobule” combining function and anatomy 
(MacSween, 2002, Malarkey, 2005, Matsumoto, 1979, McCuskey, 2008, Teutsch, 
1999). 
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Figure 1.3 A diagrammatic representation of the classic lobule and liver acinus 
The classic lobule is represented on the right, and the liver acinus (metabolic zones) to 
the left. Donuts at the corners of hexagons represent portal tracts and the circles at the 
centre represent central veins. The hexagons not only outline each lobule, but 
represent the path of vascular septa (adapted from (Cattley, 2002)). 
 
 
 
Figure 1.4 A histological representation of the F344 rat liver lobule  
There is a repeating pattern of a central venule (C) surrounded by portal tracts (P) 
lacking connective tissue and vascular septa. Lines were added to roughly outline 
each lobule. The section was stained with Periodic acid Schiff (bar = 200 µm). 
CENTRAL
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There is often variability in response to disease and toxicity within and across each 
liver lobe. Reasons for this are not well understood, however portal streamlining 
could influence variability (Malarkey, 2005). Blood flow to each lobe or lobule can be 
regulated by nerve stimulation or contraction of hepatic stellate cells (HSCs) 
(Reynaert, 2002), and the blood supply (branching of portal tracts) to each lobe varies. 
In addition there can be incomplete mixing of blood from the spleen and 
gastrointestinal tract, resulting in a variation of nutrients, toxins, and oxygen supply 
being delivered to each lobe. There are also differences in gene expression patterns 
across and between each liver lobe that could lead to variability in response to disease 
and toxins (Irwin, 2005). 
 
1.1.2    Liver ultrastructure  
1.1.2.1    The sinusoids and hepatocyte cords 
The hepatic sinusoids, stretching between the portal tract and central venules (fig 1.2), 
are different to true capillary beds in that the endothelium lacks a proper basement 
membrane and is full of open transcellular pores (fenestrations) of approximately 0.1 - 
0.2 µm in diameter that facilitate the unimpeded passage of blood plasma. Each 
sinusoid lumen is 7 - 15 µm in diameter, and is wider with smaller and more 
numerous fenestrations in Zone 3 than Zone 1 (Oda, 2006, Wisse, 1985).  
 
The sinusoid wall can be classified into four concentric layers (Wake, 1999) (fig 1.5). 
The innermost luminal layer comprises the resident liver macrophages, Kupffer cells 
(KCs), and resident lymphocytic cells, pit cells and dendritic cells that travel the 
sinusoid lumens. The next layer contains the liver endothelial cells (LSECs) and the 
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third the hepatic stellate cells (HSCs), with a very underdeveloped basement 
membrane between the two. The outermost layer contains a small number of 
perisinusoidal sheaths of collagen (type 1 and 3 (Geerts, 1990)) fibrils for structural 
support, and occasional nerve fibres. The area between the LSEC and hepatocyte cell 
body (containing microvilli, stellate cells and ECM) is defined as the perisinusoidal 
space of Disse (SoD) (see section 1.4) (Wisse, 1985). 
 
 
 
 
Figure 1.5 A transmission electron micrograph displaying layers of the sinusoid wall 
from an F344 rat 
The space of Disse (SoD) contains the cytoplasmic processes of a hepatic stellate cell 
(HSC) and hepatocyte microvilli. The arrow points to fenestrations in a liver 
sinusoidal endothelial cell (EC) cytoplasm, and a Kupffer cell (KC) resides in the 
sinusoid lumen (bar = 2 µm). 
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Hepatocyte cords (otherwise known as sheets or plates) run between the sinusoids, 
joined together by desmosomes and tight junctions. Bile is produced by hepatocytes 
and secreted from their apical membrane. It flows through bile canaliculi (1 - 2 µm 
wide) made from the apical membranes of adjoined hepatocytes and sealed by tight 
junctions (fig 1.6). The bile then empties into the Canals of Hering and intrahepatic 
bile ductules that reside near the outer edges of each lobule, lined partially by 
cholangiocytes (epithelial cells of the bile ducts) and partially by a limiting plate of 
hepatocytes (fig 1.7). The bile then collects into the larger bile ducts of the portal tract 
before the hepatic duct (Saxena, 2004, Saxena, 1999, Strazzabosco, 2008). 
 
 
 
Figure 1.6 A scanning electron micrograph from an F344 rat displaying the one cell 
thick hepatocyte plates that run between the sinusoids. E = endothelium, R = RBC, H 
= hepatocyte, B = bile canaliculi, K = Kupffer cell, SD = space of Disse, the white 
arrow points to a fenestration, the black arrow indicates a collagen fibril, the open 
arrows indicate tight junctions between two hepatocytes (bar = 5 µm). 
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1.1.2.2    The perisinusoidal space of Disse 
The perisinusoidal space of Disse (SoD), named after the German anatomist and 
histologist Joseph Disse (1852-1912), contains abundant hepatocyte microvilli, 
hepatic stellate cells, and extra cellular matrix (ECM), and marks the region between 
the hepatocyte cell body and LSEC. The flow of plasma and macromolecules in and 
out of the SoD via fenestrations is influenced by the passage of blood cells through 
the sinusoidal lumen and the composition of ECM. Blood cells (particularly white 
blood cells) are often larger than the diameter of the sinusoid and thus squeeze 
through the luminal space, sometimes modulating their shape to do so. This action 
promotes “forced sieving” of substances through fenestrations, and compression of 
the SoD by the movement of larger more rigid white blood cells along the lumens 
(“endothelial massage”) promoting displacement of fluid in the SoD (McCuskey, 
1979, Wisse, 1985). Movement of blood cells may also increase the uptake and 
exchange of substances by liver cells, and influence the flow and formation of lymph. 
Lymph (protein rich cell-free plasma) is believed to form in the SoD and be 
channelled through the collagen fibres (Ohtani, 2008) to the periportal tissue of Mall 
(or space of Mall), the area between the limiting plate of hepatocytes surrounding the 
portal tract and the portal tract interstitium (fig 1.7). It then drains through the portal 
interstitium to the portal lymphatic vessels before reaching the thoracic duct (Heath, 
1998, MacSween, 2002, Ohtani, 2003, Saxena, 1999).  
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Figure 1.7 A transmission electron micrograph showing the connection of the SoD to 
the portal interstitium and portal tract in an F344 rat. An arrow points to the passage 
joining the SoD to the portal interstitium (PI) and lymphatic vessels in the portal tract. 
BD = bile duct, BC = bile canaliculi, L = sinusoid lumen, LP = limiting plate of 
hepatocytes (bar = 10 µm). 
 
 
The ECM components in the SoD are primarily produced by HSCs and are very low 
density, allowing for mostly unimpeded transfer of substances through the 
fenestrations whilst providing some structural support for the parenchyma and LSECs 
(Yang, 2003). In the rat, ECM is made primarily of microfilamentous type VI 
collagen and minor amounts of other interstitial collagens (for example XIV and 
XVIII), few bundles of fibrillar collagen I and III (Benyon, 1998, Musso, 1998), and 
other macromolecules such as glycoproteins, proteoglycans, and adhesion proteins 
laminin and fibronectin (Kmiec, 2001, Reid, 1992). Alterations in the ECM modulate 
the phenotype and function of the surrounding cells including HSCs, hepatocytes, and 
LSECs (Benyon, 1998, McGuire, 1992, Reid, 1992). In fibrotic diseases of the liver 
the normal ECM is disrupted by the upregulation of enzymes such as matrix 
metalloproteinases and excess collagen (particularly fibril-forming types I and III) is 
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deposited (Musso, 1998). These changes interrupt the free passage of macromolecules 
and plasma through fenestrations and normal hepatocyte function (Neubauer, 2001, 
Yang, 2003). 
 
1.2   Ultrastructure and function of liver cells 
1.2.1    Liver sinusoidal endothelial cells 
1.2.1.1    Structure and function 
The liver sinusoidal endothelial cell (LSEC) was first distinguished as a unique cell 
type after the advent of high quality fixation and electron microscopy (Wisse, 1970, 
Wisse, 1972). As discussed in section 1.1.2.1, sinusoidal endothelial cells of the liver 
are distinct to those of other organs in that they are very thin and perforated with 
fenestrations of approximately devoid of diaphragms (Wisse, 1970) with very little 
underlying extra cellular matrix (Reid, 1992). This facilitates virtually unimpeded 
transfer of plasma and substances smaller than fenestrations between the sinusoid 
lumens and the SoD (Wisse, 1996). Maintenance and induction of this unique 
endothelial cell phenotype is regulated via paracrine secretion of vascular endothelial 
growth factor (VEGF) by neighbouring hepatocytes and HSCs, and autocrine 
production of nitric oxide by endogenous nitric oxide synthase (DeLeve, 2004). Each 
fenestration is supported by a cytoskeletal ring of actin and myosin, rendering them 
dynamic structures able to contract or dilate in response to various stimuli. Liver 
diseases, toxicity, and ageing are associated with loss of fenestrations and alterations 
of LSEC phenotype (as will be discussed further in sections 1.3 and 1.4). 
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LSECs form a continuous tubular lining of the vascular sinusoid lumens, sometimes 
extending cytoplasmic processes between hepatocytes (“tails”) and into neighbouring 
sinusoids (“intersinusoidal bridges”) (Wake, 1989). The LSEC perikaryon is found 
bulging into the sinusoid lumen or fitting snugly into a corner between hepatocytes, 
and contains the majority of cell organelles (fig 1.8). These include rough and smooth 
ER, Golgi apparatus, mitochondria, centrioles, and an abundance of lysosomes (dense 
bodies), clathrin-coated micropinocytotic vesicles, macropinocytotic vacuoles, and 
small uncoated vesicles important for scavenger functions (Blouin, 1977, Wisse, 
1972). The remaining cytoplasm is much thinner, and contains sieve plates 
(fenestrated areas devoid of organelles) interspersed between cytoplasmic arms 
containing limited organelles, membrane rafts and caveolae (Braet, 2007, Svistounov, 
2012, Wake, 1988, Wisse, 1972). 
Figure 1.8 Micrographs of the LSEC perinuclear region and intercellular junction 
from an F344 rat 
A) Arrows indicate different stages of receptor-mediated endocytosis via bristle- or 
clathrin-coated micropinocytotic vesicles. mv = macropinocytotic vacuoles, v  = 
vacuole, db = dense bodies (lysosomes), rer = rough endoplasmic reticulum, N = 
nucleus, H = hepatocyte, HSC = hepatic stellate cell, L = sinusoid lumen, SoD = 
space of Disse (bar = 500 nm).  
B) The arrow points to an intercellular junction between LSEC cytoplasmic processes. 
H = hepatocyte, L = sinusoid lumen (bar = 1 µm). 
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LSECs are professional pinocytes with specialised receptor-mediated endocytic 
scavenger functions, clearing the body of waste products such as acetylated and 
oxidised low density lipoproteins, advanced glycation end products, breakdown 
products of extra cellular matrix, and denatured plasma proteins (Parker, 2005, 
Smedsrod, 1990). Being in a prime position in the sinusoid with immediate exposure 
to sinusoidal blood, they work with KCs to form the reticuloendothelial system of the 
liver  (DeLeve, 2007b, Smedsrod, 1997, Smedsrod, 1990) and possess high lysosomal 
enzyme activity similar or higher to that of KCs in order to efficiently degrade 
endocytosed macromolecules (Knook, 1980). By clearing the blood of foreign and 
physiological waste molecules, antigens, and viral particles, LSECs are important 
contributors to innate immunity (DeLeve, 2009, Sorensen, 2012). LSECs also 
contribute to adaptive immunity and have important immunomodulatory functions 
(Warren, 2006). They process and present antigens primarily to induce immune 
tolerance towards non-harmful antigens, and express cellular adhesion molecules 
(CAMs) for leukocyte adhesion and migration (DeLeve, 2007b, Parker, 2005). In 
addition, LSECs have a secretory role, synthesising substances that effect 
neighbouring and distant cells, such as endothelin, prostanoids, nitric oxide, and 
various other cytokines that activate and recruit leukocytes (Kmiec, 2001, Smedsrod, 
1994). LSECs also secrete tissue specific growth factors, for example hepatocyte 
growth factor, that are vital for liver regeneration and hepatocyte proliferation during 
liver disease and toxicity (Kato, 2011). They also contribute to the production of ECM 
(Smedsrod, 1994) and express enzymes for xenobiotic metabolism (Steinberg, 1987). 
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1.2.1.2    The sieving function of LSECs 
Fenestrations in the LSEC cytoplasm facilitate the size-dependent exchange of 
macromolecules and the free passage of vital nutrients and plasma proteins to and 
from the SoD, often described as the “liver sieve” (Fraser, 1995). This sieving 
function regulates the filtration of chylomicron remnants from the blood into the SoD 
and plays a critical role in lipid homeostasis. Chylomicron remnants deliver fat-
soluble vitamins, dietary cholesterol, and other lipoproteins to HSCs and hepatocytes 
for processing. The diameter of fenestrations determines the size of remnants that are 
able to pass into the SoD, keeping the larger triglyceride-rich chylomicrons and 
remnants in circulation (Fraser, 1978). The “liver sieve” also enables lipoproteins 
such as very low density lipoproteins synthesised in hepatocytes (less than 90 nm in 
diameter) (Smedsrod, 1994) and retinoids released from hepatocytes and HSCs a 
passage to the blood, thereby influencing the fat and fat-soluble vitamin balance 
between the liver and other organs (Fraser, 1995, McCuskey, 2008). Reduction in size 
and/or number of fenestrations has been associated with hyperlipidemia (Cogger, 
2006) and atherosclerosis (Fraser, 1995). Alterations or increases in the ECM of the 
SoD during disease states (such as cirrhosis) or toxicity alter lipid homeostasis by 
hindering the free passage of chylomicron remnants, as well as changing the LSEC 
phenotype to a less fenestrated form (Fraser, 1995, McGuire, 1992).  
 
Fenestrations allow both drugs bound to albumin (or other serum proteins) and 
unbound drugs entry to the SoD. As unbound drug is taken up by the hepatocyte, the 
proportion of bound and unbound drug in the SoD re-equilibrates such that the 
fraction of drug cleared during one pass through the liver exceeds the unbound 
fraction, enhancing clearance and metabolism of drugs that are highly extracted 
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(DeLeve, 2009). Fenestrations also maximise oxygen delivery from the blood to 
hepatocytes. Sinusoidal blood is less oxygenated than blood from other tissues as it is 
a combination of arterial and venous blood. The thin cytoplasm of the LSEC that is 
devoid of a basal lamina and contains open fenestrations minimises the distance from 
the sinusoid to hepatocyte and maximises oxygen delivery (DeLeve, 2009). 
Defenestration and increased endothelial thickness has been associated with 
hepatocyte hypoxia (Le Couteur, 2001). 
 
1.2.1.3    Fenestration structure 
In the nineteenth century, free communication via small channels between the 
sinusoid lumens and SoD was observed using light microscopy and a technique of 
injecting dye (Fraser, 1895). However fenestrations, being smaller than the resolving 
power of a light microscope, could not be visualised before the advent of electron 
microscopy in the mid 20th century (Cogger, 2009, Fawcett, 1955). Wisse, using a 
high quality ultrastructural fixative and perfusion fixation, was first to document the 
structure and organisation of fenestrations (Wisse, 1970, Wisse, 1972). Fenestrations 
(fig 1.9) are grouped into sieve plates of 10 - 100 fenestrations that occupy about 5 - 
10 % of the cell surface (Svistounov, 2012). The size of fenestrations are 
approximately 50 - 200 nm in diameter and differ slightly in different species (Braet, 
2002). Actin microfilaments encircle each fenestration (fig 1.9 C) (Nagai, 2004), and 
a ring of F-actin supports each sieve plate, indicating the LSEC cytoskeleton 
influences the formation and modulation of fenestrations (Braet, 2007, Yokomori, 
2006). The calcium-calmodulin-actomyosin complex is crucial to the regulation of 
fenestral diameter, and Rho A (a GTPase protein that regulates the actin cytoskeleton) 
is one of the key regulators of fenestration contractility (Yokomori, 2004a, Yokomori, 
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2004b). Enzymes associated with contraction and relaxation of the cytoskeleton, 
endothelial nitric oxide synthase (Yokomori, 2001) and calcium ATPase (Yokomori, 
2004a), have been identified on the membranes of fenestrations. 
 
 
 
Figure 1.9 Electron micrographs from an F344 rat displaying transverse and 
obliquely sectioned views of fenestrations on TEM and a 3-dimensional view on SEM 
A) TEM: Transverse section of the cytoplasmic extension of an LSEC containing 
transcellular fenestrations (arrow) and obliquely cut fenestrations (star). Hepatocyte 
microvilli (MV) fill the SoD interspersed with a collagen bundle (Co) (bar = 1 µm). 
B) SEM: Three dimensional image of the LSEC cytoplasm showing a sieve plate 
interspersed between thicker regions containing organelles and “pits” or caveolae 
(black arrows). A white arrow indicates hepatocyte microvilli that are visible through 
a fenestration (bar = 0.5 µm). 
C) TEM: An obliquely sectioned LSEC cytoplasm showing actin microfilaments that 
encircle fenestrations (arrow). MV = hepatocyte microvilli (bar = 1 µm). 
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Fenestrations are not always of the simple single-layered type, but are sometimes 
organised into labyrinthine structures of unknown function found mostly in the 
perinuclear region (Braet, 2009). These structures have previously been described as 
tortuous or meandering canaliculi (Ohata, 1984) and resemble vesiculo-vacuolar 
organelles (Dvorak, 2001). “Pored domes” (Ohata, 1984) or “loops” (Braet, 2007) are 
another frequently observed fenestration-associated structure of unknown function. 
With the appearance of a fenestrated vacuole, they are usually found over the nuclear 
area of the LSEC.  
 
Gaps represent pores in the LSEC cytoplasm greater than approximately 300 nm. 
Gaps are thought to occur as a result of fusion of fenestrations, with the maximal size 
of a gap equalling that of a sieve plate (Wisse, 1985). Dumbell shaped fenestrations 
have occasionally been observed in the LSEC cytoplasm and may represent a stage in 
the fusion of fenestrations during the process of gap formation (Shin, 1997). It is not 
known whether gaps are present in normal physiological conditions as large 
chylomicrons, that would have otherwise traversed through the gaps, are not found in 
the SoD (Wisse, 1985), and gaps can form after inadequate fixation techniques and 
high-pressure perfusion of fixative (Braet, 2004, Fraser, 1980). However, gaps also 
form in LSECs as a result of cellular injury in disease states and toxicity (Ito, 2006).  
 
1.2.1.4    Fenestration formation 
The mechanism of fenestration formation and loss remains unclear, and no markers 
have been found that specifically label fenestrations. It has been postulated that 
fenestrations form from fusion between opposite sheets of plasma membrane that are 
depleted of intramembrane particles, or from coated-pits and caveolae that share a 
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similar size and position to fenestrations (Braet, 2007). Caveolae are invaginations of 
the plasma membrane abundant in several types of endothelial cells (Yokomori, 
2012). Their functions include transcytosis, cytoplasmic calcium regulation, 
potocytosis, and signal transduction, and they are a specific type of membrane raft 
(Sowa, 2001). Caveolar formation is dependent on the presence of caveolin, a 
transmembrane scaffolding protein. Caveolin is sometimes found in the membranes 
around fenestrations (Yokomori, 2003b), however it has recently been shown that 
caveolin is not necessary for the formation of fenestrations as LSECs of caveolin-
knockout mice are normally fenestrated (Warren, 2010). 
 
It is now known that the regulation of membrane rafts (found in the thicker 
cytoplasmic regions between sieve plates) is influential to the formation of 
fenestrations. Membrane rafts are highly dynamic sterol and sphingolipid enriched 
lipid-ordered domains of the cell membrane that compartmentalise cellular signalling 
molecules. Rafts range from 10 - 200 nm in width and may aggregate into micrometer 
sized structures (“platforms”) for signal transduction (Viola, 2007). They are tethered 
to the actin cytoskeleton, essential to the maintenance of their structure and integrity. 
Actin disruptors decrease the presence of membrane rafts and increase the number of 
sieve plates such that rafts and sieve plates may have an inverse relationship in the 
LSEC cytoplasm (Svistounov, 2012). Fenestrations have also been observed to form 
in non-raft lipid-disordered (fluid) regions once the stabilising effects of actin and 
rafts are depleted, and it is possible that fenestrations are created as a result of vesicles 
that spontaneously form in the cell membrane after it is destabilised (Svistounov, 
2012). Agents that increase fenestration number (table 1.1) contract F-actin, therefore 
it is also possible that fenestrations spontaneously form in response to stretching and 
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thinning of the cytoplasm between the contracted ring of F-actin (Cogger, 2010) 
analogous to the manufacture of expanded film ultrafiltration membranes (Baker, 
2004). Areas of cytoplasm containing fenestrations are about 50 nm, approximately 
half as thick as the cytoplasm surrounding the sieve plate (Cogger, 2010).  
 
It is also possible to induce acute fenestration formation (within minutes) via actin-
disrupting agents (table 1.1). Studies on acute fenestration formation have revealed a 
structure named the “fenestration forming centre” that may be involved in fenestration 
formation. It consists of thin filaments that fan out from the centre of sieve plates that 
may serve to guide newly formed fenestrations into position. A potential 
“defenestration centre” has also been proposed (Braet, 2002, Braet, 2007). 
 
1.2.1.5    Fenestration modulation 
A combination of human and animal clinical and experimental studies have shown 
that fenestration diameter and frequency can be modulated through acute and chronic 
exposure to a number of substances and conditions (table 1.1) including cytokines and 
hormones, inflammation, dietary fat load, ECM, ageing, toxicity, and disease states 
(Cogger, 2009). The exact mechanisms that govern how LSEC size is maintained in 
vivo is not fully understood. However it is known that fenestration diameter is 
regulated by the calcium-calmodulin-actinomyosin complex (the cytoskeleton ring 
shown in fig 1.9 C) around fenestrations, and thus contraction of fenestrations is 
associated with calcium influx (Braet, 2002). Intracellular calcium binds with 
calmodulin, activating myosin light chain kinase which phosphorylates the 20 kD 
subunit of myosin light chain initiating contraction of actin filaments. Calcium 
ionophores and substances that stimulate G-protein coupled receptor opening of 
 22
calcium channels (such as serotonin) induce contraction of fenestrations, whereas 
substances that chelate extracellular calcium, calcium channel blockers, and 
calmodulin antagonists suppress contraction (Gatmaitan, 1996). For example, 
prostaglandin E1 is a fenestration dilating agent as it enhances calcium ATPase pump 
activity on the membranes of fenestrations, leading to fenestration dilation (as 
cytoplasmic calcium is extruded) (Oda, 1997). On the other hand endothelin 1 is a 
fenestration contracting agent as it diminishes calcium ATPase pump activity, thereby 
increasing the concentration of intracellular calcium (Yokomori, 2003a).  
 
How LSECs regulate their number of fenestrations in vivo is also not completely 
understood. It is known that actin disruptors (cytochalasins and latrunculins for 
example) induce profound changes in microfilament organisation in the LSEC, 
including depolymerisation and destabilisation of the actin cytoskeleton, and increase 
the number of fenestrations per cell (Braet, 1996). The actin cytoskeleton is bound to 
lipid rafts in order to tether and maintain lipid raft structure (Chichili, 2009, Viola, 
2007), and recently it has been shown that disruption of both actin filaments and lipid 
rafts act via a similar or associated mechanism to increase fenestrations. 7-
Ketocholesterol, a membrane disrupting lipid raft destabilising agent (Kahn, 2011), 
and cytochalasin D, an actin disruptor, similarly increased the number of fenestrations 
when applied to LSECs in vitro (Svistounov, 2012). In addition, substances that are 
associated with increasing lipid-ordered membrane and lipid raft formation, such as 
triton X-100 (Ingelmo-Torres, 2009), reduce the number of fenestrations when 
applied to LSECs in vitro (Svistounov, 2012). 
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Alterations to fenestrations influence many in vivo processes such as chylomicron 
trafficking (Fraser, 1978, Hilmer, 2005), drug clearance (Mitchell, 2010), oxygen 
supply to hepatocytes (Le Couteur, 2001), and immune function. T-lymphocytes in 
the sinusoid lumens project cytoplasmic extensions through fenestrations (see 
Appendix 5, A3) in order to interact with major histocompatibility complex/peptide 
complexes and intercellular adhesion molecules expressed on the hepatocyte 
perisinusoidal surface (Warren, 2006). These interactions are crucial to immune 
modulation and may be important for immune tolerance and activation of naïve T-
lymphocytes. Table 1.1 lists a number of substances, environmental factors, and 
disease states that influence fenestration size and the number of fenestrations per 
LSEC. 
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Table 1.1 Modulation of fenestration diameter and number via particular substances, disease, 
and environmental factors, adapted from (Cogger, 2009) and (Braet, 2002). 
Treatment Diameter of fenestrations 
Number of fenestrations 
per cell 
Actin disruptors   
Cytochalasin B and D ↑↓ ↑ 
Dihydrohalichondramide ↓ ↑ 
Latrunculin A ↓ ↑ 
Misakinolide ↓ ↑ 
Swinholide A ↓ ↑ 
Other   
Acetylcholine ↑ ? 
Adrenaline ↓ ? 
Bethanechol ↑ ? 
Calmodulin agonist W-7 ↑ ? 
Carbon tetrachloride ↑ ↓ 
Cocaine and ethanol ? ↓ 
Collagen IV n.c. ↑ 
Diethyl nitrosamine ? ↓ 
Dimethyl nitrosamine n.c. ↓ 
DOI (2,5-dimethoxy-4-iodoamphetamine) young mice 
(Furrer, 2011) n.c. n.c. 
DOI (2,5-dimethoxy-4-iodoamphetamine) old mice 
(Furrer, 2011) ↑ ↑ 
Endothelin 1 ↓ ↓ 
ETA-R antagonist (BQ123) ↑ ? 
Ethanol acute dose ↑ ↓ 
Ethanol chronic dose ↑↓ ↓ 
Fatty liver ? ↓ 
Hypoxia ↑ ? 
Hepatectomy ↑ ↓ 
Hepatitis C ↓ ↓ 
Ionophore A23187 ↓ ? 
Irradiation ↑ ? 
Isoproterenol ↑ ? 
Jasplakinolide ↓ ↑ 
7-Ketocholesterol (Svistounov, 2012) ↑ ↑ 
Laminin n.c. ↓ 
Neuropeptide Y ↓ ? 
Noradrenaline ↓ ? 
Nicotine ↓ ? 
Pantethine ↑ ↑ 
Phalloidin ↑ ? 
Phorbol myristate acetate n.c. ↑↓ 
Pressure ↑ ? 
Prostaglandin E1 ↑ ? 
Serotonin ↓ ? 
Temperature 4 ºC ? ↓ 
Thioacetamide ↓ ↓ 
Triton X-100 (Svistounov, 2012) ↓ n.c. 
Tumour cells ↓ ↓ 
TNF-α ? ↓ 
Vasoactive intestinal peptide ↑ ? 
Vascular Endothelial Growth Factor ↑ ↑ 
Legend: ↑ = increase, ↓ = decrease, ↑↓ = conflicting reports, n.c. = no change, ? = unknown. 
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1.2.1.6    Methods for the study of fenestration modulation 
The study and measurement of fenestrations is performed using a variety of methods 
(Braet, 2007, Cogger, 2009). Isolation of LSECs from rat livers has been the 
predominant method of studying fenestration biology and modulation in response to 
numerous stimuli, with subsequent viewing on electron or confocal microscopy 
(Cogger, 2009). A controlled dose of a chemical may be directly added to an in vitro 
culture of cells, and conditions may be altered such as temperature and oxygen 
tension, much more accurately than in vivo. However, there are issues associated with 
the in vitro method that must be taken into consideration on using this method for 
analysis. LSECs only remain viable for 1 – 2 days when cultured alone on collagen 
coated-wells (Sellaro, 2007), gradually changing from a fenestrated to a defenestrated 
phenotype (DeLeve, 2004). The fenestrated LSEC phenotype is maintained in vivo by 
a combination of paracrine and autocrine factors and a specific ECM. Thus, 
maintenance of fenestrations and increased cell survival in culture requires addition of 
paracrine factors to the culture media (such as VEGF) (DeLeve, 2004, Krause, 2000), 
using ECM of a similar nature to the sinusoids as a substrate (Sellaro, 2007), and 
maintaining the culture in an environment of physiological oxygenation (Martinez, 
2008). The method of density gradient centrifugation and selective adherence has 
been thoroughly documented (Braet, 1994, Smedsrod, 1985) and produces high purity 
confluent LSEC cultures of a fenestrated phenotype, however this method is time 
consuming (DeLeve, 2009). Other simpler methods using immunomagnetic beads to 
sort LSECs from other liver cells are also currently used such as the anti-CD146 
antibody immunomagnetic sorting method as CD146 is more expressed by LSECs 
than other liver cells (Tsuchiya, 2013). However as there are no known antigens 
specific to LSECs this method may yield mixed cell populations (DeLeve, 2009). 
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Anti-CD31 antibody separation was another immunomagnetic cell sorting method 
previously used to isolate LSECs, but was shown only to isolate LSECs of the 
defenestrated or capillarised phenotype and therefore results from this method were 
not reliable (DeLeve, 2006).  
 
The formation of gaps as a result of non-specific cellular injury may occur in vitro and 
artefactually increase the average diameter of fenestrations during the analysis of 
fenestration diameter (Cogger, 2009). This occurs particularly when the mean 
diameter of fenestrations is taken before they are grouped into size-categories (for 
example from 0 – 300 nm, and greater than 300 nm). Porosity measurement may also 
be affected if gaps are not taken into consideration, as porosity is a measure of the 
perforated surface area of each cell (Wisse, 1983). Methods for fenestration diameter 
and porosity measurement are not standardised and thus subjectivity exists, however, 
thousands of fenestrations are measured in each study, increasing the confidence of 
results and providing important information on fenestration modulation. 
 
1.2.2   Hepatic stellate cells 
Hepatic stellate cells (HSCs) are also commonly known as fat-storing cells, vitamin 
A-storing cells, lipocytes, or Ito cells (as they were first described in detail by Ito and 
Nemoto in 1952) (Kmiec, 2001). They are perisinusoidal cells (residing in the SoD) 
with their nuclei commonly found wedged between hepatocytes (fig 1.10), and are 
more abundant in periportal regions of the liver (McCuskey, 2008, Senoo, 2004). 
HSCs have long, thin, and branching subendothelial processes that surround LSECs, 
and interhepatocellular (or intersinusoidal) processes that penetrate hepatocyte cell 
plates and extend processes along up to three adjacent sinusoids (Reynaert, 2002, 
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Zimmermann, 1999). These processes contain smooth muscle actin and desmin 
filaments, and can influence blood flow to sinusoids by constricting or relaxing in 
response to vasoactive substances (including contraction by endothelin-1, and 
vasopressin, and relaxation by nitric oxide) (Kawada, 1993, Reynaert, 2002). 
 
HSCs regulate retinoid homeostasis (Senoo, 2007). In their quiescent state they store 
approximately 80 % of retinoids in the body as retinyl (vitamin A) palmitate in lipid 
droplets. They are the principle synthesisers of hepatic ECM, and also secrete ECM 
degrading components such as matrix metalloproteinases, cytokines, and growth 
factors, in order to regulate the SoD microenvironment (Arthur, 1995, Reynaert, 
2002). In addition, HSCs are antigen presenting cells, eliciting T-cell responses as 
efficiently as dendritic cells (see section 1.2.4.3). Their location in the SoD gives them 
an optimal vantage point for detecting any pathogens that have crossed the 
endothelium to attack hepatocytes (Winau, 2007). 
 
In their activated state (induced to aid in the repair of injury), HSCs adopt the 
phenotype of a myofibroblast, lose their lipid vitamin A droplets, express more 
smooth muscle actin (become more contractile), and alter their synthesis and 
degradation of ECM components (Senoo, 2007, Zimmermann, 1999). Chemotactic 
and autocrine stimulation as well as altered ECM composition stimulates proliferation 
of HSCs and their migration to areas of injury (Yang, 2003). Under chronic 
inflammatory and pathological conditions HSCs can promote and intensify the 
persistence of liver injury. Their continuing proliferation, release of proinflammatory 
cytokines, and increased ECM production can eventually lead to fibrosis and cirrhosis 
of the liver (Le Bail, 1990, Reynaert, 2002, Yang, 2003).  
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Figure 1.10 Transmission electron micrograph of a hepatic stellate cell, F344 rat 
This micrograph shows the perikaryon of a HSC containing lipid droplets and 
producing fibrillar collagen (C). An arrow points to fenestrations in an LSEC 
cytoplasm. H = hepatocyte, L = sinusoid lumen (bar = 2 µm).  
 
1.2.3    Hepatocytes  
Hepatocytes comprise about 80 % of the total volume of the liver, forming the bulk of 
the parenchyma but representing only about half of the number of total cells (Kmiec, 
2001). They have a role in almost all of the primary liver functions such as 
carbohydrate, lipid, and amino acid metabolism and storage, blood glucose regulation, 
and bile, cholesterol, and plasma protein (for example albumin) synthesis. They are 
also the main site of xenobiotic metabolism and transamination reactions in the body 
(Steinberg, 1987) and have the capacity for antigen presentation and T-cell activation 
(Crispe, 2011, Warren, 2006). The first thorough ultrastructural analysis of the 
hepatocyte was by Fawcett (Fawcett, 1955). 
 
C HSC 
C 
C 
H 
L 
H 
 29
Hepatocytes are a polarised multifaceted polyhedral cell. They are mostly organised 
into plates of single cells (hepatocyte cords) supported by a fine reticular fibre 
(collagen III) framework, and surrounded by vascular sinusoids maximising their 
exposure to the blood (fig 1.6) (Cattley, 2002). The sinusoidal (basolateral) surfaces 
of the hepatocyte are abundant in microvilli that increase the area for hepatocyte 
substance uptake and exchange by six-fold and often protrude into the lumen through 
fenestrations (Wisse, 1985). The canalicular (apical) surfaces of the hepatocyte are its 
secretory poles where bile is released and are positioned between the lateral surfaces 
that face adjacent hepatocytes (figs 1.6, 1.7 and 1.12). These contain the zonula 
occludens (or tight junctions) that seal the bile canaliculi, and the adhering junctions 
(including intermediate junctions and desmosomes) that link neighbouring 
hepatocytes and express gap junctions facilitating intercellular communication and 
exchange (Kuntz, 2008).  
 
Hepatocytes contain a high density of cytoplasmic organelles (fig 1.11) including over 
1500 mitochondria that take up 20 - 30 % of the cell volume, and are abundant in 
smooth and rough ER, free ribosomes, Golgi apparatus, lysosomes, and peroxisomes 
(Blouin, 1977, Kmiec, 2001, Kuntz, 2008). They also possess great regenerative 
capacity, being able to proliferate rapidly in order to replace lost or damaged cells 
after partial hepatectomy and during disease and toxicity (Fausto, 2003). Hepatocytes 
have different functions and enzymatic expression depending on what zone of the 
acinus they reside in. Those hepatocytes closest to the portal tract (Zone 1) receive a 
blood supply richer in oxygen and nutrients than hepatocytes in Zones 2 and 3, such 
that their capacity for oxidative energy metabolism, glucose output, urea and bile 
synthesis, and antioxidant ability (with more glutathione storage and ability for 
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replenishment) is greater. Hepatocytes closest to the central vein have the highest 
capacity for glucose uptake, glutamine formation, and xenobiotic metabolism 
(Jungermann, 2000) which is a particularly important function of hepatocytes. 
Biotransformation of xenobiotics is generally classified into two phases (Gonzalez, 
2006). Phase I metabolising enzymes (known as “oxygenases”) include the large 
family of cytochrome P450 (CYP) enzymes located in the endoplasmic reticulum. 
Phase I enzymes carry out oxidative, reductive, or hydrolytic reactions to inactivate 
drugs, however are also able to activate pro-drugs such as cyclophosphamide into 
active metabolites, and activate pro-toxic substances and drugs such as carbon 
tetrachloride and acetaminophen into highly reactive radicals (Cattley, 2002, Kuntz, 
2008). Phase II metabolism (Jancova, 2010) involves conjugation by specific 
transferases (such as glucuronidation and sulfation) that inactivate and increase the 
hydrophilicity of drugs for elimination via the bile canaliculi (sometimes termed as 
the phase III pathway) or via the blood stream to the kidneys, and detoxify substances 
including those metabolites of atoxic drugs that were transformed into toxic 
metabolites during phase I reactions. An abundant supply of the antioxidant 
glutathione in hepatocytes is often necessary for phase II detoxification of toxic 
metabolites (Lauterburg, 2002). If the presence of a toxic metabolite is too great such 
as during overdose or poisoning, glutathione stores may deplete, resulting in cellular 
injury by oxidative damage and conjugation of toxic metabolites with important 
cellular proteins (Jaeschke, 2012a). Zone 3 or centrilobular hepatocytes are 
particularly vulnerable to such injury (Cattley, 2002) as they express the highest level 
of CYP450s, combined with the lowest glutathione stores and the lowest capacity to 
replenish these stores after depletion. 
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Fig 1.11: Transmission electron micrograph of a hepatocyte nucleus and cell body 
showing a typical abundance of rough ER, mitochondria, and some smooth ER. The 
arrows point to the outer membranes of two adjacent hepatocytes (bar = 2 µm). 
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1.2.4    Resident macrophages and lymphocytic cells of the liver 
Being the first organ exposed to gut and intestinal blood and the body’s first line of 
defence against pathogens, the liver contains a dense supply of specialised resident 
macrophages (Kupffer cells) and is constantly surveyed by lymphocytes (Lalor, 2002) 
and dendritic cells. 
 
1.2.4.1    Kupffer cells 
Kupffer cells (KCs) are a long lived resident macrophage population of the liver and 
are of monocyte origin (McCuskey, 1990, Naito, 2004, Smedsrod, 1994). They were 
discovered by von Kupffer in 1876, although were not distinguished as a distinct cell 
type from the LSEC until the early 1970s (Wisse, 1972). KCs form the frontline of 
host defence, being the first macrophage population exposed to freshly ingested 
pathogens and toxins from the gut. They have an important role in the phagocytosis 
and destruction of bacteria and bacterial endotoxin, viruses, fungi, and parasites. They 
also help to clear the sinusoids of cellular debris and of cells that are foreign or old 
and damaged such as effete RBCs and dead leukocytes, and are more numerous with 
greater endocytotic ability in the periportal regions where the portal blood first enters 
(Kmiec, 2001, Parker, 2005). KCs act synergistically with pit cells (see section 
1.2.4.2) in the killing of tumour cells (Wisse, 1997) and are antigen-presenting cells 
(Bouwens, 1992). They have an important role in immunomodulation through 
secretion of various cytokines (interleukins, prostanoids, TNF-alpha, nitric oxide) and 
reactive oxygen species, and as such their persistent activation and proliferation can 
contribute to the pathogenesis of liver disease and drug toxicity (Bilzer, 2006). 
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KC cytoplasms contain well developed ER and Golgi apparatus as well as many 
digestive organelles such as lysosomes (dense bodies), clear vacuoles, and fuzzy 
coated vacuoles, along with vermiform processes (worm-like bodies) and bristle 
coated micropinocytotic vesicles (fig 1.12) involved in their phagocytic and cytotoxic 
action (McCuskey, 2008). They are irregularly shaped cells with many cytoplasmic 
projections (including microvilli, pseudopodia, lamellopodia, filopodia) that increase 
upon their activation (Bilzer, 2006) and are involved in their phagocytotic functions, 
migration, and anchoring. KCs travel through the sinusoids adherent to the luminal 
membrane of LSECs, projecting their cytoplasmic processes through fenestrations for 
further anchorage and to contact HSCs and hepatocytes. They are occasionally 
observed in direct contact with hepatocytes interdigitated between LSECs 
(McCuskey, 2008).  
 
Figure 1.12 Transmission electron micrograph of a Kupffer cell from an F344 rat  
N = nucleus, mpv = micropinocytotic vesicles, vp = vermiform process, ly = 
lysosomes, v = endocytic vacuoles, f = filopodia, rer = rough endoplasmic reticulum, 
H = hepatocyte, R = RBC, C = collagen (bar = 2 µm). 
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1.2.4.2    Pit cells 
Pit cells, so named due to their characteristic dense spherical cytoplasmic granules or 
‘pits’, are large granular lymphocytes exclusive to the liver and first described in 1976 
(Wisse, 1976). They are a type of natural killer (NK) cell that are differentiated from 
precursor blood NK cells into liver specific NK cells (pit cells) on reaching the liver. 
Pit cells are found in the sinusoid lumens (fig 1.13) often in contact with KCs, 
adherent to LSECs (Nakatani, 2004), and project their long pseudopodia through 
fenestrations to contact hepatocytes (Luo, 2000). The pit cell cytoplasm is polarised 
with a kidney-shaped nucleus on one side and an array of organelles on the other. 
They are not easily morphologically distinguished from peripheral NK cells, however, 
pit cells generally contain numerous small sized granules whereas blood NK cells 
have larger and fewer granules and less rod-cored vesicles (Luo, 2000). Pit cells, 
similar to NK cells, possess cytotoxic activity and are able to kill tumour and virus-
infected cells without prior sensitisation by releasing their granules containing 
lysosomal enzymes. They are more cytotoxic than other natural killer cell lineages 
(Bouwens, 1992, Luo, 2000) and are able to induce apoptosis of target cells, release 
cytokines that influence activity of other immune cells, and participate in resistance to 
microbial pathogens. The discovery and recognition of the pit cell and its function in 
the liver helped to establish the liver’s early role in the defence against tumour and 
microbial targets, and the liver as an immunological organ (Nakatani, 2004). 
 
1.2.4.3    Dendritic cells and lymphocytes 
Dendritic cells are bone marrow-derived professional antigen presenting cells that 
travel the liver sinusoids (typically located near central veins and portal tracts), 
capturing and processing antigens before translocating to the portal interstitium and 
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lymphatic vessels (Ohtani, 2003). Eventually they accumulate in lymph nodes where 
they present the antigens to T- and B-cells in order to initiate immune response or 
tolerance (Matsuno, 2000). Dendritic cells have characteristic veils (long, thin 
membrane extensions) and sometimes bundles of microvilli on their surface, 
important for their interaction with T-cells (Fisher, 2008, Setum, 1993). Along with 
LSECs, HSCs, and KCs, and hepatocytes, dendritic cells present antigens to 
lymphocytes (fig 1.13) scattered throughout the liver sinusoids and portal tracts from 
the innate (NK and NK T-cells) and adaptive (T- and B-cells) immune systems 
(Crispe, 2009, Racanelli, 2006, Winau, 2007). 
 
 
 
 
Figure 1.13 Transmission electron micrograph of a KC, pit cell, and lymphocyte from 
an F344 rat. The lymphocyte is extending processes through fenestrations. 
P = Pit cell, K = Kupffer cell, Ly = lymphocyte, L = sinusoid lumen, S = stellate cell, 
C = collagen bundle, SD = space of Disse, E = endothelium, arrows point to 
fenestrations, H = hepatocyte, B = bile canaliculi, open arrows indicate a tight 
junction between hepatocytes (bar = 5 µm). 
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1.3    The effect of fasting on the liver 
During fasting the body adapts in order to survive long periods of starvation. The liver 
plays a crucial role in energy metabolism and is therefore significantly affected. An 
overnight fast reduces the weight of the liver by about 30 % in rats, primarily due to a 
loss of water that is bound to glycogen and protein (Rothacker, 1988). Liver weight 
loss correlates to a decrease of liver cell size rather than a loss of cells (as non-
essential cellular components are broken down to liberate nutrients) (Sokolovic, 
2008). Glycogen stores are depleted in order to liberate glucose, and falling insulin 
levels induce hepatocyte autophagy releasing a substantial amount of amino acids for 
gluconeogenesis (Ezaki, 2011). Enzymes associated with amino acid metabolism such 
as those from the urea cycle, tricarboxylic acid cycle, malate aspartate shuttle, in 
addition to genes for ammonia detoxification, aspartate transferase and proteins from 
the electron transport chain, are all upregulated throughout fasting (Sokolovic, 2008). 
 
Despite liver weight loss, liver structure and metabolic zonation are maintained during 
fasting (that is fasting does not change the lobular distribution of enzymes) 
(Sokolovic, 2008). Zonal differences in gene expression of the antagonistic enzymes 
of glucose metabolism, glucokinase (predominant in the central zone) and glucose-6-
phosphatase (predominant in the portal zone), compartmentalise storage and 
production of glucose, enabling net glucose output from the periportal hepatocytes 
and net glucose uptake from the centrilobular hepatocytes in the fed state 
(Jungermann, 1982). During fasting, the expression of glucokinase and glucose-6-
phosphatase are regulated to enable more glucose production and output than glucose 
uptake and storage (Jonges, 1992, Jungermann, 1982, Sokolovic, 2008). In addition, 
the expression of phosphoenolpyruvate carboxykinase, a key enzyme in 
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gluconeogenesis, is upregulated across the lobule in the fasted state to favour glucose 
production, remaining distributed in the same lobular pattern as during feeding (most 
strongly expressed in the periportal hepatocytes, with a decreasing gradient to the 
centrilobular hepatocytes) (Giffin, 1993).  
 
Glycogen is steadily lost during fasting (to liberate glucose). As glucose storage is a 
dominant function of centrilobular cells these are the last to be depleted of glycogen. 
Thus a centrilobular glycogen pattern persists later into the fast where periportal cells 
are glycogen deplete (Giffin, 1993). During a prolonged fast (after 1 - 2 days of 
fasting in rats) centrilobular glycogen begins to be replenished (from the 3rd to 5th 
day of fasting in rats) after its initial depletion exclusively in centrilobular hepatocytes 
(Minassian, 1994). This is probably due to an increase in the glyconeogenic substrate 
glucose-6-phosphate and the very low expression of glucose-6-phosphatase in 
centrilobular hepatocytes, although the mechanism is not fully understood (Sokolovic, 
2008). 
 
There is an increase in intrahepatic lipid during fasting in both humans (Moller, 2008) 
and murine animals (Trotter, 1967). The hormonal profile of low insulin, and high 
glucagon, glucocorticoid, and noradrenaline/adrenaline serum concentrations in 
fasting liberates fat from adipose tissue, increasing the concentration of serum free 
fatty acids (FFAs) available for uptake by hepatocytes. This accommodates the 
increased requirement for hepatic fatty acid oxidation essential for glucose and ketone 
production (Kalderon, 2000, Kersten, 1999). Some of the FFAs taken up by 
hepatocytes are re-esterified into triacylglycerol for very low density lipoprotein 
(VLDL) formation. Cholesterol trafficking genes are upregulated in the liver probably 
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due to an increased need for VLDL secretion as not many chylomicrons are being 
produced (Sokolovic, 2010). VLDL secretion contributes to the maintenance of 
normal blood cholesterol and triglyceride levels. 
 
1.3.1 Fasting and xenobiotic metabolism 
 
Fasting prior to the exposure of xenobiotics metabolised by the cytochrome P450 
pathway increases hepatotoxicity, primarily because of a reduced availability of 
glutathione (GSH) (Pessayre, 1979, Strubelt, 1981). GSH is a molecule used in 
important cellular processes such as DNA repair and gene expression, and is essential 
to detoxifying electrophilic metabolites that would otherwise irreversibly bind to 
cellular proteins, damaging the cell (Lauterburg, 2002). During fasting, GSH (made 
from cysteine, glutamate, and glycine) stores cannot be replenished from dietary 
amino acids and are reduced by about 50 % after a 24 hour fast in mice (Strubelt, 
1981). Even more GSH than usual is broken down during fasting to liberate its amino 
acid components for energy and protein synthesis (Cho, 1981, Tateishi, 1977). During 
xenobiotic metabolism via the cytochrome P450 pathway, toxic metabolites are 
produced that are inactivated via conjugation with GSH. As GSH stores are depleted 
by fasting there is less GSH available to deactivate these metabolites. Thus a fasted 
animal is more vulnerable to hepatotoxicity at a lower dosage of a drug metabolised 
by cytochrome P450s than a fed animal.  
 
Fasting is also associated with increased inflammatory cell recruitment in drug 
induced liver injury (Antoine, 2010). Inflammation is associated with free radical 
production and an increase in inflammation may exacerbate drug induced 
hepatotoxicity. 
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1.3.2 Fasting and the LSEC 
 
Most of the studies on fasting and the liver have investigated hepatocytes therefore 
little is currently understood about changes to the LSEC during fasting. A study on 
isolated LSECs from 24 hour fasted rats reported an increased amount of mannose/N-
acetylglucosamine receptors (a type of scavenger receptor also involved in the innate 
immune response) on LSECs, and a significant decrease in the activity of the 
mitochondrial enzyme succinate dehydrogenase (an enzyme of the electron transport 
chain) (Summerfield, 1982). Currently there are no ultrastructural studies on the 
effects of fasting on the LSEC. 
 
 
1.4    Drug-induced liver injury 
The liver is particularly vulnerable to drug induced liver injury (DILI) because of its 
extensive role in drug metabolism (Russmann, 2009). DILI can occur after acute or 
chronic use of xenobiotics (including synthetic drugs, alcohol, herbal medications 
(Teschke, 2011) and dietary supplements) and is a significant cause of liver failure 
and mortality. The process of DILI involves direct liver injury by a drug and/or its 
metabolites and a subsequent inflammatory reaction (Russmann, 2009). Diagnosis and 
management is often difficult as DILI can mimic any form of acute and chronic 
hepatobiliary disease (such as acute hepatitis and cholestatic liver disease), has a 
highly variable clinical presentation (Au, 2011), and on some occasions renal toxicity 
is associated (Mazer, 2008). In many cases of DILI there is currently no effective 
treatment other than stopping the drug and providing supportive care. Fulminant liver 
failure may occur as a result of severe DILI (Gotthardt, 2007) often requiring liver 
transplantation (Fontana, 2008).  
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Certain people (and animals) are more vulnerable to DILI than others because of 
genetic polymorphisms in metabolic and drug-transporter enzymes (Au, 2011, 
Heinloth, 2004) and idiosyncratic adverse drug reactions are not uncommon 
(Boelsterli, 2007, Fontana, 2008). Nutritional status and fasting (Pessayre, 1979), 
gender, age (Le Couteur, 1998), co-infections (such as HIV), alcohol and recreational 
drug consumption (Trigueiro de Araujo, 1993), environmental exposure to other 
toxins, and co-administration of drugs (Neal, 1992), all influence the toxicity of a 
drug (Au, 2011).  
 
1.4.1    Drug-induced liver injury and the hepatic microvasculature 
The liver microvasculature plays a key role in the course of DILI (during both acute 
and chronic toxicity) (DeLeve, 2007a) and the ability of the liver to repair and 
regenerate after an insult (Donahower, 2010, Furrer, 2011, Kato, 2011). Endothelial 
dysfunction is often an early event in the process of liver injury (DeLeve, 2007a, 
Iwakiri, 2012, Iwakiri, 2007). LSECs in particular are susceptible to DILI as they are 
directly exposed to portal blood, express CYP450 enzymes for drug metabolism, have 
a low storage capacity for glutathione (GSH, an antioxidant detoxifying molecule), 
and are directly exposed to toxins released from hepatocytes that become concentrated 
in the SoD (DeLeve, 2007b). In particular, damage to the LSEC (and other hepatic 
cells) occurs as toxic metabolites covalently bind and form adducts with important 
cellular proteins and mitochondria damaging their function. After an overwhelming 
amount of oxidative stress, onset of mitochondrial permeability transition (MPT) 
occurs. This stops ATP production in those mitochondria affected and leads to cellular 
necrosis, apoptosis, and more free radical production (Hinson, 2004, Jaeschke, 2002, 
Kim, 2003). With increasing oxidative stress and production of toxic metabolites, 
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cellular stress and inflammation perpetuates causing severe microvascular dysfunction 
(Au, 2011, Jaeschke, 2006, Jaeschke, 2012a, Roth, 2009).  
 
 
1.4.2    Morphology of the injured LSEC 
Some common morphological changes to LSECs during the process of DILI injury 
are (Le Bail, 1990): 
1) An increase or decrease in fenestration number and size, altering the crucial 
substance exchange process between the SoD and blood (sieving function). 
2) Gap formation in the LSEC cytoplasm facilitating hemorrhage of RBCs and direct 
exposure of blood contents to hepatocytes. 
3) Overload of dense bodies and/or lipid vacuoles in the cytoplasm, resulting in LSEC 
swelling and reduction of sinusoid lumen diameter. 
4) LSEC hyperactivity or activation, resulting in an increased number of organelles 
(such as ER, Golgi apparatus, and pinocytotic vesicles) and thickening of cell 
processes, thereby decreasing oxygen availability to hepatocytes and HSCs. 
 
These LSEC changes accompany alterations to the microenvironment of the SoD, 
such as SoD dilation, increased ECM, decreased hepatocyte microvilli, and HSC 
activation (Sanchez-Valle, 2012). In addition, LSEC injury stimulates platelets to 
aggregate and release additional mediators that further stimulate HSC activation and 
promote vascular stasis (Burt, 1993, Zarbock, 2007). After overwhelming injury, 
necrotic or dying LSECs often appear as “bubbling cells” with the cell membrane 
exhibiting focal interruptions, detachments, and projections into the sinusoid lumen, 
with hydropic swelling of the cytoplasm. Mitochondria swell, ER dilates, organelles 
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are frequently damaged and often expelled (therefore reduced in number), and most of 
the pinocytotic vesicles and glycogen disappear (Le Bail, 1990). 
 
1.4.3    Oxidative stress and the LSEC in drug-induced liver injury 
Oxidative stress is a major cause of LSEC dysfunction during DILI (Jaeschke, 2002). 
LSECs (in addition to HSCs and KCs) have a much lower capacity to store GSH than 
hepatocytes, rendering them more vulnerable to oxidative injury (Cogger, 2004, 
DeLeve, 1998, Sanchez-Valle, 2012). In DILI, oxidative stress is induced early from 
inadequate detoxification of highly reactive drug metabolites as GSH stores deplete. 
In addition, reactive oxygen and nitrogen species (such as superoxide, hydrogen 
peroxide, and hydroxyl radicals) are released during the inflammatory reaction to 
injury and as a result of mitochondrial stress (Sanchez-Valle, 2012). Peroxynitrite, a 
highly potent oxidant that damages cell DNA, mitochondria, and other important 
cellular functions, is also subsequently produced on reaction of superoxide and nitric 
oxide (NO) (Hinson, 2004). Peroxynitrite is normally detoxified by GSH however 
GSH is sparingly available as DILI progresses. 
 
In physiological conditions, cellular endogenous nitric oxide synthase (eNOS) in 
LSECs produces a small amount of NO. This is required to maintain perfusion of the 
microcirculation and appropriate vascular tone (Iwakiri, 2012), inhibit neutrophil 
adhesion and migration, inhibit platelet aggregation (Clemens, 1999), and maintain a 
fenestrated LSEC phenotype (Iwakiri, 2007). However, in conditions of oxidative 
stress, eNOS activity is lowered and superoxide reacts with NO to form peroxynitrite, 
thus increasing oxidative stress, causing LSEC dysfunction, and having prothrombotic 
effects (Iwakiri, 2012).  
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As DILI progresses, there is upregulation of inducible NOS (iNOS) in all types of 
liver sinusoidal cells and hepatocytes in response to increasing injury and 
inflammation (Clemens, 1999). In comparison to eNOS, iNOS produces large 
quantities of NO, having both a vasodilatory and inflammatory cell chemotactic effect 
(Jaeschke, 2002). Such a massive release of NO under these conditions also increases 
production of peroxynitrite as superoxide is readily produced and released by 
damaged mitochondria and inflammatory cells (including KCs and neutrophils) 
(Hinson, 2004, Knight, 2004). 
 
1.4.4    Capillarisation of the sinusoidal endothelium 
Hepatic sinusoidal capillarisation is a sign of LSEC toxicity and can arise as a result 
of chronic disease, oxidative damage, and drug toxicity (see table 1.2) (DeLeve, 2009, 
Sanchez-Valle, 2012). During capillarisation, the LSEC phenotype changes from 
fenestrated, to thickened and defenestrated, resembling the phenotype of a vascular 
capillary endothelial cell. LSEC capillarisation is generally accompanied by 
increasing subendothelial ECM (DeLeve, 2009) and formation of a continuous 
basement membrane (Le Bail, 1990). Capillarisation (and loss of the liver sieve) 
significantly affects liver function. It contributes to hepatocyte hypoxia (DeLeve, 
2009, Le Couteur, 2005), reduced drug clearance (DeLeve, 2007a, Le Couteur, 2005), 
hindered hepatocyte-blood substance exchange (causing reduced chylomicron 
remnant clearance and promotion of atherosclerosis) (Fraser, 1978, Fraser, 1995), 
vasoconstriction and portal hypertension (Iwakiri, 2007), and altered immune function 
such as decreased T-cell tolerance (Iwakiri, 2012, Warren, 2007) stimulating even 
more inflammation and oxidative stress.  
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1.4.5    Fibrosis and Cirrhosis 
Sinusoidal fibrosis is initiated as part of the liver’s tissue repair response to hepatocyte 
and LSEC injury, and is preceded by LSEC capillarisation (DeLeve, 2007a, DeLeve, 
2009). The capillarised LSEC becomes “hypoactive” (Iwakiri, 2007) and loses the 
ability to revert activated (myofibroblastic) HSCs to a quiescent phenotype (DeLeve, 
2008, Xie, 2012). HSCs subsequently produce large quantities of ECM, particularly 
fibrillar collagens type I and III (Bataller, 2009, Bedossa, 1990, Benyon, 1998, Burt, 
1993, Reeves, 2002, Sanchez-Valle, 2012). Production of NO and other vasodilators 
in hypoactive capillarised LSECs decreases, enhancing sinusoidal vasoconstriction 
(Iwakiri, 2012).  
 
Fibrosis is often associated with chronic hepatic diseases (Boyer, 2012, Burt, 1993, Le 
Bail, 1990, Sanchez-Valle, 2012) and drug toxicity (Cederbaum, 2006, Dasarathy, 
2007, Iwakiri, 2007, Trigueiro de Araujo, 1993) (see table 1.2). In cases of chronic 
liver injury, a continuous wound-healing (fibrotic) process is activated that progresses 
to hepatic cirrhosis in a large number of diseases and drug induced toxicity (see table 
1.2) (Govindarajan, 2009, Le Bail, 1990). During cirrhosis, liver function is severely 
affected as capillarisation of sinusoids, vasoconstriction, and anatomical remodelling, 
lead to a blockage of blood flow that contributes to portal hypertension and venous 
thrombosis (Iwakiri, 2012). Progressive accumulation of ECM results in areas of 
permanent fibrous scar tissue replacing those areas once filled with hepatocytes and 
sinusoids, a feature characteristic of cirrhosis (Bosch, 2007, Sanchez-Valle, 2012).  
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1.4.6    Drug induced liver injury following direct LSEC toxicity 
When DILI is initiated by a substance directly toxic to LSECs rather than hepatocytes, 
hepatic injury commonly manifests with some or all of the features of sinusoidal 
obstruction syndrome and peliosis hepatis (DeLeve, 2007a). 
 
1.4.6.1    Sinusoidal Obstruction Syndrome  
Sinusoidal obstruction syndrome (SOS) begins with LSEC injury, initiating a cascade 
of events including severe microvascular disruption, followed by hepatocyte necrosis 
and liver failure (DeLeve, 2003a). SOS is often associated with the myoablative 
conditioning regimes used prior to hematopoietic stem cell transplantation, including 
chemotherapy, radiation therapy, and immuno-suppressant drugs (for a 
comprehensive list of drugs refer to (DeLeve, 2011)). An animal model that 
accurately resembles the clinical and histological symptoms of human SOS is 
produced by treatment with monocrotaline or other pyrrolizidine alkaloids (DeLeve, 
1999). These alkaloids were first discovered to induce SOS after accidental dietary 
ingestion by humans and cattle (DeLeve, 2007a).  
 
LSEC injury first occurs after profound GSH depletion, resulting in an inability to 
neutralise the toxic metabolites of a drug or toxin. Covalent binding (adduct 
formation) of the toxic metabolites to the LSEC cytoskeleton causes F-actin to 
depolymerise, resulting in “rounding up” of LSECs and gap formation between and 
within LSEC cytoplasm. This stimulates production and increased activity of matrix 
metalloproteinase (MMP) -2 and MMP-9, both degrading the supportive ECM (thus 
loosening the tethering of LSECs to the sinusoid wall) and further inducing gap 
formation and defenestration. As the LSECs swell and the SoD enlarges (as a result of 
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loosened LSEC tethering), sinusoid lumens decrease in size, so much that the SoD 
becomes the path of least resistance for blood flow. Gaps between and within LSEC 
cytoplasms allow infiltration of RBCs into the SoD. Such hemorrhage increases the 
size of the SoD even more and consequently LSECs completely detach, together with 
the other cells of the sinusoid wall, the Kupffer and hepatic stellate cells. Aggregates 
of these cells embolise downstream, and along with monocytes that adhere to denuded 
sections of the sinusoid, obstruct sinusoidal flow. This process eventually leads to 
occlusion and fibrosis of the central vein, ischemia, and centrilobular necrosis 
(DeLeve, 2009, DeLeve, 2003a, DeLeve, 2002). In the animal model of SOS, LSEC 
injury is preventable by early administration of N-acetylcysteine (a glutathione 
precursor) and metalloproteinase inhibitors (DeLeve, 2003b). 
 
Histological, ultrastructural, and biochemical features of early SOS resemble the early 
features of acetaminophen (APAP) poisoning. However, in APAP poisoning, the 
congestion and hemorrhage resolve relatively early in the course of toxicity, and 
injury does not progress to sinusoidal fibrosis or fibrotic occlusion of central veins 
(DeLeve, 2007a, DeLeve, 2009). Reasons why the microvasculature is able to rapidly 
repair during APAP toxicity and not during SOS are unknown. It has been suggested 
that as the LSECs remain more strongly tethered to the sinusoid wall during APAP 
toxicity, the general structure of the sinusoid wall is maintained, allowing for rapid 
repair of the microvasculature (Walker, 1983).  
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1.4.6.2    Peliosis Hepatis 
Peliosis has the gross appearance of multiple cyst-like blood filled cavities measuring 
less than 1 mm to several centimetres, and may occur within any parenchymatous 
organ (DeLeve, 2007a, Tsokos, 2005). Peliosis hepatis (liver) is associated with 
toxicity from a wide variety of drugs such as immunosuppressant medications (for 
example steroids), oral contraceptives, intravenous drug use, and chronic alcoholism 
(Tsokos, 2005). Peliosis has been directly linked to drugs known to directly damage 
the LSEC (for example azathioprine, 6-thioguanine, oxaliplatin, urethane) and is often 
initiated after LSEC injury (DeLeve, 2009, DeLeve, 2011). 
 
There are different types of peliotic lesions. “Parenchymal peliosis” describes 
irregular blood-filled cavities between atrophic, degenerating cords of hepatocytes 
lined neither by cells nor fibrous tissue. “Phlebectatic peliosis” describes blood-filled 
cavities that appear spherical and lined by one or multiple layers of littoral cells (for 
example LSECs, HSCs, or KCs) and/or a fibrin network and fibrous tissue (Tsokos, 
2005, Zafrani, 1984a). Peliosis generally involves a combination of these cavity types 
(DeLeve, 2007a, DeLeve, 2009, DeLeve, 2011) and its clinical presentation varies 
according to the underlying disease process or toxicity (Zafrani, 1984b).  
 
In peliotic lesions that are initiated subsequent to direct LSEC injury (during LSEC 
infection or drug toxicity for example) the first signs of microvascular damage are 
similar to sinusoidal capillarisation - LSEC gaps and defenestration, cytoplasmic 
swelling, formation of a basement membrane, and altered ECM composition (Zafrani, 
1984a). The sinusoid lumen size decreases and RBCs enter the SoD through gaps in 
and between LSECs, such that the SoD becomes markedly dilated and eventually 
 48
denuded. Subsequently hepatocytes have no protective barrier from the blood and 
become increasingly subjected to hypoxic conditions. This leads to hepatocyte 
atrophy and degeneration, and the formation of “blood lakes” after disintegration of 
hepatocyte cords and sinusoid structure (Lee, 1983). Hepatocellular necrosis in 
conjunction with elevated intrahepatic vascular pressure results in severe congestion 
and sinusoid dilation, as well as dilation of portal veins (Tsokos, 2005). Rupture of a 
peliotic lesion can be fatal, resulting in intraperitoneal hemorrhage or hepatic 
hematoma. However peliosis may resolve with amelioration of the precipitating 
toxicity, disease, or infection (DeLeve, 2011). 
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Table 1.2 Symptoms of injury to the microvasculature during disease and toxicity 
 
Disease process Microvasculature 
symptom 
References 
Alcoholic hepatitis Capillarisation 
Fibrosis 
Cirrhosis 
(McCuskey, 2004) (Karsan, 2012) 
Autoimmune hepatitis Capillarisation 
Cirrhosis 
(Fallatah, 2012) (Warren, 2007) 
Budd-Chiari syndrome 
(hepatic vein obstruction) 
Sinusoid dilation, 
Congestion,  
Fibrosis, Cirrhosis 
(Ferral, 2012) (Tsokos, 2005) 
Chronic alcoholism Cirrhosis 
Peliosis 
(Horn, 1987) (Tsokos, 2005) (Bataller, 
2009) (Dasarathy, 2007) (Rehm, 2010) 
Chronic drug use Fibrosis (Trigueiro de Araujo, 1993) 
Chronic hypervitaminosis 
A 
Peliosis (Zafrani, 1984a) 
Drug Induced Liver Injury Capillarisation, 
Fibrosis, Cirrhosis, 
SOS, Peliosis 
(DeLeve, 2009) (Au, 2011) (Russmann, 
2009) (Wanless, 1996) 
Diabetic microangiopathy Capillarisation 
Fibrosis 
(Tooke, 1995) (Harrison, 2006) 
(Hudacko, 2009) (Latry, 1987) 
Extrahepatic cholestasis 
(bile duct obstruction) 
Capillarisation (Gulubova, 1996) 
Hepatic amyloidosis Fibrosis  (Sarsik, 2012) 
Hepatocellular carcinoma Capillarisation 
Cirrhosis 
(Duffy, 2013) (Gomaa, 2008) (Yang, 
2008) 
Hepatic hemochromatosis Fibrosis 
Cirrhosis 
(Bacon, 2011) (Bataller, 2009) 
Infection of LSEC in 
AIDS by Bartonella bacilli 
Peliosis (DeLeve, 2007a) (DeLeve, 2009) 
(Tsokos, 2005) 
Non Alcoholic Fatty Liver 
Disease (NAFLD) 
Capillarisation 
Fibrosis 
(Fontana, 2013) (Farrell, 2008) 
Steatohepatitis Fibrosis (McCuskey, 2004) 
Toxic (acute) hepatitis Capillarisation (Bardadin, 1984) (Ramachandran, 2009) 
Viral Hepatitis Fibrosis  
Cirrhosis 
(Protzer, 2012) (Schroeder, 2009) 
(Bardadin, 1984) (Bataller, 2009) 
Wilsons disease Fibrosis (Reeves, 2002) (Bataller, 2009) 
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1.5    Ageing and the liver 
Liver function is well maintained in ageing however there are some distinct structural 
and functional changes that occur. “Brown atrophy” is a distinct feature of the ageing 
liver whereby the liver reduces in size, and accumulates lipofuscin (pigmented lipid 
residues of lysosomal digestion) in hepatocytes giving it a distinct brown colour 
(Jansen, 2002, Le Couteur, 1998, Popper, 1986). Changes in hepatic microcirculation 
also accompany ageing. There is a substantial decrease in blood flow to the liver by 
about 40 % likely due to a reduction in splanchic blood flow that reduces the input of 
blood into the portal vein (Le Couteur, 1998). There is also a reduction in liver 
perfusion (the blood flow per mass of liver) due to ageing changes in the 
microvasculature (Jansen, 2002). In old people and animals, LSECs become thicker 
and HSCs accumulate more fat, narrowing the sinusoids and impairing sinusoidal 
perfusion (Ito, 2007). In addition, a chronic low grade activation of the immune 
system in ageing (Licastro, 2005) increases the number of macrophages and 
leukocytes accumulating in sinusoids (See Appendix A4), also contributing to 
impaired blood flow (Ito, 2007). Kupffer cells are morphologically unchanged by 
ageing, although are reported to have a decreased phagocytic capacity, prolonging the 
circulation of harmful substances in the blood such as endotoxin (Brouwer, 1986). 
 
Apart from increased number of cytoplasmic lysosomes and dense bodies (Popper, 
1986), hepatocytes have a similar ultrastructure in young and old age (Schmucker, 
1978). Other reported hepatocyte ageing changes such as decreased SER, increased 
nuclear polyploidy and binucleation, and changes in hepatocyte size, have not been 
consistently confirmed (Schmucker, 1998). An age-related reduction in the phase I 
(CYP450) metabolism of certain drugs by hepatocytes has been reported in murine 
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studies however this has not been confirmed in primate or human studies (Schmucker, 
2005, Woodhouse, 1990).  
 
Impairment of drug clearance and a subsequent increase of adverse drug effects in 
ageing has been widely reported (Le Couteur, 1998). It is unlikely that this is due to 
an age-related deficiency in hepatocyte drug metabolism or an impaired detoxification 
of electrophilic metabolites (Woodhouse, 1992, Woodhouse, 1984). Changes to 
hepatic drug metabolism during ageing are primarily a result of reduced blood flow, 
decreased liver size (Woodhouse, 1988, Wynne, 1990), and age-related changes of the 
hepatic microvasculature (see section 1.5.1) (Le Couteur, 2008, McLean, 2003).  
 
Alterations to the function and morphology of the LSEC during ageing with 
significant implications for age-related diseases and drug metabolism include: 
 
1) A reduction in LSEC endocytosis and scavenger function (Brouwer, 1985, Le 
Couteur, 2008, Simon-Santamaria, 2010, Smedsrod, 1990, Yannariello-Brown, 1995). 
2) A reduction in activity of some LSEC enzymes involved in the utilisation of energy 
(for example glucose-6-phosphatase, Mg-ATPase, and glucagon-stimulated adenyl 
cyclase) (De Leeuw, 1990). 
3) An accumulation of iron ferritin both in dense bodies and free in the cytosol (De 
Leeuw, 1990). 
4) Decreased expression of caveolin-1 (Jamieson, 2007). 
5) Increased expression of von Willebrand factor and ICAM-1, a sign of endothelial 
injury and inflammation (Le Couteur, 2001, McLean, 2003). 
6) Pseudocapillarisation (Le Couteur, 2001) (see section 1.5.1). 
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1.5.1    Implications of age-related pseudocapillarisation of the LSEC 
The incidence of liver disease and DILI increases with age (Junaidi, 2007, Lee, 1983, 
Schmucker, 2005). As cells are the basic components of tissues and organs, cell 
deterioration and stress have a significant impact on the ageing of an entire organism. 
It is uncertain how or why degenerative cell changes occur during ageing, however 
they may be due to a combination of genetic programming, randomly occurring errors 
during DNA/RNA replication, repeated exposure to ingested toxins, free radicals, and 
radiation (De Leeuw, 1990, Knook, 1982), increased cell sensitivity to oxidative stress 
(Schmucker, 2005), and/or an age-related overactive immune system (Licastro, 2005). 
 
Pseudocapillarisation (first described by (Le Couteur, 2001)) of the liver sinusoids 
occurs as a result of ageing. It is an incomplete form of endothelial capillarisation that 
involves thickening of the LSEC (by approximately 50 %), decrease in fenestration 
number (by 30 - 50 %), a mild increase of collagen fibrils and sporadic formation of 
basal lamina, and a high number of non-activated lipid-engorged HSCs. 
Pseudocapillarisation has been observed in a number of species including rats (Le 
Couteur, 2001), baboons (Papio hamadryas) (Cogger, 2003), mice (Furrer, 2011, Ito, 
2007, Stacchiotti, 2008, Warren, 2005) and humans (McLean, 2003). Age-related 
pseudocapillarisation is not a disease process in itself, although it has serious 
implications for the alteration of liver function, drug metabolism (Le Couteur, 1998), 
and the increased incidences of toxicity, disease, and dyslipidemia in ageing (Le 
Couteur, 2008), and may be regarded as a therapeutic target for prevention and 
treatment of age-related diseases.  
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Some of the functional implications of pseudocapillarisation in ageing include: 
decreased oxygen availability of hepatocytes (Le Couteur, 2001); impaired transfer of 
lipoproteins between the blood and SoD (Hilmer, 2005, Le Couteur, 2002, Le 
Couteur, 2005) leading to post-prandial hyperlipidemia and increasing risk of 
atherosclerosis (Cogger, 2006, Krasinski, 1990); decreased drug clearance and 
metabolism increasing the potential for adverse drug reactions and overdose (Le 
Couteur, 1998, Mitchell, 2011); vulnerability to hemostasis and inflammation (see 
Appendix 5 A4) with increased expression of von Willebrand factor and ICAM-1; 
vasoconstriction as a result of LSEC thickening; and increased vulnerability to 
autoimmune disease because of defenestration (Warren, 2006).  
 
Werner’s syndrome, a genetic disease that resembles premature ageing, is also 
associated with LSEC pseudocapillarisation, hyperlipidemia (see Appendix 5 A5, A6, 
and A7) (Murata, 1985), and significantly raised levels of serum hyaluronan  
indicative of decreased LSEC endocytotic capability (Tanabe, 2001). 
Pseudocapillarisation was ameliorated with antioxidant (vitamin C) treatment in an 
animal model of Werner’s syndrome (Massip, 2010), highlighting the significance of 
the impact of oxidative stress. Reduction of oxidative stress in ageing such as during 
caloric restriction (decreasing oxidant dietary load) and antioxidant administration 
have been found to ameliorate pseudocapillarisation and slow the ageing process in 
animal models (Jamieson, 2007), reinforcing the importance of healthy LSEC 
functioning as a therapeutic target for ageing, toxicity, and disease. 
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1.6    Scope and aims of the thesis 
The hepatic microvasculature plays a major role in the initiation, progression, and 
amelioration of multiple disease states, toxicity, and ageing, and plays a major part in 
the maintenance of homeostasis during health. Yet much of the focus has been on the 
role of the hepatocyte. This thesis endeavours to broaden the knowledge of the role of 
the liver sinusoids in health and toxicity, focusing on the LSEC, with the following 
specific aims and hypotheses: 
 
In Chapter 3 we aim to study the impact of fasting on fenestration modulation to 
determine if this biological state alters porosity and fenestration size. We hypothesise 
that fenestration size and LSEC porosity will be increased in order to adapt to the 
decreased amount of circulating macronutrients in the fasted state, enabling more 
efficient uptake of nutrients into the hepatocytes improving homeostasis. Fenestration 
diameter and porosity analysis of fed and fasted rats will be done using scanning 
electron microscopy, and blood serum analysis will be performed to measure lipids 
and markers of liver injury. 
 
Acetaminophen (APAP) is a commonly used over the counter medication to relieve 
pain and fever. High doses of APAP are hepatotoxic and accidental or deliberate 
overdose of APAP is a leading cause of drug induced liver injury. A toxic dose of 
APAP may result in severe liver injury with substantial hepatocyte death that can lead 
to fulminant liver failure. However in many cases the liver is able to regenerate 
without pharmaceutical intervention. The role of the LSEC both in APAP toxicity and 
subsequent hepatocyte regeneration after APAP toxicity is not completely understood. 
In Chapter 4 using electron microscopy we will observe whether LSECs thrive in 
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areas of severe hepatocyte necrosis during APAP toxicity in order to provide a 
scaffold and blood supply by which hepatocytes can regenerate, and investigate the 
ultrastructure of LSECs in areas of low and high hepatocyte injury to observe whether 
LSECs are injured to the same degree as hepatocytes. Histological and blood analysis 
will be performed to determine the degree of centrilobular hemorrhage and hepatocyte 
necrosis in each rat. We hypothesise that alterations to LSEC ultrastructure during 
APAP toxicity will play a role in both the progression of hepatocyte injury, and later 
in hepatocyte regeneration. We will also compare the sinusoids of rats fed and fasted 
before overdose, as fasting has been found to increase APAP toxicity. We hypothesise 
LSECs will sustain more injury in fasted rats due to decreased availability of energy 
and reduced antioxidant capacity. If increased numbers of necrotic LSECs are 
observed in fasted rats it may be linked to an increase in the severity of hepatocyte 
injury and poorer survival outcomes previously reported in APAP overdose after 
fasting. 
 
In Chapter 5 we will investigate the therapeutic potential of P407 on hepatotoxicity 
and LSEC injury during APAP overdose in fed and fasted rats. P407 is a non-toxic 
substance already used in human pharmaceutical preparations, and is known to 
defenestrate LSECs. Our hypothesis is that administration of P407 before or after 
APAP overdose will protect the livers of fed and fasted rats from APAP toxicity. It 
may do this by defenestrating the LSECs thus decreasing the amount of APAP that 
will traverse from the sinusoid lumen to the hepatocytes, and by coating and forming 
a protective layer over the LSECs, preventing gap formation and hemorrhage. 
Histology and serum analysis will be conducted primarily to observe whether P407 
treatment protected against hemorrhage and centrilobular necrosis, and an 
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ultrastructural (TEM and SEM) analysis will be conducted to observe whether P407 
protected LSECs early and late in the course of toxicity. 
 
Studies on LSEC ultrastructure are often performed in vitro rather than in vivo, as it is 
a good method of testing the direct effect of a variety of pharmacological agents on a 
particular isolated cell and without the challenge of getting a substance into an animal. 
No studies have previously been performed to assess isolated LSECs from old F344 
rats, a breed that is commonly used in the study of ageing. In Chapter 6, scanning 
electron microscopy will be used to observe the ultrastructure of LSECs isolated from 
ageing rats in order to determine whether changes to the LSEC observed in vivo also 
occur in vitro. We hypothesise that LSECs isolated from old rats will reflect changes 
observed in vivo such as reduced fenestration size and porosity. If in vivo and in vitro 
studies prove to be congruent, isolation of LSECs from old rats may be useful in 
testing substances that could potentially modulate ageing changes, such as 
pseudocapillarisation, in vivo. 
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Chapter 2: 
Methodology 
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A variety of methods were used to study morphology and ultrastructure in livers 
including histological and electron microscopic analysis as discussed below. 
2.1    Fixation 
Chemical fixation involves a reaction between the fixative and chemical groups in 
living tissue to preserve and freeze the structure of the tissue, thereby creating an in 
vivo “snapshot” for subsequent analysis on light and electron microscopes. Inter and 
intra molecular cross-linking of molecules by the fixative enables the cellular 
substructures within the tissue to survive further processing including dehydration and 
exposure to a vacuum and electron beam during electron microscopy (Hayat, 2000). 
Fixation must occur immediately after biopsy to arrest metabolic processes and 
subsequent autolysis of the cells that can occur within seconds or minutes (Wisse, 
2010). The liver in particular is very susceptible to autolysis because it contains a 
dense concentration of metabolic enzymes. Chemical fixation also prevents attack by 
bacteria during processing and storage (Hopwood, 1969). Fixation quality is affected 
by the method of applying the fixative, fixative osmolarity, pH, temperature, ionic 
strength and composition, length of fixation, and specimen size (Hayat, 1981). 
 
2.2    Light microscopy 
2.2.1    Histological fixation 
Immersion fixation using formaldehyde is a suitable method for histological analysis. 
The specimens should not be thicker than 0.5 cm, and the fixative volume at least ten 
times that of the specimen for optimal and rapid fixation. Cross-linking of proteins 
occurs slowly, thus specimens should be incubated overnight to allow proper fixation 
 59
(fig 2.1). Proteins in blood or bodily fluids will inactivate the fixative and washing in 
saline or exsanguination before fixation is essential (Bancroft, 2008). 
 
 
Figure 2.1 Examples of good and poor histological fixation 
A) H&E stained specimen, good fixation. The specimen was fixed overnight in 
formaldehyde after exsanguination. Cells are intact and sinusoids are open. CV= 
central venule.  
B) H&E stained specimen, poor fixation. The specimen was fixed in formaldehyde for 
an insufficient time. Many of the sinusoids are collapsed and the hepatocytes are not 
well preserved.   
C) PAS stained specimen from an ad libitum fed rat, good fixation. The specimen was 
fixed overnight in formaldehyde after exsanguination. Glycogen (coloured magenta) 
is evenly distributed throughout the hepatocytes.  
D) PAS stained specimen from an ad libitum fed rat, poor fixation. The specimen was 
fixed in formaldehyde for an insufficient time. There is pooling of glycogen at the 
edge of hepatocytes and leakage of glycogen from the cells. 
 
All bars = 20 µm.  
 
 
B 
D 
A 
CV 
C 
CV 
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2.2.2    Embedding of specimens 
After fixation, water must be removed from biological specimens to allow infiltration 
of an appropriate embedding media. This enables mechanical support during thin 
sectioning of the specimens for microscopy and gives protection during long-term 
storage. Ethanol is used as the dehydrating agent as it ensures complete dehydration 
of biological specimens and also enhances the fixation as it is a coagulant fixative. 
However ethanol is not miscible with paraffin wax, the usual embedding medium for 
histological sectioning. Thus after dehydration the specimens are incubated in xylene, 
a clearing agent, that removes all traces of ethanol enabling subsequent infiltration of 
paraffin wax into the specimen (Bancroft, 2008). 
 
2.2.3    Histological staining 
After specimens are embedded in paraffin and sections cut, the sections are stained for 
analysis and viewing under the microscope (see Appendix 2 for protocols). Sections 
must first be re-hydrated to allow affinity for the dyes. After staining they are again 
dehydrated and cleared with xylene so that they may be coverslipped using a 
permanent mounting media, analysed with the microscope, and stored safely for long 
periods of time. The following 3 stains were used in our experiments.  
 
2.2.3.1    Hematoxylin and eosin 
Hematoxylin and eosin (H & E) is a stain routinely used to view the general pathology 
of the specimen. Hematoxylin stains cell nuclei (chromatin) blue, and eosin stains the 
cytoplasm and connective tissues different shades of pink, orange, and red, and red 
blood cells intensely red (fig 2.1 A).  
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2.2.3.2    Periodic acid-Schiff  
The periodic acid-Schiff (PAS) stain is used to visualise glycogen, basement 
membranes, and neutral mucosubstances. Oxidation with periodic acid exposes the 
aldehyde groups in sugars that subsequently react with the chromophores in Schiff’s 
reagent, producing a bright pink colour. A basic stain such as Harris’ Hematoxylin is 
used as a counterstain to stain the cells blue (fig 2.1 C).  
 
2.2.3.3    Sirius red 
The Sirius red stain is an extremely hydrophilic dye that stains collagen, reticulin 
fibres, basement membranes, and mucins red, and is used to evaluate liver fibrosis. 
Fast Green FCF is a dye that primarily stains proteins and is useful as a counterstain 
for Sirius red. 
 
 
2.2.4    Viewing on the compound light microscope 
After staining and coverslipping, sections are viewed on a compound light microscope 
using bright field illumination. Light is focused through a condenser lens and passed 
through the specimen. The light is then collected by an objective lens and eyepieces 
that magnify and focus the specimen image. Contrast comes from the absorption of 
light by the specimen. The image can also be captured by a light-sensitive camera. 
Maximum resolving power of a compound microscope is 0.2 µm.  
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2.3    Electron microscopy 
2.3.1    The electron microscope 
Electron microscopes were developed due to the limitations in resolving power on the 
light microscope. The transmission electron microscope (developed in the 1930s) has 
a resolving power of 0.2 nm or less, and can thus reveal the ultrastructure of 
individual cells (Bancroft, 2008). A focused electron beam is fired upon an ultrathin 
section of a prepared specimen under a vacuum. An image is formed as some 
electrons are reflected off the tissue (or scattered), and other electrons pass through 
the specimen where there is no tissue. The scanning electron microscope (developed 
in the mid 20th century) has a resolving power of 2.5 nm and provides a three 
dimensional surface image of a specimen such as a cell or block of hepatic tissue. A 
focused electron beam is scanned across the surface of a prepared specimen under a 
vacuum. Morphological detail is collected as the electrons hit the specimen surface 
causing secondary electrons to be released from the specimen (inelastic collisions) 
and collected by a detector. An image of the specimen is created according to the 
secondary electrons’ energy, number, and angle of their path. The image is then sent 
to a television screen for viewing (Slayter, 1992). 
 
2.3.2    Ultrastructural fixatives and buffers 
Glutaraldehyde is the most effective aldehyde fixative for preserving ultrastructure, 
stabilising microtubules and microfilaments better than any other fixative. It has an 
aldehyde group on both ends of the molecule facilitating more extensive, rapid, and 
irreversible cross-linking of proteins. Glutaraldehyde and its oligomers are larger than 
formaldehyde and penetrate the tissue much slower (Bancroft, 2008). Thus, a fixative 
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including a mixture of glutaraldehyde and formaldehyde is optimal for ultrastructural 
fixation. Formaldehyde penetrates quickly, initiating structural stabilisation before 
thorough and rapid cross-linking of proteins by glutaraldehyde. Osmolarity of the 
fixative is crucial to maintaining appropriate osmotic pressure during fixation, 
preventing extraction of cellular materials and swelling or shrinking of cells. 
Osmolarity can be altered by addition of electrolytes (such as calcium) to the fixative 
buffer that have additional membrane stabilising properties, and non-electrolytes 
(such as sucrose) that act as osmotic stabilisers due to their slow rate of penetration 
through cell membranes. Sodium cacodylate buffer is commonly used for electron 
microscopy because it does not precipitate calcium ions and resists bacterial 
contamination during storage. The pH of the fixative must remain close to that of the 
tissue (ideally between pH 7.2 - 7.4) to avoid alterations to the structure and 
behaviour of tissue proteins that are responsible for cell shape. 
 
2.3.3    Methods of primary ultrastructural fixation 
The two main methods of ultrastructural fixation are perfusion and immersion 
fixation. Perfusion fixation is primarily used in animal experiments and fixative is 
perfused through the blood vessels. It is the most superior method of chemical 
fixation (Dariush Fahimi, 1967, Wisse, 2010) particularly for the liver. The portal 
vein is cannulated and fixative is perfused through the sinusoids enabling fast and 
direct contact of the fixative with the cells, and good consistency of fixation quality. 
Brief exsanguination (via perfusion with heparinised saline for example) before the 
fixative prevents thrombosis and improves the subsequent perfusion of the fixative 
(Dariush Fahimi, 1967). It is also important that the perfusion pressure be kept low (at 
about 5 - 10 ml per 100 g animal per minute), and the IVC cut at the diaphragm 
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immediately before perfusion, as damage to the hepatocytes, sinusoids and LSEC 
fenestrations occurs if the pressure is too high (Fraser, 1980, Wisse, 1970) (fig 2.2).  
 
 
Figure 2.2 Histological and electron micrographic representation of high perfusion 
pressure artefact in hepatocytes and liver sinusoids 
A) H & E stained histological section after high perfusion pressure. Hepatocytes 
contain vacuoles (arrow). Bar = 20 µm.  
B) Scanning electron micrograph after high perfusion pressure. The LSEC 
fenestrations are disrupted and large gaps appear in the cytoplasm (arrow). The 
hepatocytes are vacuolated and damaged (white arrow). Bar = 2 µm. 
 
 
 
Incubation in a fixative volume of at least ten times that of the tissue blocks overnight 
after the initial perfusion ensures adequate penetration of the fixative and increases 
the cross-linking of proteins as fixation proceeds slowly (fig 2.3 A). This is carried 
out at 4 ºC to decrease extraction of cellular constituents and minimise post-mortem 
change (Bancroft, 2008). Specimens can be left in fixative for more extended periods 
of time. After incubation in fixative for 7 days at 4 ºC the tissue appeared well fixed 
and had not deteriorated when assessed with SEM analysis (fig 2.3 B). 
 
Needle fixation is a variant of this process that involves injection of the fixative 
directly into biopsied tissue. The aim is for fixative to be flushed through the blood 
vessels in order to exsanguinate them and directly and quickly expose the cells inside 
A B 
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the tissue block to fixative. In needle fixation of the liver, care must be taken to keep 
the injecting pressure low to avoid destroying the sinusoids (Wisse, 2010). Although 
this method is not as fast or consistent as perfusion fixation, it is a far superior 
alternative to immersion fixation and can be used on human biopsies. 
 
In the process of immersion fixation, blocks of tissue are removed during surgery, 
minced into small blocks whilst in fixative, and incubated in fresh fixative for 1 - 4 
hours at room temperature, or overnight at 4 ºC. This method is the least ideal for 
ultrastructural analysis because of the slow penetration of fixative through the tissue 
resulting in autolytic changes at the centre of the blocks and poor consistency of 
fixation (Dariush Fahimi, 1967, Hayat, 2000, Wisse, 1970) (fig 2.3 E and F). There is 
also the potential for mechanical damage during the mincing process as the tissue (and 
particularly the centre of the tissue because of the slow penetration of fixative) has 
often not yet hardened sufficiently from its brief exposure to fixative (fig 2.3 D).  
 
Different levels of fixation quality can be visually recognised early in the fixation 
process and inadequately fixed tissue may be discarded before processing. Whilst 
immersed in the primary fixative, well-fixed tissue appears a yellow-brown colour 
and is transparent and firm, whereas poorly fixed areas appear pale-brown or red-
brown and soft. On washing of the tissue blocks after fixation in sodium cacodylate 
buffer then distilled water, unfixed areas change from brown to white, whereas the 
well-fixed areas remain hard and yellow brown (Dariush Fahimi, 1967). 
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Figure 2.3 Examples of good and poor ultrastructural fixation of liver sinusoids from 
F344 rats for SEM 
A) Good fixation with a combined glutaraldehyde-formaldehyde fixative. Perfusion 
fixation followed by incubation in fixative overnight. Fenestrations, and hepatocyte 
microvilli are well defined (bar = 1 µm). 
B) Good fixation with a combined glutaraldehyde-formaldehyde fixative. Perfusion 
fixation followed by incubation for 7 days in fixative (bar = 1 µm). 
C) A poorly fixed sinusoid, LSEC cytoplasm is defenestrated with gaps (bar = 1 µm). 
D) Mechanical damage to the hepatocytes during mincing before the tissue has 
sufficiently hardened. CV = central venule (bar = 50 µm). 
E) and F) This specimen was immersion fixed in 2.5 % glutaraldehyde without 
formaldehyde overnight at 4 ºC. Fixation quality is very poor. CV = central vein in 
(E) and an arrow points to an LSEC in (F). In (E) the scale bar = 100 µm, and in (F) 
the magnification is higher, bar = 10 µm. 
 
A 
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2.3.4    Secondary fixation and contrast enhancing of specimens 
Secondary-fixatives are applied to specimens after the primary (aldehyde) fixation 
step. Specimens are immersed in secondary fixatives to strengthen and enhance the 
initial fixation, and increase contrast of the specimen for viewing on the electron 
microscope. These are discussed below. 
 
2.3.4.1    Osmium 
Osmium tetroxide is routinely used as a secondary fixative (Griffith, 1974, Hayat, 
2000). It fixes and cross-links unsaturated lipids by reacting with their double bonds, 
and incorporates into cell membranes by binding with phospholipids. Osmium is a 
heavy metal oxide that has a high electron density. Thus incorporation of osmium into 
the specimen increases the scattering of the electron beam and greatly improves 
specimen contrast (fig 2.4). Osmium only penetrates tissue to about 1 mm deep and so 
specimen blocks should ideally be 1 - 2 mm3 (Bancroft, 2008). The primary aldehyde 
fixative must be thoroughly washed out of the specimen before incubation in osmium 
to avoid precipitation of osmium (“peppering”) throughout the specimen caused by its 
cross-reaction with free aldehyde groups. 
 
2.3.4.2    Tannic acid 
Tannic acid is a contrast-enhancer and supplemental fixative that may be applied to 
the specimens after primary fixation. It has mordant properties and forms complexes 
with heavy metals such as osmium, lead, and uranium, increasing their uptake into the 
tissue and improving contrast of fine cellular structures (fig 2.4 D). Tannic acid is a 
large molecule with many active groups and can interact with a diverse array of 
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cellular components and increase their electron density even without the aid of 
osmium (Hayat, 1993). It is more routinely used in specimen preparation for SEM 
than TEM. 
 
2.3.4.3    Uranyl 
Uranyl acetate is the acetate salt of uranium (an electron dense heavy metal), and is 
commonly used as an en bloc stain (of the whole specimen rather than a section) after 
osmication in TEM specimen preparation to improve the contrast of membranes (fig 
2.4 B and C). It also has some fixation properties (Hayat, 2000). Uranyl can bind with 
tannic acid and further increase the electron density and contrast of a specimen 
(Dykstra, 1992) (fig 2.4 D). It is also a mordant for lead staining that is performed 
after sectioning, resulting in a much more intense stain. The use of en bloc uranyl 
acetate staining in liver specimens is often omitted as it causes leaking of hepatocyte 
glycogen.  
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Figure 2.4 Micrographs displaying the effect of uranyl acetate and tannic acid en 
bloc staining on TEM specimen contrast. All specimens (from F344 rats) were 
perfusion fixed with formaldehyde-glutaraldehyde, secondary fixed with osmium, and 
stained after sectioning with uranyl acetate and lead citrate. L = sinusoid lumen. 
A) Hepatocyte and sinusoid from an ad libitum fed F344 rat without en bloc uranyl or 
tannic acid treatment (bar = 2 µm). 
B) Micrograph from an ad libitum fed rat and C) from a fasted rat (with low glycogen 
stores) en bloc stained with uranyl acetate (bar = 2 µm). There is increased membrane 
staining and contrast in (B) and (C) compared to (A). Patches of glycogen are marked 
with white arrows and mitochondria and ER are marked with black arrows. Areas of 
glycogen are less dense in (B) than (A), as some glycogen has leaked out of the 
hepatocytes (marked H) during the uranyl en bloc incubation (bar = 2 µm).  
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D) and E) show micrographs of the perikaryon of LSECs. In (D) the specimen was 
incubated with tannic acid before osmication and en bloc stained with uranyl acetate. 
The cell and organelle membranes show much stronger contrast than in micrograph 
(E) where there was no tannic acid or uranyl en bloc treatment (bar = 1 µm). 
 
 
2.3.5    Dehydration, embedding, sectioning, and staining for TEM analysis 
Dehydration of specimens after secondary fixation with a series of ethanols and 
acetone is performed to remove water so that specimens can be infiltrated with 
embedding media (resin). Resins provide stability for the specimen during sectioning 
and under the electron beam. Prior to ultrathin sectioning, semithin sections are cut at 
0.5 µm and stained with toluidine blue. Subsequent viewing of toluidine blue stained 
sections under the light microscope provides information about the quality of fixation 
and location of the block within the liver (fig 2.5).  
 
 
Figure 2.5 Toluidine blue stained 0.5 µm thick sections showing that the specimen 
has good fixation and that the region is a periportal zone (arrows point to portal 
tracts). Lipid vacuoles are clearly seen in the hepatocytes, as are LSEC (black 
arrows) and HSC (white arrows) nuclei, and KCs/leukocytes in the sinusoids. PV = 
portal venule. (A) Bar = 100 µm, (B) Bar = 20 µm. 
 
Ultrathin sections are then cut at 80 nm with a diamond knife, mounted on grids and 
stained first with uranyl (acetate) then lead (citrate) before viewing on the TEM. As 
described in section 2.3.4.3, uranyl adds electron density to the specimens by binding 
A B 
PV 
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with proteins, phospholipids and nucleic acids, and is a mordant for lead staining. 
Lead enhances the stains effected by other metals such as osmium and uranyl 
primarily by binding to them, and this scatters electrons very effectively (Dykstra, 
1992, Hayat, 1993). Uranyl acetate solutions are saturated and care must be taken not 
to draw solution from the bottom of the bottle where precipitate is found otherwise 
angular uranyl acetate crystals will be found on the specimens. Artefactual lead stain 
(globular) deposits can also form as lead will precipitate to highly insoluble lead 
carbonate crystals on reaction with carbon dioxide and oxygen in the air. These can 
present as very fine or large globular deposits (fig 2.7 A). 
 
2.3.6    Reprocessing paraffin embedded tissue for TEM analysis 
Tissue fixed in formaldehyde and embedded in paraffin can be reprocessed for 
transmission electron microscopy when extra specimens are required for 
ultrastructural analysis (Lighezan, 2009). Mincing of glutaraldehyde-formaldehyde 
perfusion fixed tissue into 1 mm3 blocks and preparing them for EM immediately 
after surgery is a somewhat random and blinded process, and as such, critical areas for 
analysis may not be sampled. It is much easier to select samples for EM analysis from 
a specific region of a paraffin block after histological sections have been viewed on a 
light microscope, however the quality of fixation is comparatively poor (Wang, 1987). 
Formaldehyde (as discussed earlier) is less effective for preserving ultrastructural 
components of cells. Poorly preserved structures commonly include the loose 
components of the cells such as lipid, glucose, and ribosomes (Nasr, 2007). In 
addition, the reprocessing includes an extra dehydration step before the initial paraffin 
embedding thus there is increased tissue dehydration, resulting in greater extraction of 
lipids, proteins and subsequent shrinkage of cells and subcellular components (fig 2.6 
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B). However, reprocessed formaldehyde-fixed specimens can still provide important 
diagnostic information. 
 
Figure 2.6 Examples of transmission electron micrographs from F344 rat specimens 
prepared after perfusion fixation and after reprocessing from a formaldehyde-fixed 
paraffin block 
A) A sinusoid and hepatocyte from a formaldehyde-glutaraldehyde fixed specimen. 
EC = LSEC, H = hepatocyte, SoD = space of Disse, L = sinusoid lumen (bar = 1 µm). 
B) A sinusoid and hepatocyte from a reprocessed formaldehyde-fixed specimen. H = 
hepatocyte, V = a vacuole in the hepatocyte cytoplasm, EC = LSEC, SoD = space of 
Disse, L = sinusoid lumen (bar = 2 µm).  
The clarity and definition of the LSEC cytoplasm and fenestrations are much higher in 
(A) than (B) (arrows), although it is still possible to see fenestrations in (B). Some 
lipid and cell components have been extracted from the hepatocytes in (B), and the 
LSEC cytoplasm is much thinner probably also due to cell component extraction. 
Both specimens were en bloc stained with uranyl acetate. 
 
 
2.3.7    Dehydration and specimen preparation for the SEM 
After secondary fixation, specimens must be dehydrated and dried to remove all water 
from the sections as the SEM specimen chamber is at high vacuum. Dehydration is 
carried out in a gradient series of ethanols to absolute ethanol. Hexamethyldisilazane, 
a drying agent, is then added to the specimens, removed and evaporated, before the 
specimens are mounted onto aluminium stubs with double sided conductive tape 
(Dykstra, 1992). Next the specimens are coated in metal. Biological materials are 
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good insulators and if the net specimen current is not grounded the specimen will 
build up negative charge, repel the electron beam, and result in image distortion. 
Coating with a conductive material helps to alleviate this problem. Sputter coaters are 
used to produce a cloud of metal atoms (usually gold or platinum) to finely and evenly 
coat specimens. Colloidal carbon paint is also applied to reduce charge by being 
painted down one side of the specimen to the tape (Dykstra, 1992). Specimens are 
then ready to be placed in the specimen chamber of the SEM and viewed. 
 
2.3.8    Indicators of poor ultrastructural fixation on electron micrographs  
Two of the most sensitive indicators of poor fixation quality include swollen 
mitochondria and endoplasmic reticulum (Bancroft, 2008) (fig 2.7 B). The absence of 
fenestrations in LSECs or the appearance of large gaps can also indicate poor fixation 
(fig 2.3 C) or inadequate perfusion pressure (fig 2.2 B) (Wisse, 2010). Collapsing of 
sinusoids and accumulation of RBCs within them are commonly signs of poor 
perfusion of the fixative (fig 2.7).  
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Figure 2.7 Examples of poor fixations of F344 livers and specimen artefacts on TEM 
A) Poor perfusion of sinusoids has resulted in poor LSEC fixation and collapsed 
lumens (arrows). There is an artefactual lead stain deposit on the specimen (white 
arrow). The long parallel stripes through the section are knife marks, a result of nicks 
and debris on the diamond knife edge scarring the section (bar = 10 µm). 
B) Closer view of a poorly perfused poorly fixed sinusoid. The hepatocyte appears 
swollen and the LSEC is not clearly defined (arrows). This section also displays 
chatter artefact, parallel lines through the section caused by vibration during 
sectioning. Chatter occurs perpendicularly to knife marks. L = lumen (bar = 1 µm). 
 
 
Some experience is required to distinguish between artefact and real structures in a 
diseased specimen. If the fixation process is carried out carefully and thoroughly and 
poorly fixed areas of tissue are discarded, the presence of artefacts will be minimal, 
and an accurate diagnosis of the tissue is possible. 
 
2.4    Experimental materials and protocols 
2.4.1    Animals 
Male Fischer F344 rats were obtained from the Animal Resources Centre (ARC), 
Perth, Western Australia. Rats were housed in cages of 2 or 3 at 25 ˚C, fed with 
standard rat chow and allowed access to water at all times. Ethical approval for 
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experiments was given by the Sydney South Western Area Health Service Animal 
Welfare Committee. 
 
2.4.2    Blood analysis 
The rats were weighed then deeply anaesthetised by an intraperitoneal injection of 2 
ml/kg ketamine (60 mg/ml) and xylazil (6 mg/ml), a laparotomy was performed and 
the intestines pushed aside to reveal the portal vein. Approximately 3 ml blood was 
taken from the inferior vena cava (IVC) and transferred into an EDTA tube. Blood 
was spun at 1500 rpm for 10 min at 25 ˚C. Using a ruler, the packed RBC layer and 
the total volume including plasma was measured in centimetres. The hematocrit was 
then calculated by dividing packed RBC layer height by the total volume height then 
multiplying by 100. The plasma was removed and stored at -20 ˚C before analysis (of 
blood biochemistry and liver function tests) by the Biochemistry Department, 
Diagnostic Pathology Unit, Concord RG Hospital, using the automated Roche 
Diagnostics Modular Analytics Serum Work Area (F. Hoffman-La Roche Ltd). 
Lipoclear (Lomb Scientific, product number: LC40), a non-ionic solution used to 
remove lipoproteins, was added to grossly lipemic samples to yield clear samples 
suitable for analysis. 
 
2.4.3    Perfusion fixation protocol 
Following from the procedure described in section 2.4.2, the portal vein was 
cannulated using an 18 gauge intravenous cannula. Care was taken to prevent air 
bubbles from entering the portal vein during perfusion. The liver was exsanguinated 
with approximately 5 - 10 ml heparinised phosphate buffered saline (PBS; 1 PBS 
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tablet dissolved in 100 ml dH2O, heparin 1000 I.U. per ml, pH 7.4). The perfusion 
flow was set at 5 - 10 ml per minute using a gravity-mediated system. Perfusion of 
PBS was only continued until the liver became a tan colour indicating the removal of 
blood from the sinusoids. Both the abdominal and thoracic IVC were cut immediately 
at the commencement of perfusion to reduce any pressure build up in the sinusoids 
and to allow perfusate to freely flow out. Fixative was then perfused through the liver 
until the tissue became hard (approximately 20 ml) indicating adequate fixation. The 
liver was removed and prepared for both histology and electron microscopy analysis 
as described below. 
 
2.4.4    Histological specimen preparation 
The fixative used for histology was 4 % formaldehyde (freshly prepared from 
paraformaldehyde) in PBS with 1 % sucrose, pH 7.4. Fixative pH was adjusted with 
concentrated sodium hydroxide and hydrochloric acid. Liver lobes were sectioned into 
pieces with a scalpel, placed in fixative (4 % formaldehyde, 1 % sucrose in PBS, pH 
7.4), and left overnight in the fridge (at 4 ˚C). The fixative was then removed and the 
pieces washed in buffer (PBS with 1 % sucrose, pH 7.4) three times. Liver pieces 
were placed in cassettes and using a Leica® Microsystems (North Ryde, Australia) 
TP 1020 automatic tissue processor, dehydrated through a graded series of ethanol 
before clearing with xylene and infiltration by paraffin wax (see Appendix 1B). Liver 
pieces were placed into moulds and set in paraffin wax on a cold plate, ready for 
sectioning. Sections were cut on a microtome at 4 µm, and firmly stuck on Superfrost 
Plus® glass slides by heating in the oven at 60 ˚C for 10 min before rehydration and 
staining with hematoxylin and eosin, PAS, or Sirius red (see Appendix 2 for 
protocols). After staining, sections were dehydrated with ethanol and cleared with 
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xylene, coverslipped with mountant and coverglass, and observed on a compound 
light microscope. Micrographs were taken using a Zeiss AxioCam MRc camera.  
 
2.4.5    Electron microscopy specimen preparation 
The fixative used for electron microscopy was 2.5 % glutaraldehyde (EM grade) /2 % 
formaldehyde (prepared fresh from paraformaldehyde) in sodium cacodylate buffer 
(0.1 M sodium cacodylate, 10 mM CaCl2, 1 % sucrose, pH 7.4, 440 mOsmol). 
Fixative pH was adjusted with concentrated sodium hydroxide and hydrochloric acid. 
Immediately after perfusion fixation and removal of liver, sections of liver were 
immersed in EM fixative and cut into small blocks of approximately 1 mm3. The 
blocks were placed in tubes containing EM fixative, designated for scanning or 
transmission electron microscopy, left overnight in the fridge (4 ˚C), then processed 
as described below.  
 
2.4.5.1    Scanning electron microscopy 
Approximately 10 blocks per liver were washed 3 times (1st wash 10 min, 2nd wash 
overnight, 3rd wash 10 min) in 0.1 M sodium cacodylate buffer to remove any trace of 
fixative before incubation in 1 % tannic acid (in 0.15 M sodium cacodylate buffer 
with 1 % sucrose) for 1 hour. Blocks were then washed 3  in sodium cacodylate 
buffer before secondary fixation in 1 % osmium in 0.1 M sodium cacodylate buffer 
pH 7.4 with 1 % sucrose for 1 hour. After osmication, specimens were washed 3  10 
min each in sodium cacodylate buffer then dehydrated in a series of ethanols: 3  50 
% (5 min each wash), 4  70 % (5 min each), 3  90 % (10 min each), 3  95 % (10 
min each), 4  100 % (10 min each) ethanol. Specimens were immersed in 
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hexamethyldisilazane for 10 min. After the hexamethyldisilazane was removed the 
specimens were left in the fume hood for 10 min so that any remaining 
hexamethyldisilazane could evaporate, and placed in a dessicator overnight. Specimen 
blocks were mounted onto stubs using double sided carbon tape and carbon paint, and 
gold coated in a sputter coater under argon (45 secs at 40 mV). They were viewed and 
micrographs taken using a JEOL JSM-6380 scanning electron microscope. Pictures 
were taken at an acceleration voltage of 15 kV and specimens stored in a dessicator.  
 
 
2.4.5.2    Transmission electron microscopy 
Approximately 5 blocks per liver were processed in a Lynx™ Electron Microscopy 
Tissue Processor where they were washed in 0.1 M sodium cacodylate buffer, 
secondary fixed in 2 % osmium, again rinsed in buffer, and dehydrated in a series of 
ethanols and acetone before being infiltrated with Spurr’s resin (see Appendix 1A for 
full protocol). Blocks were placed at the bottom of BEEM® capsules (moulds) that 
were filled with Spurr’s resin. They were left to set overnight in an oven at 75 ˚C. 
Semithin sections were then cut on an ultratome with a glass knife at 0.5 µm and 
stained with toluidine blue (see Appendix 3A) to observe the orientation of sections 
on a light microscope and to ensure good fixation. Once this was achieved, ultrathin 
80 nm sections were taken using a diamond knife and stuck on formvar-coated nickel 
slot grids (ProSciTech-Australia) to be viewed on the Philips CM10 transmission 
electron microscope fitted with a Megaview III camera and Analysis® software 
(Olympus).  
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2.4.5.3    Reprocessing paraffin-embedded specimens for TEM analysis 
There are different methods of reprocessing as described (Hayat, 2000, Lighezan, 
2009). All are based on a generalised protocol of deparaffinisation, rehydration, 
osmication, dehydration, and embedding of the specimen in resin. The method we 
applied is as follows. A 4 µm histological section was cut from a paraffin-embedded 
formaldehyde-fixed specimen and stained with Hematoxylin and Eosin. After viewing 
on the light microscope, the areas of interest that contained examples of a particular 
pathological process were selected from the section, and referred to the face of the 
tissue in the paraffin block that contained the adjacent layer of tissue to the section. 
Four 1 - 2 mm3 blocks were cut from these selected areas of the paraffin block using a 
scalpel blade. Blocks were deparaffinised by incubation in xylene (occasionally 
agitating) for 2 hours and rehydrated by being immersed for 15 min each in a solution 
of 50:50 xylene/100 % ethanol, then a series of ethanols (100 %, 95 %, 90 %, 70 %, 
50 %), and washed in distilled water then sodium cacodylate buffer for 15 min each. 
The blocks were subsequently processed for transmission electron microscopy exactly 
as described in section 2.4.5.2 including osmication, dehydration, and embedding of 
the specimen in resin. In addition, after osmication the specimens were en bloc stained 
with uranyl acetate (see Appendix 1A for protocol) in order to increase the contrast 
and improve specimen preservation (Bancroft, 2008). Specimens were viewed and 
pictures taken as described in section 2.4.5.2. 
 
2.4.5.4   SEM analysis of fenestration and gap diameter using Image J 
Micrographs of LSEC cytoplasm from each rat were opened using Image J software. 
The scale bar from each micrograph was used to calibrate the measurements. A line 
was drawn through each fenestration and gap in the LSEC cytoplasm by selecting the 
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longest straight line from one side of the fenestration to the other (fig 2.8). This was 
defined as the diameter. Selecting the longest line increases the measurement 
accuracy as fenestrations are sometimes on an angle and appear oval, and keeps the 
measuring process consistent.  
 
 
 
Figure 2.8 An example of an Image J analysis of the LSEC cytoplasm. A line was 
drawn through each fenestration (black arrow) to calculate fenestration diameter. Pits 
on the LSEC cytoplasmic arms (bold black arrow) that look similar to fenestrations 
were not measured. A line was drawn around the LSEC cytoplasm (indicated by the 
bold white arrows) to calculate the area of the cell surface for porosity and 
fenestration frequency measurements. 
 
 
The length of the diameter of each fenestration was calculated using Image J (fig 2.8). 
The average fenestration diameter was recorded from the total number of fenestrations 
from each animal. SigmaPlot 11.0 was used for statistical analysis. Standard deviation 
of averages from each rat was calculated. A Student’s t-test was also performed to 
calculate any significant difference (defined by a p value of < 0.05) between groups. 
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2.4.5.5    SEM analysis of porosity and fenestration frequency  
Porosity is a measurement of how porous the cell surface is and is calculated with the 
formula: 
Porosity (%) = (sum of fenestration areas/sum of cell surface areas) × 100, where 
fenestration area = (π(fenestration diameter/2))2. 
 
Fenestration frequency is a measure of how many fenestrations there are per area of 
cell and is calculated by the formula: 
Fenestration frequency = total number of fenestrations/total cell surface area. 
 
Total cell surface area was defined as the total area of LSEC cytoplasm in the 
micrograph excluding any areas covered in debris on the LSEC that obscured 
fenestrations from view.  
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Chapter 3:  
The Effect of Fasting on Fenestrations in 
the Liver Sinusoidal Endothelial Cell 
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3.1    Introduction 
 
To maintain homeostasis of energy metabolism when the dietary nutrient supply is 
stopped, significant changes occur in hepatocyte metabolism and gene expression 
(Sokolovic, 2008). In order to sustain adequate blood glucose levels, glycogen stores 
are depleted, gluconeogenic pathways are upregulated, and there is increased 
oxidation of fatty acids and amino acids (for glucose and energy production). The role 
of the LSEC in metabolic homeostasis during fasting has not been studied. However 
as LSECs form a fenestrated and dynamic barrier between the blood and hepatocytes 
they may play an important role in regulating nutrient supply to and from hepatocytes 
in the fasted state. 
 
The regulation and normal function of LSEC fenestrations, and their changes in 
disease and aging, suggest that fenestrations have important implications for hepatic 
metabolism and subsequent systemic exposure to many substrates and toxins (Arias, 
1990, Cogger, 2009, Fraser, 1995). The effects of a variety of pathological states on 
the LSEC and its fenestrations have been widely reported. In general, acute and toxic 
injury causes large gaps to form in the LSEC while chronic disease states and aging 
are associated with reductions in the diameter and/or frequency of fenestrations 
(Clark, 1988, Cogger, 2009, Cogger, 2004, DeLeve, 1999, Le Couteur, 2008, 
McCuskey, 2006, Warren, 2007). 
 
Because of technical difficulties associated with the study of fenestrations in LSECs, 
physiological regulation of fenestrations is less clear (Cogger, 2009). Studies where 
livers or isolated LSECs have been treated acutely with external agents have shown 
that vascular endothelial growth factor (VEGF) increases the diameter and frequency 
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of fenestrations (Funyu, 2001) while endothelin 1, calcium, noradrenaline and 
serotonin reduce the diameter of fenestrations (Cogger, 2009, Gatmaitan, 1996, 
Kamegaya, 2002, Wisse, 1980). Although it has been proposed that fenestrations are 
dynamic structures that respond to physiological stimuli (Arias, 1990, Wisse, 1985), it 
is as yet unknown whether fenestrations do change in response to such stimuli in vivo.  
 
Nutritional state influences the levels of VEGF (Dandona, 2003, Wang, 2003), 
noradrenaline (Blum, 1992, Young, 1977), serotonin (Blum, 1992), and endothelin 1 
(Ferri, 1995), and has effects on endothelial cells in many tissues (Alipour, 2007). 
Furthermore, if fenestrations are involved in the transfer of nutrients between 
hepatocytes and blood, it is plausible that fenestrations might respond to feeding and 
fasting. For these reasons, it was hypothesized that nutritional status influences 
fenestrations and in this study the effects of fasting on fenestrations were investigated. 
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3.2    Materials and Methods 
 
3.2.1    Animals 
Male F344 rats (as described in section 2.4.1), 3 months old, weighing 290 - 330 g 
were used. Eight animals were housed in cages of 2. Four rats received ad libitum 
access to rat chow and water until time of surgery, and 4 received only water for 48 
hours prior to surgery.  The study was approved by the Sydney Southwest Area 
Health Service Animal Ethics Committee. 
 
3.2.2    Surgery and specimen preparation 
All surgery was performed in the afternoon between 2 and 4 pm. Rats were 
anesthetised as described in section 2.4.2 and surgery and perfusion fixation were 
performed as described in section 2.4.3. Liver specimens from each rat were 
processed for scanning electron microscopy and viewed on a Jeol JSM 6380 scanning 
electron microscope as described in sections 2.4.5 and 2.4.5.1. 
 
3.2.3    SEM analysis 
Scanning electron micrographs of ten sinusoids that appeared flat from regions 
midway between the portal and central vein were taken for each liver at 25000  
magnification for analysis of fenestration diameter, porosity (percentage of the LSEC 
surface area perforated with fenestrations), and frequency (number of fenestrations 
per area of cell) using Image J (1.41 NIH, USA) as described in section 2.4.5.4 and 
2.4.5.5. In addition, fenestrations were grouped into size categories to observe the 
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frequency (number) of fenestrations of a particular size in each group. This data was 
displayed as a frequency distribution graph. All evaluations were blinded.  
 
3.2.4    Liver weights and blood analysis  
Livers were weighed, then separated into four main lobes (caudate, median, left, right) 
and each lobe weighed individually. The right kidney was also weighed as a 
reference. Blood was removed from the inferior vena cava during surgery and 
processed and analysed as described in section 2.4.2. Hematocrit was measured after 
centrifugation of the samples and the plasma was tested for alanine transaminase 
(ALT), aspartate transaminase (AST), cholesterol, triglyceride, urea, and creatinine 
concentrations (Department of Pathology, Concord RG Hospital, NSW).  
 
3.2.5    Statistical analysis 
Statistical differences between means were determined using Student’s t-test and 2.  
A p-value of < 0.05 was considered to be statistically significant. Data is presented as 
means ± standard deviation (SD). The fenestration frequency distribution graph data 
was tested for significant difference by a non-parametric t-test comparing the medians 
of each fenestration size category from the fed group with the medians of each 
fenestration size category from the fasted group. 
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3.3    Results 
 
Figure 3.1 shows representative scanning electron micrographs of LSECs from a fed 
and a fasted rat. Results of the quantification of the fenestrations are shown in Table 
3.1. There was a significant difference between mean fenestration diameters (p = 
0.003) and the frequency of fenestrations (p < 0.05). In the fasted state, the 
fenestrations were approximately 10 % larger than in the fed state. Porosity was not 
significantly influenced by fasting state because of a concomitant decrease in the 
frequency of the fenestrations.  
 
 
 
 
Figure 3.1 Scanning electron micrographs of sinusoids from livers of (A) fed and (B) 
fasted F344 rats. Fenestrations are clustered into sieve plates and there is a 
significantly increased fenestration size in the fasted rat LSEC (bar = 1 µm). 
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Table 3.1 Quantification of the fenestrations in LSECs of fasted and fed rats.  
There was an increase in the diameter of the fenestrations in the fasted state associated 
with an increased in fenestration frequency. Data is presented as mean ± SD. 
 
  
*p < 0.005, **p = 0.05. 
 
 
Table 3.2 shows the effects of feeding and fasting on weights and blood 
measurements of renal and hepatic function. With fasting, AST was significantly 
increased (71  9 vs 54  2 U/L, p < 0.05) while there was a decrease in triglycerides 
(0.4  0.1 vs 1.7  0.4 µmol/L, p < 0.01), urea (4.6  0.3 vs 8.0  0.3 mmol/L, p < 
0.001) and liver weight. Such changes are well recognized with fasting and reflect 
altered utilization of energy sources during starvation (Moriyama, 2008). Liver weight 
loss during fasting was fairly evenly distributed across the lobes, although the largest 
lobes lost a greater amount of weight than the smaller lobes (fig 3.2). Figure 3.3 
shows the frequency distribution graph of fenestration diameter. There was an overall 
shift to the right for fenestration size distribution in the fasted group compared to the 
fed (p < 0.001). 
 
 
 
F344 rats Fed rats Fasted rats 
Fenestration diameter (nm) 90.7  11.7 99.0  12.11* 
Frequency of fenestrations per 
µm2 8.45 ± 2.43 7.39 ± 2.28** 
Porosity (%) 5.93  2.05 6.07  1.96 
No of animals 4 4 
No of fenestrations counted 5142 4551 
Surface area analysed (µm2) 607 617 
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Table 3.2 The effects of fasting on liver weight and blood measures of hepatic and 
renal function.  
 
F344 Rats Fed rats Fasted rats 
Body weight at time of surgery (g) 321  13 290  15* 
% Body weight loss after fast - 5.8  0.7 
Liver wet weight (% body weight) 3.1  0.22 2.4  0.14*** 
Right kidney wet weight (% body 
weight) 0.33  0.03 0.34  0.02 
ALT (U/L) 38  2 40  4 
AST (U/L) 54  2 71  9* 
Bilirubin (µmol/L) 1 1 
Total cholesterol (µmol/L) 1.4  0.1 1.5  0.1 
Triglycerides (µmol/L) 1.7  0.4 0.4  0.1** 
Creatinine (µmol/L) 25  2 24  2 
Urea (mmol/L) 8.0  0.3 4.6  0.3*** 
   
  *p < 0.05, **p < 0.01, ***p < 0.001 
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Figure 3.2 Liver weight of the whole liver and of four liver lobes relative to body 
weight in fed and fasted F344 rats. Kidney weight relative to body weight remained 
consistent in fed and fasted groups (*p < 0.05, **p < 0.01, ***p < 0.001). 
 
 
Figure 3.3 Frequency distribution of fenestration diameter between fed and fasted 
F344 rats. There is a shift to the left indicating larger fenestrations in the fasted state. 
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3.4    Discussion 
Fenestrations are dynamic structures that can alter their frequency and diameter in 
response to a wide variety of stimuli (Cogger, 2009, Fraser, 1995, Wisse, 1985). This 
has been investigated widely for disease states, toxic injuries and aging. However 
whether fenestrations change in response to physiological stimuli in vivo has not 
previously been established. In this study, fasting was associated with an increase in 
fenestration diameter of approximately 10 % with a reduction in fenestration 
frequency of a similar magnitude. The result is the first in vivo demonstration that 
fenestrations alter with physiological stimuli, in this case, the fasting or fed state. 
There are several possible mechanisms and mediators for this response. A number of 
cytokines and vasoactive agents have been reported to influence fenestrations. 
Fenestration diameter is increased by VEGF (Funyu, 2001). Endothelin 1, calcium, 
noradrenaline and serotonin reduce the diameter of fenestrations (Cogger, 2009, 
Gatmaitan, 1996, Kamegaya, 2002, Wisse, 1980). Whether these have any effect on 
overall porosity is less clear. Porosity depends upon both diameter and frequency of 
fenestrations, and frequency is technically more difficult to assess especially in 
isolated LSECs (Cogger, 2009). Even so, it is known that fasting influences the levels 
of these agents, in a direction that would tend to increase fenestration diameter. For 
example, VEGF has been reported to be suppressed by insulin which is released in the 
fed state (Dandona, 2003), whereas fasting is associated with decreased levels of 
noradrenaline (Blum, 1992, Young, 1977), serotonin (Blum, 1992), calcium 
(Karkkainen, 1997), and endothelin 1 (Ferri, 1995). It is of note that Kupffer cells 
become inactivated after 2 days of fasting in rats (Sankary, 1995). The responses of 
fenestrations to many other parameters that change with feeding (such as insulin, 
glucose, leptin, ghrelin, shear stress) have not been reported. 
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A change in fenestration size during fasting will have implications for the transfer of 
substrates and plasma between blood in the lumen and hepatocytes. The fenestrated 
LSEC is somewhat analogous to an ultrafiltration system because it is a low pressure 
system with pores approximately 100 nm in diameter. The structure of the liver sieve 
is comparable to the typical structure of anisotropic (asymmetrical) membranes 
(Baker, 2004). These have a thin surface layer (the permselective layer), analogous to 
the LSEC layer, supported by a thicker porous substructure, analogous to the HSC 
layer. In anisotropic membranes, filtration rate is determined only by the surface layer 
of the membrane, with the substructure functioning as mechanical support and having 
virtually no separating function. 
 
The transfer of fluid, and subsequently substrates in fluid smaller than the filtration 
pores, across an ultrafiltration system is estimated by the Hagen Poiseuille equation 
for ultrafiltration (Cherkasov, 1990) : 
 
J =  (fR2∆P)/(8ŋl) 
 
Where J = the volume flux of fluid, f = the porosity of the membrane, R = the 
diameter of the pores, ∆P = the pressure gradient across the membrane, ŋ = viscosity, 
and l = thickness of the membrane. Thus the flux of fluid per unit area is proportional 
to the membrane porosity and the diameter of the pores. The hydraulic pressure 
driving filtration through LSEC fenestrations is a very low and fairly constant 
sinusoidal pressure of only a few centimetres of water (Le Couteur, 1992). Thus the 
influence of changes to porosity of the LSEC and diameter of fenestrations could have 
a significant effect on flux of plasma and substrates from the lumen to the SoD. In the 
current study an increase in fenestration diameter without a change in porosity during 
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fasting would therefore be associated with an increase in the flux of plasma through 
fenestrations compared to the fed state (assuming there is no change in the pressure 
gradient, LSEC thickness, or blood viscosity with nutritional status). This could have 
implications for increasing the efficiency of nutrient delivery to hepatocytes for 
gluconeogenesis (such as free fatty acids and amino acids), and increasing delivery of 
newly formed glucose and VLDL to the lumen to maintain blood glucose, 
triglyceride, and cholesterol levels.  
 
In addition, the diameter of the fenestrations will determine the permselectivity, that 
is, the size of the particles or solutes that are retained in the blood. The sieving 
relationship provides an estimate of the ratio of the concentrations of the solute on 
either side of the ultrafiltration membrane. This is determined from the size of the 
solute and the diameter of the pores (Baker, 2004, Cherkasov, 1990). When applied to 
the LSEC, it is apparent that lipoproteins with diameters of 20 - 100 nm are most 
likely to be influenced by changes in fenestration diameter (such as chylomicrons, 
chylomicron remnants and VLDL remnants) (Warren, 2005). Thus, the reduction in 
fenestration diameter with feeding might contribute to the postprandial increase in 
circulating lipoproteins such as chylomicron remnants (Yu, 2001). Fasting for 24 
hours in mice leads to an improvement in the clearance of chylomicron remnants 
(Martins, 2002). A possible mechanism is the increase in fenestration diameter 
associated with fasting seen in this study. Also there is increased production and 
secretion of VLDLs in fasting probably in response to the near cessation of 
chylomicron production (Sokolovic, 2010). An increase in fenestration diameter could 
facilitate the increased secretion of VLDL to the blood. 
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Results of our study also showed that liver weight loss was fairly evenly distributed 
across all the lobes of the liver and was not restricted to any one lobe in particular. 
Consistent with previous findings (Rothacker, 1988), kidney weight relative to body 
weight remained constant in both the fed and fasted rats, whereas liver weight 
decreased relative to body weight after the fast. Liver weight loss in fasting is mainly 
due to a combination of carbohydrate (glycogen) and water loss from the liver during 
fasting, and a less prominent loss of protein content. The carbohydrate loss results in a 
metabolic shift from glycogen and free fatty acids to protein and free fatty acids as a 
source of energy (Rothacker, 1988). Such a metabolic shift could explain the 
significant decrease in serum triglycerides we observed in the fasted rats. 
 
In conclusion, nutritional state influences the diameter and frequency of fenestrations 
in the LSEC. This confirms that fenestrations are indeed dynamic structures that are 
influenced by physiological factors. Furthermore, the observation provides an 
additional mechanism for the effects of nutritional state on circulating large 
lipoproteins. 
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Chapter 4: 
Acetaminophen Toxicity and the Liver 
Sinusoids of Fed and Fasted F344 Rats 
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4.1    Introduction 
Paracetamol (also known as acetaminophen, N-acetyl-p-aminophenol, or APAP) is 
the most widely used over the counter drug in the world. It is involved in many 
accidental and deliberate self-poisonings that require hospitalisation, and is the 
leading cause of acute fulminant liver failure in the western world (Jaeschke, 2012b). 
At therapeutic doses, APAP is primarily metabolised via the sulfation and 
glucuronidation pathways to non-toxic metabolites. A small percentage of APAP is 
metabolised via the CYP450 pathway (mainly CYP2E1) (Hinson, 2010) to the very 
reactive electrophile and oxidant N-acetyl-p-benzoquinone imine (NAPQI), that is 
then detoxified by glutathione (γ-L-glutamyl-L-cysteinylglycine or GSH; fig 4.1). 
After larger doses of APAP, the non-toxic metabolic pathways become overwhelmed, 
and more APAP is converted to NAPQI. As hepatic GSH stores deplete and NAPQI 
continues to be produced it can no longer be detoxified. It begins to react with cellular 
components and form protein adducts, a process that can eventually lead to confluent 
hemorrhagic hepatic necrosis, and progress to fulminant liver failure (Jaeschke, 
2012a).  
Figure 4.1 Pathways of APAP metabolism. NAPQI = N-acetyl-p-benzoquinone imine, 
NAC = N-acetylcysteine.  
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Toxicity from APAP metabolism is exacerbated if GSH stores and anti-oxidant 
capacity are reduced before dosage, such as during fasting (Pessayre, 1979, Pessayre, 
1980, Price, 1987, Walker, 1982, Whitcomb, 1994). Covalent binding of APAP 
metabolites to liver proteins is greater and develops more rapidly in fasted animals 
because the amount of GSH in hepatocytes is about 50 % lower than the fed state. 
Fasting does not change CYP450 content or microsomal monooxygenase activity thus 
increased toxicity is primarily a result of the reduced ability of the fasted liver to 
deactivate toxic metabolites of APAP rather than a greater production of these 
metabolites (Walker, 1982). There is also a decreased capacity for non toxic 
glucuronidation pathways in fasting (approximately 60 % of that of fed animals) at 
least partially due to the reduced availability of glucose for conversion to glucuronic 
acid (Price, 1987). In addition, more lipid peroxidation occurs in fasted animals in 
conjunction with increased protein binding of toxic APAP metabolites (Wendel, 
1979). Fasting may also potentiate APAP toxicity through the actions of glucagon 
which activates receptors coupled to cyclic AMP causing a positive sensitivity 
modulation to calcium (Saville, 1988). GSH depletion in APAP toxicity is linked with 
increased cytosolic calcium levels as calcium is released from intracellular 
compartments such as ER and mitochondria as the cell becomes increasingly damaged 
by toxic metabolites. Increased cytosolic calcium concentration alters cell function to 
promote toxicity by activating enzymes such as phospholipases (that damage 
membranes), proteases (that break down proteins), endonucleases (responsible for 
DNA and chromatin fragmentation), and ATPases (that hasten the depletion of ATP) 
(Kumar, 2009). Increased calcium sensitivity in the cells of fasted animals during 
APAP toxicity further increases the activation of these enzymes, promoting even 
more cellular damage than in fed animals (Saville, 1988). An increase in intracellular 
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calcium is also associated with fenestration contraction and could be a contributing 
factor to LSEC defenestration in APAP toxicity. Hemorrhage and congestion of RBCs 
in the liver, a sign of endothelial injury, is also increased in fasted animals resulting in 
enlargement of livers to a greater extent than in fed animals (Walker, 1982). This 
suggests that LSECs sustain greater levels of injury in animals fasted prior to APAP 
overdose. 
 
The main current therapeutic drug for APAP toxicity is N-acetylcysteine (NAC) 
which is a cysteine prodrug that can stimulate GSH synthesis (refer to fig 4.1), and 
has antioxidant properties (Cacciatore, 2010). It also has antithrombotic properties 
primarily via limiting platelet aggregation (Chen, 2011). If administered early enough 
after overdose, NAC can reverse some of the liver damage preventing liver failure and 
death. However, in some less severe cases the patient survives the initial insult (which 
usually lasts for 3 or 4 days after the overdose in humans and 1 or 2 days in rats and 
mice) regeneration of the liver begins and the necrosis and congestion resolve 
naturally (Rowden, 2005). In addition to hepatotoxicity, nephrotoxicity and tubular 
necrosis may occur in about 1 - 2 % of human patients presenting after APAP 
overdose, although rats may be more susceptible (Mazer, 2008, McMurtry, 1978, 
Newton, 1982). 
 
The earliest histopathologic changes found in APAP toxicity prior to any signs of 
necrosis are hydropic vacuolisation of hepatocytes along the sinusoidal margins in 
centrilobular zones, followed by a mild steatosis of centrilobular hepatocytes and 
centrilobular congestion (Walker, 1980). As oxidative stress increases, alterations in 
calcium homeostasis disrupt mitochondria stopping the production of ATP and 
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promoting hepatocyte degeneration and necrosis (Hinson, 2010). Centrilobular 
hepatocytes are most vulnerable to APAP toxicity because they contain much higher 
levels of CYP2E1 (and CYP450s) than periportal hepatocytes and thus produce much 
more NAPQI (Gooding, 1978). In addition, hepatocytes in centrilobular zones contain 
much less GSH than periportal hepatocytes, lowering their ability to detoxify NAPQI 
(Smith, 1979). Oncotic necrosis is the primary mechanism of hepatocyte death in 
APAP toxicity, with relatively mild amounts of apoptosis occurring (Gujral, 2002, 
Jaeschke, 2002). Eventually necrosis becomes confluent in centrilobular zones and is 
accompanied by an inflammatory response. In severe cases the necrosis spreads to 
midzonal cells, and periportal hepatocytes develop hydropic vacuoles (Dixon, 1971). 
The pattern of toxicity and necrosis in APAP overdose is variable across the liver and 
not every central zone is equally affected (Walker, 1985).  
 
The severity of toxicity in mice can be greatly decreased by pre-treatment with 
heparin suggesting that congestion has an important role in increasing hepatotoxicity, 
and that damage to the liver can be significantly reduced without reducing APAP 
bioactivation to NAPQI (Ganey, 2007). Studies at an ultrastructural (Lim, 1995, 
Walker, 1983) and in vivo microscopic level (Ito, 2003, McCuskey, 2006) reveal that 
there is microvascular injury before any histopathological changes or rise in serum 
aminotransaminase levels that are indicative of hepatocyte injury (Hessel, 1996), 
however the exact mechanism by which APAP is toxic to the endothelium is still not 
clear. Initial signs of injury to LSECs in APAP overdose in mice can occur as early as 
30 minutes into toxicity and include swelling of the LSEC cytoplasm and reduced 
endocytosis mediated by the scavenger receptor (Ito, 2003). Also development of gaps 
(0.5 - 3 µm in diameter) in the LSEC cytoplasm early on facilitate the movement 
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RBCs into the SoD resulting in congestion by collapsing the sinusoid lumen and 
reducing blood flow (McCuskey, 2008, Walker, 1983). The congestion becomes 
increasingly aggravated as platelets enter the SoD and fibrin is deposited, resulting in 
secondary ischemic damage (Walker, 1985). Dilation of sinusoids in centrilobular 
regions becomes prominent by 8 hours after APAP overdose in rats, and is thought to 
be contributed to increased pressure in the sinusoids that are directly adjacent to 
congested sinusoids affected by hemostasis and congestion (Lim, 1995).  
 
Free radicals released as a result of oxidative stress (such as superoxide and nitric 
oxide) are injurious to LSEC (Deaciuc, 1999) and mitochondrial dysfunction and 
peroxynitrite formation in LSECs may be a critical factor for microvascular injury in 
APAP overdose (Knight, 2004). In vitro studies have shown that APAP is directly 
more toxic to LSECs than hepatocytes, and also that LSECs are capable of 
metabolising APAP and may produce small amounts of NAPQI (DeLeve, 1997, 
Steinberg, 1987). Additionally, LSECs are directly exposed to NAPQI released from 
both viable and necrotic or lysed hepatocytes and concentrated in the SoD (DeLeve, 
2007b). LSECs contain GSH stores, but these are much less concentrated than 
hepatocytes and thus may render LSECs more vulnerable to APAP toxicity (DeLeve, 
1998).  
 
Although there is microvascular damage and hemorrhage in APAP toxicity, 
ultrastructural studies (by Walker et al) in the 1980s found that the main sinusoid 
structure appears mostly to be conserved throughout the course of toxicity. 
Intercellular junctions between LSECs remain intact, and LSECs are anchored to 
hepatocyte and Ito cell processes in areas of SoD enlargement and sinusoid lumen 
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collapse (Walker, 1983). At least some LSECs are preserved in areas of hepatocyte 
necrosis as they were observed in a fenestrated phenotype overlying necrotic 
hepatocytes on scanning electron microscopy (Walker, 1983). It is possible that initial 
injury to LSECs in APAP-induced hepatotoxicity is repaired during the process of 
toxicity (DeLeve, 2007a) and that preservation of LSECs and their place in the 
sinusoid by attachments to Ito cells and degenerate hepatocytes is pivotal in enabling 
recovery from congestion and reducing ischemic insult later in toxicity (Walker, 
1983). Recent studies have found that the ability of the liver parenchyma to regenerate 
and recover from APAP-induced toxicity is highly dependent on the ability of the 
liver to first repair its microvasculature and to attenuate LSEC dysfunction 
(Donahower, 2010, Kato, 2011, Papastefanou, 2007). Damage to endothelium 
(assessed by measuring serum hyaluronic acid levels) in human patients with severe 
hepatotoxicity from APAP overdose is greater in those that do not recover than the 
survivors (Williams, 2003) suggesting the extent of damage to LSEC in APAP 
toxicity influences prognosis. 
 
The purpose of this chapter was to observe the various features of APAP toxicity, 
comparing the hepatotoxicity in rats fed to rats fasted prior to APAP dosage. We 
focused on observing morphological changes to LSECs during the course of 
hepatotoxicity to determine their viability in both necrotic and non-necrotic areas. We 
particularly aimed to provide further information on what happens to the LSEC at an 
ultrastructural level in necrotic zones as there is currently little information available. 
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4.2    Materials and Methods  
4.2.1    Animals and APAP dosage 
The rats used in experiments were male Fisher 344 rats, approximately 3 months old 
weighing 300 - 400 g. Rats were housed in groups of 3 on a 12 hour light and dark 
cycle, temperature at 25 ºC. APAP was dissolved in warm distilled water, and 
administered to rats via gavage at a dose of 1000 mg/kg.  
 
Six rats were allowed free access to standard chow and water until food was removed 
at the time of APAP gavage in order to maximise toxicity by preventing 
replenishment of GSH stores as APAP was being metabolised (fig 4.2). Ten rats were 
fasted from 24 hours prior to APAP gavage (1000 mg/kg) to increase toxicity by 
depleting GSH stores prior to APAP dose (fig 4.2). All rats were allowed free access 
to water at all times. An additional 8 rats used as controls (the same rats as used for 
the study in Chapter 3) were ad libitum fed or fasted but were not given APAP, and 
were analysed in the same way as rats administered APAP (fig 4.2). A more extensive 
blood and histological analysis was carried out on the fasted rats than the fed. 
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     Fischer Rats 
         (n = 24) 
 
  Fed                 Fasted 
 
 
      
Control  24 hrs after   Control       6hrs after     24 hrs after  
    APAP              APAP   APAP 
 (n = 4)              (n = 6)       (n = 4)    (n = 5)   (n = 5) 
            
 
Figure 4.2 Experimental treatment groups: Rats were fed or fasted until APAP 
gavage, then culled at either 6 or 24 hrs after APAP. Controls were not given APAP. 
 
4.2.2    Surgery and specimen preparation fed groups 
Twenty-four hours after APAP gavage, rats were placed under general anaesthesia 
and a laparotomy and perfusion performed as described in Chapter 2 (general 
methods). Briefly, blood was taken from the IVC for liver function tests measuring 
serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and total 
bilirubin. The liver was then briefly perfused with PBS to exsanguinate the sinusoids.  
The right inferior lobe was tied off with a suture, cut out, and immersed in fixative for 
histology before the remainder of the liver was perfused with fixative for electron 
microscopy. After the liver sufficiently hardened it was removed and prepared for 
scanning and transmission electron microscopy as described in Chapter 2. 
 
4.2.3    Surgery and specimen preparation fasted groups 
Five rats were placed under general anaesthesia 6 hours after APAP (6 hour rats), and 
5 rats at 24 hours after APAP gavage (24 hour rats), and 4 control rats were fasted for 
48 hours before surgery but not administered APAP. Twenty four hours was chosen 
because this is a time reported in studies at which aminotransferase levels and 
No APAP No APAP APAP  APAP  APAP  
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necrosis is high in rats (Papastefanou et al., 2007), and the 6 hour time point was 
chosen to examine LSEC before hepatocyte necrosis was expected to occur. Body 
weights were recorded at the beginning of the fast and after anaesthesia. Surgery and 
perfusion were carried out as previously described in Chapter 2.  Briefly, a 
laparotomy was performed and approximately 3 ml of blood was taken from the IVC 
to be analysed for ALT, AST, total bilirubin, total cholesterol, triglycerides, 
creatinine, urea, and hematocrit. The portal vein was cannulated, and 10 ml of PBS 
was perfused to exsanguinate the liver. Immediately after, approximately 40 ml of 4 
% paraformaldehyde in PBS pH 7.4 was perfused through the liver. When the 
perfusion ended, the liver was removed and weighed. A sample from each lobe was 
prepared for histological analysis, and another sample was placed in EM fixative 
where it was sectioned into approximately 10 to 20 blocks (approx 1 mm3) with a 
scalpel and prepared for scanning and transmission electron microscopy analysis as 
previously described in Chapter 2. The left kidney in the fasted groups was also 
removed immediately after surgery and incubated in 4 % paraformaldehyde (with 1 % 
sucrose in PBS) overnight then processed for histology (in the same way as described 
for liver processing). 
 
4.2.4    Histology fed and fasted groups 
Livers were prepared and sectioned for histology as described in Chapter 2. Sections 
from the right lobe were stained with Hematoxylin and Eosin (see Appendix 2A for 
protocol) to observe any necrosis, hemorrhage, and congestion. In addition, sections 
were taken from four liver lobes (median, right superior, left lateral, caudate) and 
stained with Hematoxylin and Eosin to observe any intra and inter lobular variability 
in toxicity in the 6 and 24 hour fasted groups. Sections were graded on the average 
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amount of necrosis across the section. 0 = no necrosis or focal necrosis of only a few 
single cells, + = minor levels of centrilobular confluent necrosis, ++ = major levels of 
centrilobular confluent necrosis with spreading of necrosis to midzonal cells, +++ = 
severe levels of centrilobular confluent necrosis with prominent bridging necrosis 
across midzones and occasionally some necrotic periportal cells. 
 
A section was cut and stained with Periodic Acid Schiff’s (PAS, see Appendix 2B for 
protocol) to observe glycogen distribution, and another section cut and stained with 
Sirius Red (see Appendix 2C for protocol) to observe any increase in sinusoidal 
collagen or fibrosis. Sections at a magnification of 100  were graded blinded for 
degrees of collagen in sinusoids. 0 = no increase compared to controls, + = mild 
increase, ++ = moderate increase, +++ = severe increase. Sections from the kidney 
were also cut at 4 µm and stained with Hematoxylin and Eosin, PAS, and Sirius Red 
(staining protocols are described in Appendix 2) to observe for any pathology such as 
tubular necrosis. 
 
4.2.5    Electron microscopy fed and fasted groups 
Approximately 20 pieces sampled from all liver lobes were cut into blocks 1 mm3, 
incubated in EM fixative, and processed for scanning and transmission electron 
microscopy as described in Chapter 2. If not enough blocks were adequately fixed 
from the necrotic zones of a particular rat (as the fixative did not always penetrate 
well enough through congested and necrotic areas of the liver during perfusion), extra 
blocks were cut from paraffin embedded livers from specific areas targeted after 
observing H & E stained sections and reprocessed for viewing on TEM (as described 
in Chapter 2). At least 5 blocks per liver on SEM, and 2 - 3 blocks on TEM were 
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observed to analyse the liver cells at an ultrastructural level, particularly looking at 
LSEC morphology in areas of low to severe toxicity. Measurements were taken using 
Image J of control and APAP rats to estimate the size of the sinusoid lumen, SoD, 
fenestrations, gaps, and LSEC cytoplasm in different areas of the liver. The 
intralobular toxicity was variable, thus average fenestration diameter and porosity 
could not be analysed to accurately determine whether there were any statistically 
significant differences between control and APAP-treated rats.  
 
4.2.5    Statistical analysis 
Data from blood analysis comparing control and APAP rats was analysed using 
Microsoft Excel. An F-test was performed between control and APAP groups to 
measure the variance. The student’s t-test was then used (according to whether the 
groups displayed equal variance or not) to determine any significant differences. A 
statistically significant difference was defined as p < 0.05.  
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4.3    Results: Fed rats at 24 hours after APAP 
4.3.1    Macroscopic Observations 
Twenty-four hours after APAP gavage rats were observed to be quiet and sleepy. 
During laparotomy particularly in the severely damaged livers, there was obvious 
variability in each lobe as to the extent of damage sustained. 
4.3.2    Blood results 
Total bilirubin levels were significantly raised in APAP rats. Serum aminotransferase 
data was quite variable in the APAP rats and as such there were no statistically 
significant differences, however, there was a trend towards increased ALT and AST 
(table 4.1). Only 1 rat out of 5 had a sharp increase in serum ALT with 2 other rats 
mildly increased (from 1.3 to 19  higher than normal), and 4 out of 5 rats had 
increased AST from mild to severe (from 1.5 to 9  the normal average). These results 
suggest some form of hepatocellular injury occurred in at least 4 of 5 APAP-treated 
rats. We did not obtain blood from one rat that was expected to have high range LFTs 
(as histology showed severe hepatotoxicity). 
Table 4.1 Mean and individual serum aminotransferase levels, total bilirubin, 
and weight loss at 24 hrs after APAP in fed rats. Mean fed control values are 
displayed for comparison.  
 
 
 
 
 
 
 
 
 
 
 
 
* = significant difference to control rats, p=0.0001 
Rat ALT (U/L) AST (U/L) TBil (µmol/L) 
% Weight 
loss 
1 48 96 3 4.9 
2 38 86 6 4.4 
3 52 104 4 3.8 
4 16 32 1 4.8 
5 702 459 3 4.9 
6 no data no data no data no data 
Mean±SD 171.2±297 155.4±172 3.4±1.8* 4.6±0.5 
Mean±SD 
ctrls 36.8±3 52.4±4 1±0 - 
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4.3.3    Histology 
Four of 6 APAP treated rats showed only some mild levels of damage to the liver 24 
hours after APAP gavage. There were vacuoles in centrilobular hepatocytes and 
presence of inflammatory cells particularly in centrilobular zones, with some focal 
necrosis of centrilobular hepatocytes (fig 4.3 A). These rats had LFTs in the lower 
range, corresponding to a lower degree of hepatic damage. The remaining 2 of 6 rats 
(one with high range LFTs, and the other where no blood sample was collected) had 
more severe hepatotoxicity displaying confluent hemorrhagic necrosis of centrilobular 
zones (and midzones) with increased numbers of inflammatory cells in these areas 
(fig 4.3 B). Sinusoids that lay adjacent to necrotic regions were dilated and 
hepatocytes were affected by vacuolar and fatty degeneration.  
 
PAS staining revealed glycogen was mostly depleted in 4 of the 6 APAP rats, but was 
present in the periportal zones in 2 of 6 rats (one with severe centrilobular necrosis 
and one without) (fig 4.3 C). Two out of 6 rats had increased collagen in the central 
venules of necrotic areas (fig 4.3 D and also refer to the electron micrograph fig 4.6 
A), and displayed a mild increase in sinusoidal collagen in necrotic zones. Some of 
the increased collagen staining around necrotic hepatocytes may have also been 
related to the reticular framework collapsing (fig 4.4 D-F).  
Table 4.2 Grade of necrosis, sinusoidal collagen, and glycogen distribution 24 
hrs after APAP in fed rats. 
 
Rat Necrosis Sinusoidal Collagen Glycogen 
1 0 0 Deplete 
2 0 0 Deplete 
3 0 0 Deplete 
4 0 0 PP 
5 ++ + PP 
6 +++ + Deplete 
 109
 
Figure 4.3 H&E, PAS, and Sirius Red stained sections from fed APAP-treated rats 
A) H&E stain of an area of mild toxicity. There is vacuolisation of CL hepatocytes, 
the PP area is histologically normal. C = central venule, bar = 100 µm.  
B) H&E stain of an area of severe toxicity. There is a zonal pattern of damage with 
necrosis, congestion, and hemorrhage (arrow) primarily in CL and ML zones. 
Adjacent PP zones are mildly affected with toxicity including sinusoidal dilation and 
vacuolisation of hepatocytes. P = portal venule, bar = 100 µm.  
C) PAS stain of an area of CL necrosis with glycogen present in PP hepatocytes. The 
collapsed reticular fibre network around necrotic/degenerate hepatocytes stained pink 
(indicated by arrow). Bar = 100 µm.  
D) Sirius Red stain of an area of CL necrosis with some thick collagen fibres (see 
arrow). Bar = 100 µm. 
E) Sirius Red stain of an area not affected by necrosis in a low toxicity rat. There is no 
increase in sinusoidal collagen. Bar = 100 µm. F) Sirius Red stain on the border of a 
necrotic and viable zone. There are some thick collagen fibres (see arrow) and 
congested RBCs stained brown. Bar = 20 µm.  
F 
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E 
B A 
C 
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C 
C 
C 
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4.3.4    Electron microscopy 
In the rat with the most severe hepatotoxicity, LSECs were often dead and surrounded 
by fibrin in the worst affected centrilobular zones (fig 4.4 B). As observed in 
histology, large areas of coagulative hepatocyte necrosis were present with major 
congestion of sinusoids and leakage of RBCs into the SoD through gaps in the injured 
LSEC cytoplasm (fig 4.4 A). In periportal zones LSECs were viable although many 
platelets were observed in the sinusoid lumens. 
 
In the rat with less severe centrilobular hemorrhagic necrosis, no dead LSECs were 
observed in areas of hepatocyte necrosis in the specimens analysed. The LSECs were 
closely associated with HSCs, and there was increased extracellular matrix deposition 
between these cell types (fig 4.5 B) particularly where the once underlying 
hepatocytes had died or retracted from the sinusoidal cells. It also appeared that there 
were increased numbers of HSCs that may have migrated to or proliferated in the 
necrotic regions (fig 4.5 C). HSC processes seemed to increase their surface area so 
that they were maximally in contact with the LSECs, often completely covering LSEC 
cytoplasms or nuclear regions in places where there were no underlying hepatocytes 
(fig 4.5 - 4.7). Both LSECs and HSCs formed attachments to necrotic and 
degenerating hepatocytes, tethering the sinusoids and parenchyma together and 
maintaining some organisation of the cells. Sinusoid lumens were significantly 
reduced in size (by at least 50 % compared to controls) or completely collapsed, 
although LSEC cytoplasms still contained some fenestrations (fig 4.5 - 4.7). Again, 
there was hemorrhage of RBCs into the SoD although fibrin deposition in necrotic 
areas and platelets (in sinusoid lumens and the SoD) were less common. Inflammatory 
cells were most concentrated in necrotic areas (fig 4.8). 
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Figure 4.4 Transmission electron micrographs of specimens reprocessed from 
paraffin from the fed APAP-treated rat with the most severe toxicity 
A) Two congested sinusoids with collapsing lumens (L) and hemorrhage of RBCs 
into the SoD (S). Arrows point to the outline of a degenerating LSEC, marking the 
border of the lumen and SoD. The hepatocytes (H) are affected by oncosis. The RBC 
marked R is in the SoD Bar = 10 µm.  
B) A dead LSEC (arrow points to the nucleus) is surrounded by a dense network of 
fibrin (F; dark fibrous material) and RBCs (R). The surrounding hepatocytes (H) are 
dead (bar = 2 µm). 
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Figure 4.5 Transmission electron micrographs from a fed APAP-treated rat with mid-
range toxicity. Viable LSECs and HSCs are surrounded by necrotic hepatocytes. 
A) In this micrograph, a viable LSEC (EC marks the nucleus and black arrows mark 
the cytoplasm) is strongly tethered to a HSC surrounded by, and attached to, necrotic 
hepatocytes. A platelet (P) and lymphocyte (Ly) are in the SoD and the sinusoid 
lumen (L) is collapsing. A white arrow points to increased ECM between the LSEC 
and HSC, and a bold arrow indicates what may be an obliquely sectioned sieve plate 
in the LSEC cytoplasm (bar = 2 µm). 
B) A section of LSEC cytoplasm in a CL necrotic zone. The long arrow points to 
basement membrane deposition between LSEC and HSC processes. The small arrow 
points to fenestrations. A RBC (R) and platelet (P) are in the sinusoid lumen. 
C) In general there appears to be increased numbers of HSCs in necrotic zones and in 
this micrograph there are two HSC nuclei adjacent to the LSEC cytoplasm, and other 
processes possibly projecting from additional HSCs to the LSEC. An RBC (R) is 
outside of the collapsed sinusoid lumen (L). H = necrotic hepatocyte. Bar = 2 µm. The 
small black dots on the surface of cells and other structures in the micrograph are an 
artefact, probably of lead staining where globular precipitates form on reaction with 
carbon dioxide. 
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Figure 4.6 Transmission electron micrograph from a fed APAP-treated rat with mid-
range toxicity. Tethering of a HSC, necrotic hepatocyte, and LSEC. 
A) The sinusoid in this micrograph is made of a tightly associated LSEC (EC) and 
HSC complex with a severely shrunken lumen. It is almost floating free of a 
degenerating hepatocyte (H) that contains a giant vacuole (V), however there are 
some points of attachment (marked by arrows). Bar = 5 µm. 
B) A close up of the sinusoid in ‘A’ shows an increased deposition of collagen 
holding the LSEC and HSC together (arrows) and an LSEC process (bold black 
arrow) is wrapped around what appears to be part of a degenerating hepatocyte, or 
else another HSC (star). There is also an area where the hepatocyte appears to be 
directly joined to the HSC (white arrow). The sinusoid lumen (L) is severely 
decreased in size. Bar = 2 µm. 
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Figure 4.7 Transmission electron micrographs of sinusoids in CL necrotic zones from 
fed APAP-treated rats with moderate toxicity. As in figure 4.5 the small black 
particles in these micrographs are an artefact of staining. 
A) Viable LSECs (EC) and HSCs amongst necrotic hepatocytes with karyolytic nuclei 
(Nu) and fatty degeneration (Li = lipid). A sinusoid lumen (L) is squashed between 
degenerating hepatocytes. A collagen bundle (c) is associated with a HSC (bottom left 
corner), and a lymphocyte (Ly) and RBC (R) are in the spaces between hepatocytes. 
The boxed area is shown enlarged in (B) (bar = 5 µm). 
B) There is basement membrane between the LSEC (arrow) and HSC, and the HSC is 
adhered to a necrotic hepatocyte. There is a neutrophil (N) in the collapsing sinusoid 
lumen (L; bar = 2 µm). 
C) On the edge of a necrotic zone LSEC and HSC processes stretch between a dead 
hepatocyte and another with fatty degeneration and RBCs (R) in its cytoplasm. The 
LSECs display an unusual morphology with wrinkled cytoplasms, as is seen more 
clearly in the enlarged micrographs of the boxed areas in (D) and (E) (bar = 5 µm). 
D) Two LSEC are adhered together via intercellular junctions (bold arrow), one LSEC 
process contains a sieve plate obliquely sectioned (top arrow). 
E) Another obliquely sectioned sieve plate on an LSEC cytoplasm (arrow). 
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Figure 4.8 Micrographs of CL necrotic zones from fed APAP-treated rats 
A) A micrograph of a CL necrotic area. There is increased collagen deposition around 
the central venule (CV), part of which lies in the bottom left hand corner. Adjacent to 
the central venule there is an eosinophil (E) next to an unknown cell-type that has 
endocytosed a large amount of lipid (Li), or is possibly a dying hepatocyte with fatty 
degeneration. A neutrophil and RBCs (R) are in a necrotic hepatocyte (H) in the top 
right hand corner. There appears to be a viable LSEC (EC) perikaryon in between the 
degenerate hepatocytes (bar = 5 µm).  
B) This micrograph displays a region of necrotic hepatocytes associated with fibrin 
(F) and platelets (P). The sinusoid structure is still somewhat intact and a RBC is 
crossing through a gap in an LSEC (arrow) (bar = 2 µm). 
C) In this micrograph, two platelets are travelling to the SoD through fenestrations 
(arrows) in an LSEC (EC) and spaces between HSC processes (bar = 2 µm). 
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In areas on the border of necrotic zones, hepatocytes were atrophied and mostly 
devoid of microvilli resulting in enlargement of the SoD and spaces between 
hepatocytes (sinusoid dilation) (fig 4.9 A). LSECs and HSCs stayed closely associated 
but were often separate from hepatocytes apart from small areas of contact between 
the cells (fig 4.9 B-D). Sinusoid lumens were mildly reduced in size. There were some 
gaps in LSECs that ranged up to approximately 3 µm in diameter and there were 
RBCs in the hepatocytes, providing evidence of hemorrhage in these areas which 
likely contributed to the sinusoid dilation. 
 
Often centrilobular zones of rats with low serum aminotransferase levels did not 
appear to be damaged. LSEC were normal and fenestrated without any gaps, and 
hepatocytes normal with abundant microvilli (fig 4.9 E). In areas of the liver with 
mild toxicity where hepatocytes contained vacuoles and were mildly steatotic, some 
LSECs were defenestrated (fig 4.9 F), some LSECs contained gaps, some LSECs 
were activated with some swollen areas containing lysosomes and many pinocytic 
vesicles (fig 4.9 G), and some LSECs displayed a combination of all these traits. 
Intercellular junctions between LSECs were always preserved and there were no gaps 
between cells. The SoD (approx 0.3 – 1 µm) and sinusoid lumen (approx 7 – 10 µm) 
were of a similar size to that measured in controls.  
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Figure 4.9 Electron micrographs of sinusoids of fed APAP-treated rats with low to 
moderate toxicity 
A) This micrograph shows an area of sinusoid dilation on the edge of a CL necrotic 
zone. The hepatocytes are degenerating and atrophied with only some microvilli 
remaining. The sinusoid lumen (L) is decreased in size. A large lipid droplet (Li) lies 
in the space between the hepatocytes (H) (bar = 10 µm). 
B) A close view of an LSEC nucleus and cytoplasm where surrounding hepatocytes 
are degenerating. The LSEC cytoplasm is thin and contains fenestrations however the 
sinusoid lumen (L) is squashed and misshapen. HSC processes (arrow) surround the 
LSEC (bar = 2 µm). 
C) TEM and D) SEM representation of an area of hepatocyte (H) degeneration and 
sinusoid dilation. A HSC process (fig C bold arrow) wraps around the LSEC where 
there is no underlying hepatocyte. There are gaps in the LSECs (arrows) and RBCs 
(R) in hepatocyte vacuoles can be seen in micrograph (C) (bar = 2 µm). 
E) SEM of a normally fenestrated LSEC from a fed APAP-treated rat (bar = 2 µm). 
F) SEM of a defenestrated LSEC from a fed APAP-treated rat (bar = 2 µm). 
G) TEM of an LSEC swollen with lysosomes (bold arrow) and pinocytic vesicles 
(arrows) in an area of mild toxicity. Microvilli are still present in the underlying 
hepatocyte (bar = 1 µm). 
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4.4    Results: Fasted rats at 6 and 24 hours after APAP 
4.4.1    Macroscopic Observations 
At 6 and 24 hours after APAP gavage rats were quiet and sleepy. On observation of 
the liver during laparotomy there was inter and intra lobular variability in 
hepatotoxicity.  
 
4.4.2    Blood Results comparing 6 to 24 hours after APAP 
Total bilirubin increased significantly from normal levels at 6 hours to elevated levels 
at 24 hours suggesting liver function was deteriorating during this time. There was a 
trend towards an increase in ALT (p = 0.055) and AST (p = 0.066) from 6 to 24 hours 
post APAP, indicating that damage to the parenchyma was increasing (see table 4.3). 
Total cholesterol significantly decreased from 6 to 24 hours after APAP, however, 
triglyceride serum levels did not change. Creatinine and urea significantly increased 
from normal at 6 hours to mildly elevated by 24 hours (see table 4.4). Average liver 
weight increased significantly from 6 to 24 hours. Hematocrit did not significantly 
change from 6 to 24 hours, but the average was higher at 24 hours (see table 4.5).  
 
4.4.3    Blood results comparing 24 hours after APAP to controls 
At 24 hours after APAP, total bilirubin was significantly raised above normal, 
suggestive of reduced liver function. There was a trend towards an increase in ALT (p 
= 0.0549) and AST (p = 0.0657). Even though all of the rats had elevated ALT and 
AST the result was not significant, probably due to variability (see table 4.3). Total 
cholesterol was significantly lower than normal, although triglyceride levels were 
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similar. Creatinine and urea were raised, but only by a very mild amount (see table 
4.4). Hematocrit was significantly higher in APAP-treated rats, and the average 
weight of the liver had increased approximately 40 % in size by 24 hours after APAP 
(see table 4.5). 
 
Table 4.3 Serum aminotransferase and total bilirubin raw data and mean from fasted 
APAP-treated rats. Mean ± SD fasted APAP-control rat data is included for 
comparison. 
 
Rat ALT (U/L) AST (U/L) TBil (µmol/L) 
6 hr 24 hr 6 hr 24 hr 6 hr 24 hr 
1 46 1129 80 1124 1 2 
2 50 124 100 143 1 2 
3 33 220 60 209 1 1 
4 45 4690 72 7053 1 3 
5 51 4550 95 6513 1 2 
Mean±SD 45±7.2 2143±2296 81.4±16.4 3008±3473 1±0 2±0.7*† 
Mean±SD 
ctrls - 40±3.6 - 70.7±9.1 - 1±0 
*p<0.05 compared to 6 hour rats. 
†p<0.05 compared to control rats. 
 
 
 
Table 4.4 Serum lipids and kidney function test raw data and mean from fasted 
APAP-treated rats. Mean ± SD of fasted APAP- control rats is included for 
comparison. 
 
Rat 
Total cholesterol 
(µmol/L) 
Triglycerides 
(µmol/L) Urea (mmol/L) Creatinine (µmol/L) 
6 hr 24 hr 6 hr 24 hr 6 hr 24 hr 6 hr 24 hr 
1 1.3 1.3 0.5 1.5 - 7.4 - 50 
2 1.5 1.2 0.8 0.9 3.8 - 13 - 
3 1.3 1.1 1.1 0.6 5.1 6.5 22 27 
4 1.2 1.1 0.7 0.2 6.3 6.2 28 27 
5 1.3 0.8 0.9 0.5 1.4 10.8 - 43 
Mean
±SD 1.3±0.1 1.1±0.2
*† 0.8±0.2 0.7±0.5 4.2±2.1 7.7±2.1*† 21±7.5 36.8±11.6*† 
Mean
±SD 
ctrls 
- 1.5±0.1 - 0.4±0.1 - 4.6±0.3 - 24.3±1.5 
*p<0.05 compared to 6 hr rats. 
†p<0.05 compared to control rats. 
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Table 4.5 Hematocrit, liver weight, and weight loss raw data and mean from fasted 
APAP-treated rats. Mean ± SD of fasted APAP-control rats is included for 
comparison. 
 
Rat 
Hematocrit % Liver wet weight % body weight 
% Weight loss from 
time of fast 
6 hr 24 hr 6 hr 24 hr 6 hr 24 hr 
1 58 73 2.9 4.9 10.4 13.7 
2 59 63 3.4 4.9 5.9 15.6 
3 63 65 3.3 3.4 8.3 12.4 
4 56 61 4.5 4.0 5.6 11.8 
5 62 50 2.7 4.1 7.4 11.3 
Mean±SD 59.5±2.7 62±8† 3.3±0.7 4.3±0.6*† 7.5±1.9 13±1.7*† 
Mean±SD 
ctrls - 52.7±2.1 - 2.5±0.2 - 7±1.6 
*p<0.05 compared to 6 hr rats. 
†p<0.05 compared to control rats. 
 
 
4.4.4    Histology  
Six hours after APAP gavage, the liver appeared mostly to be histologically normal 
(fig 4.10 A). Infrequently there was centrilobular hydropic vacuolisation of 
hepatocytes and mild amounts of centrilobular congestion and infiltrate. Renal 
histology was normal in all rats. By 24 hours after APAP, all rats had sustained some 
degree of centrilobular necrosis, and necrotic regions contained infiltrate even if the 
amount of necrosis was very mild (fig 4.10 C). Necrosis and hepatotoxicity was most 
severe in rats with the highest serum aminotransferase levels. Areas of significant 
sinusoid dilation were often observed either at the border of necrotic zones or 
surrounding central venules (fig 4.10 E). Interlobular and intralobular variability of 
toxicity was present in all rats at both 6 and 24 hours, with more extremely 
contrasting degrees of toxicity across the livers of rats with the most severe 
hepatotoxicity. Renal histology was normal in all rats at 24 hours after APAP (see 
Appendix 5 A11). 
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Sinusoidal collagen was increased at both 6 (fig 4.11 B) and 24 (fig 4.11 C) hours 
after APAP in both periportal and centrilobular zones, but mainly in centrilobular 
zones. There was increased collagen in central venules particularly in necrotic zones 
indicative of the increasing hepatotoxicity. In areas of sinusoidal dilation, collagen 
appeared to help tether LSEC and HSC processes (that mainly were located in the 
centre of the expanding sinusoids) to the degenerating hepatocytes (fig 4.11 D). 
Collagen deposition tended to be more diffuse at 6 hours than at 24 hours when 
collagen bundles appeared to be longer and more linear particularly in rats with higher 
toxicity. At least some of the collagen fibres around necrotic/degenerating hepatocytes 
could have been a part of the collapsing reticular fibre framework. The amount of 
sinusoidal collagen was variable in each rat, consistent with variable toxicity across 
the liver. 
 
At 6 hours after APAP hepatocytes were mostly devoid of glycogen (fig 4.10 B) 
however by 24 hours after APAP some of the glycogen was replenished in the 
periportal zones of 4 out of 5 rats (fig 4.10 D). Consistent with the intralobular 
variability of toxicity, the amount of glycogen was variable across the livers and some 
periportal zones were glycogen deplete. This was significantly different to control rats 
where glycogen was either depleted across the section, or mild amounts of glycogen 
were present in centrilobular zones.  
 
 
 
 
 
 122
Table 4.6 6 hrs after APAP in fasted rats- graded necrosis and sinusoidal collagen 
with comparative ALT level and glycogen presence in each rat 
 
Rat 
 
ALT 
(U/L) 
Grade of necrosis per lobe  
Collagen 
 
Glycogen Median Right Left  Caudate 
1 46 0 0 0 0 ++ Deplete 
2 50 0 0 0 0 ++ Deplete 
3 33 0 0 0 0 ++ Deplete 
4 45 0 0 0 0 ++ Deplete 
5 51 0 0 0 0 ++ Deplete 
 
 
 
 
Table 4.7 24 hrs after APAP in fasted rats- graded necrosis and sinusoidal collagen 
with comparative ALT level and glycogen presence in each rat 
 
Rat 
 
ALT 
(U/L) 
Grade of necrosis per lobe  
Collagen 
 
Glycogen Median Right Left  Caudate 
1 1129 ++ ++ ++ ++ + Deplete 
2 124 0 + + 0 ++ PP 
3 220 + + + 0 ++ PP 
4 4690 +++ +++ ++ + + PP 
5 4550 +++ +++ +++ + + PP 
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Figure 4.10 Liver Histology from fasted APAP-treated rats: H&E and PAS stains  
A) H&E. Normal histology at 6 hours after APAP. Bar = 200 µm.  
B) PAS. A glycogen depleted area at 6 hours after APAP. Bar = 200 µm.  
C) H&E. Grade 1 (+) necrosis at 24 hours after APAP, there is mild necrosis with 
increased infiltrate in CL areas (arrow). C = central venule. Bar = 100 µm.   
D) PAS. In this section at 24 hours after APAP, PP hepatocytes contain glycogen 
however CL hepatocytes are depleted. C = central venule, P = portal venule. Bar = 
200 µm.   
E) Grade 3 (+++) CL hemorrhagic necrosis in a fasted rat 24 hours after APAP. There 
is intralobular variability of toxicity. The bottom left of the micrograph shows a 
region of CL hemorrhagic necrosis, and in the top half there is less necrosis however 
the CL sinusoids are dilated. Bar = 200 µm.   
F)  A magnified image of the boxed area in fig (E) showing an area of sinusoid 
dilation with the LSEC and HSCs at the centre (arrow) and mostly detached from 
hepatocyte contact. Bar = 100 µm.   
B A 
E 
C 
F 
D 
C 
P C C 
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Figure 4.11 Sirius Red stained sections of liver from fasted APAP-treated rats 
showing increased liver collagen 
A) Control liver from a fasted rat with very little collagen in the sinusoids. Bar = 100 
µm. 
B) Increased sinusoidal collagen at 6 hours after APAP. Bar = 200 µm. 
C) A necrotic region with increased collagen around central venules and in the 
necrotic areas at 24 hours after APAP. An arrow points to an area of hemorrhage. Bar 
= 100 µm.  
D) A micrograph counterstained with Fast Green FCF. Collagen fibres (red) are 
running through dilated sinusoids in a central zone 24 hours after APAP. The fibres 
(arrows) appear to be helping to connect degenerating hepatocytes with LSECs/HSCs. 
C = central venule. Bar = 20 µm. 
  
 
 
 
 
 
 
 
 
 
  
C D
A B 
C 
 125
4.4.5    Electron microscopy at 6 hours after APAP 
LSEC cytoplasms contained gaps ranging up to 3 µm in diameter (fig 4.12 A), 
although intercellular junctions were maintained. Some LSECs had mildly swollen 
cytoplasms that contained vacuoles, dense bodies, and pinocytotic vesicles. Where 
hepatocytes were degenerating in more severely damaged centrilobular zones, 
processes from hepatocytes were found extending through the enlarged SoD to the 
LSECs appearing to tether LSECs and hepatocytes together (fig 4.12 B). Platelets 
were occasionally observed in the sinusoids. 
 
 
 
 
Figure 4.12 Electron micrographs from fasted rats 6 hrs after APAP 
A) SEM: An LSEC containing gaps (bar = 1 µm). 
B) TEM: hydropic vacuoles in hepatocytes at the sinusoid edge (V). There are 
hepatocyte processes that extend to LSECs where the SoD is expanding (black arrow) 
(bar = 5 µm). 
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V 
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4.4.6    Electron microscopy at 24 hours after APAP 
In areas of hemorrhagic necrosis most LSECs were viable (fig 4.13 A), although some 
dead LSECs with pyknotic nuclei were observed (fig 4.13 B). Sinusoid lumens were 
often decreased in size presumably because of hemorrhage and swelling of 
hepatocytes undergoing oncotic necrosis. Fibrin and platelets were present 
particularly in the SoD and adjacent to or around necrotic cells (fig 4.14 A and B). 
There was increased infiltrate including monocytes, Pit cells, neutrophils, and some 
eosinophils. Hepatocytes undergoing ballooning degeneration (with dilated ER, 
nuclear shrinkage, and loss of microvilli) were sometimes found on the edge of 
necrotic zones (fig 4.16 A), appearing to force the sinusoids between them to decrease 
in diameter.  
 
In areas affected by sinusoid dilation, LSECs maintained their fenestrated phenotype 
and were of a normal thickness (fig 4.15 A). Occasionally gaps were observed up to 2 
µm in diameter. LSECs and HSCs were tightly associated with each other, and 
maintained some attachments to the degenerating hepatocytes (fig 4.15 A and B). 
Sinusoid lumens were sometimes moderately collapsed but often remained at a 
normal size. In contrast the SoD expanded significantly (ranging up to 30 µm in 
length, instead of normally measuring 0.3 - 1 µm) as the hepatocytes atrophied and 
lost their microvilli (fig 4.15 A). Large activated KCs were found mainly in the 
periportal sinusoids containing huge vacuoles of cellular debris (fig 4.16 B). In 
periportal zones and other areas of the liver not affected by necrosis, the sinusoids 
appeared mostly normal apart from occasional vacuolar and fatty degeneration of 
hepatocytes, and some mild defenestration and gaps in LSECs.  
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Figure 4.13 Electron micrographs from fasted rats 24 hrs after APAP 
A) TEM: A viable LSEC surrounded by hepatocytes that are dead or succumbing 
oncotic necrosis. An arrow points to LSEC (EC) cytoplasm, and a longer arrow points 
to a HSC process which remains closely associated to the LSEC. H = hepatocyte, R = 
RBC, L = lumen. Bar = 2 µm. 
B) TEM: A dead LSEC in a necrotic and hemorrhagic zone with a nucleus containing 
condensed chromatin (white arrow). Bar = 10 µm. 
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Figure 4.14 Electron micrographs from fasted rats 24 hrs after APAP 
A) TEM: Fibrin deposition (black arrows) in amongst necrotic hepatocytes and 
associated with RBCs (R) that are no longer in the sinusoid lumens. A platelet clot 
(white arrow) lies next to what may be an LSEC (EC). Bar = 10 µm. 
B) SEM: An area of sinusoid dilation showing atrophied hepatocytes (H) that appear 
as thin cords, and RBCs in the SoD (black arrow), some of which are trapped in fibrin 
clots (white arrow) (bar = 10 µm). 
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Figure 4.15 Electron micrographs from fasted rats 24 hrs after APAP 
A) TEM: A 2-dimensional view of a sinusoid dilated area. The SoD is greatly 
expanded and LSECs and HSCs are mostly floating free from hepatocytes although 
maintain some attachments (arrows). L = lumen, SD = SoD, H = hepatocyte. Bar = 20 
µm. Also refer to fig 4.10 E for a histological comparison. 
B) SEM: 3-dimensional view of a sinusoid dilated area. The LSEC contains gaps 
(white arrow) and has attachments (arrow) to a degenerating hepatocyte (H). An RBC 
(R) is in the SoD, L = lumen (bar = 2 µm). 
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Figure 4.16 Electron micrographs from fasted rats 24 hrs after APAP 
A) TEM: A section of hepatocytes probably from the midlobular zone (ML) 
undergoing balloon degeneration (arrow) that are adjacent to viable hepatocytes 
probably from the periportal (PP) zone. The lumens are smaller in where they are 
surrounded by ballooning hepatocytes (bar = 10 µm). 
B) TEM: A KC in the sinusoid contains large vacuoles/lysosomes (V) full of cellular 
debris. There is an autophagic vacuole (AV) in the hepatocyte (bar = 5 µm). 
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4.4.7    Summary of differences between fed and fasted APAP-treated rats 
Overall there was less hepatotoxicity in the fed than the fasted APAP-treated rats (see 
table 4.8). On average at 24 hours after APAP fed rats had lower serum 
aminotransferase levels, less centrilobular hemorrhagic necrosis, less infiltrate in areas 
of mild toxicity, and greater resilience of LSECs in areas of centrilobular necrosis. 
Fasted rats also displayed greater amounts of sinusoid dilation with more severe 
dilation, and more collagen deposition in the sinusoids and around venules than the 
fed rats suggestive of increased oxidative damage. Refer to Appendix 4, table 1 for a 
table of means ± S.D. of APAP-treated and F344 untreated rats. 
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Table 4.8 Table of raw and mean ± S.D. data from ad libitum fed and fasted APAP 
treated rats culled 6 or 24 hours after APAP. Scores for centrilobular necrosis and 
sinusoidal collagen are the sum of the ‘+’s in each group divided by the number of 
rats 
  Rat  
APAP treated rats Group 1 2 3 4 5 6 Mean ± SD 
ALT (U/L) 
6 hr fast 46 50 33 45 51  45±7.2 
24 hr fast 1129 124 220 4690 4550  2143±2296 
24 hr fed 48 38 52 16 702 no data 171.2±297 
AST (U/L) 
6 hr fast 80 100 60 72 95  81.4±16.4 
24 hr fast 1124 143 209 7053 6513  3008±3473 
24 hr fed 96 86 104 32 459 no data 155.4±172 
Total Bilirubin (U/L) 
6 hr fast 1 1 1 1 1  1±0 
24 hr fast 2 2 1 3 2  2±0.7*† 
24 hr fed 3 6 4 1 3 no data 3.4±1.8* 
% Weight loss from time of 
fast 
6 hr fast 10.4 5.9 8.3 5.6 7.4  7.5±1.9 
24 hr fast 13.7 15.6 12.4 11.8 11.3  13±1.7*† 
% Weight loss 24 hr fed 4.9 4.4 3.8 4.8 4.9 no data 4.6±0.5 
Total cholesterol (µmol/L) 
6 hr fast 1.3 1.5 1.3 1.2 1.3  1.3±0.1 
24 hr fast 1.3 1.2 1.1 1.1 0.8  1.1±0.2*† 
Triglycerides (µmol/L) 
6 hr fast 0.5 0.8 1.1 0.7 0.9  0.8±0.2 
24 hr fast 1.5 0.9 0.6 0.2 0.5  0.7±0.5 
Urea 
6 hr fast no data 3.8 5.1 6.3 1.4  4.2±2.1 
24 hr fast 7.4 no data 6.5 6.2 10.8  7.7±2.1*† 
Creatinine 
6 hr fast no data 13 22 28 no data   21±7.5 
24 hr fast 50 no data 27 27 43  36.8±11.6*† 
Hematocrit (%) 
6 hr fast 58 59 63 56 62  59.5±2.7 
24 hr fast 73 63 65 61 50  62±8† 
Liver wet weight  % body 
weight 
6 hr fast 2.9 3.4 3.3 4.5 2.7  3.3±0.7 
24 hr fast 4.9 4.9 3.4 4 4.1  4.3±0.6*† 
Centrilobular Necrosis 
6 hr fast 0 0 0 0 0  0 
24 hr fast ++ + + +++ +++  32/25 = 1.28 
24 hr fed 0 0 0 0 ++ +++ 5/6 = 0.83 
Sinusoidal Collagen 
6 hr fast ++ ++ ++ ++ ++  10/5 = 2 
24 hr fast + ++ ++ + +  7/5 = 1.4 
24 hr fed 0 0 0 0 + + 2/6 = 0.33 
Glycogen Deposition 
6 hr fast 0 0 0 0 0  0 
24 hr fast 0 PP PP PP PP  PP 
24 hr fed 0 0 0 PP PP 0 0 - PP 
*p<0.05 compared to 6 hr rats.       
†p<0.05 compared to control rats.        
Note: The score for necrosis in the APAP 24 hr fasted group was calculated by the 
sum of all the scores for each lobe (see table 4.7) divided by the number of lobes 
analysed. 
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4.6    Discussion  
APAP overdose resulted in a pattern of centrilobular toxicity that sometimes 
developed into severe centrilobular hemorrhagic necrosis although periportal 
hepatocytes remained viable, sustaining only mild damage. Injury to the 
microvasculature and LSECs was apparent before hepatocyte necrosis, however as 
parenchymal injury increased, damage to the LSECs appeared to ameliorate until the 
hepatotoxicity became too severe for the LSECs in the worst affected centrilobular 
zones to survive. 
 
In instances of mid-range hepatotoxicity, LSECs surrounded by necrotic hepatocytes 
appeared to be very resilient to toxicity and were in their fenestrated phenotype. 
Although there was disorganisation of cells and squashed sinusoids in areas of 
significant necrosis and hemorrhage, LSECs and HSCs remained together with 
increased extracellular matrix between them and tethered to necrotic hepatocytes. 
Initial injury to LSECs could have improved and LSEC viability maintained as 
vascular endothelial growth factor A (VEGF) production and expression of VEGF 
receptors increase throughout the course of APAP toxicity (Papastefanou, 2007). 
VEGF is a cytokine important in angiogenesis and is a specific mitogen for 
endothelial cells. LSEC fenestration is normally maintained by paracrine secretion of 
VEGF by hepatocytes and HSCs (Xie, 2012) and VEGF has been shown to protect 
LSEC viability and maintain their fenestrated phenotype in vitro (Esser, 1998). 
 
In addition, LSEC viability is strengthened in hypoxic environments (Martinez, 2008), 
and stimulation of VEGF production and its release by HSCs occurs in response to 
liver injury and hypoxia (Ankoma-Sey, 2000, Zhao, 2012). LSECs contain VEGF 
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receptors that when stimulated are not only protective to LSECs, but activate the 
production of hepatocyte growth factor (HGF) and other paracrine factors that are 
essential for liver regeneration after massive necrosis (LeCouter, 2003). Endogenous 
VEGF is essential for hepatocyte regeneration in the later recovery stages of APAP 
toxicity (Donahower, 2006, Donahower, 2010, Kato, 2011, Papastefanou, 2007) 
providing strong evidence to suggest that hepatoprotective effects of VEGF in APAP 
toxicity are secondary to amelioration of LSEC injury and regeneration of the 
microvasculature. It is possible that there would have been a decreased survival rate in 
the rats with high numbers of dead LSECs in areas of confluent hepatocyte necrosis. 
 
Increased extracellular matrix production between LSECs and HSCs has been 
described in various disease states (Le Bail, 1990) and in ageing (Le Couteur, 2002), 
however has not been previously described in APAP toxicity. It is likely that the 
production of basement membrane increased the tethering of LSECs and HSCs, was 
essential to the maintenance of the sinusoid structure in disorganised necrotic areas 
(critical to the later process of liver regeneration), and helped to prevent LSECs from 
denuding and occluding sinusoids (as occurs in sinusoidal obstructive syndrome 
(DeLeve, 2007a)). The decreased lumen size where there was sinusoid dilation and 
necrosis could have been due to increased pressure in the SoD because of RBC 
accumulation, and contraction of HSC processes in order to regulate blood flow in the 
liver (Friedman, 2008, Thimgan, 1999, Vollmar, 2009) and decrease flow to areas of 
hemorrhage. 
 
LSEC injury was apparent by 6 hours after APAP and prior to parenchymal necrosis. 
Injury consisted of gaps that replaced some of the fenestrations and sieve plates in the 
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cytoplasm, and mild swelling in parts of the cytoplasm containing many pinocytotic 
vesicles, vacuoles, and dense bodies. Generally the surrounding hepatocytes had 
developed signs of degeneration including hydropic vacuoles at the sinusoid border 
and loss of microvilli. It is possible that LSEC injury occurred prior to the hepatocytes 
as described in other studies (Ito, 2003) however the 6 hour time-point in our study 
was too late to observe the very first signs of LSEC injury. Analysis at 6 hours after 
APAP confirmed that microvasculature disruption, such as congestion and the 
appearance of platelets in centrilobular zones occurred prior to necrosis (Walker, 
1985), and gaps in the LSECs and defenestration sometimes occurred where the 
underlying hepatocytes appeared to be morphologically sound. 
 
Also at 6 hours after APAP, long processes from hepatocytes that were losing 
microvilli projected across the SoD to the LSECs. This appeared tether the sinusoids 
and degenerating parenchyma together, and is consistent with that described by a 
previous study (Walker, 1983). Both injury to LSECs (Xie, 2012) and hepatocytes 
(Svegliati Baroni, 1998) can stimulate HSC activation and collagen production. 
Increased production of collagen was observed mainly in the central zones at 6 hours 
after APAP implicative of oxidative damage to the liver, and has been previously 
found to occur early in APAP toxicity as a result of decreasing GSH levels (Morsy, 
2010, Toklu, 2006).  
 
Consistent with previous studies, glycogen stores were depleted or at very low levels 
at 6 hours after APAP (Jepson, 1987, Price, 1987). Glycogenolysis can be stimulated 
by hypoxic conditions and ionic changes in cells (such as increased intracellular Ca2+) 
that can occur early in APAP toxicity (Hinson, 1983). At 24 hours both fed and fasted 
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rats displayed replenishments of periportal glycogen whilst centrilobular hepatocytes 
remained depleted. Glycogen phosphorylase activation in centrilobular hepatocytes 
occurs after glutathione levels are depleted and prior to loss of membrane integrity, 
and thus may be a sensitive indicator of early cell damage (Corcoran, 1988, Jepson, 
1987). There is also a reciprocal and concurrent increase of glycogen levels in 
periportal hepatocytes (synthesised from gluconeogenic precursors rather than 
glucose) indicating heterogeneity of the centrilobular and periportal hepatocytes in 
response to toxicity from APAP overdose (Jepson, 1987). The degree of glycogen 
phosphorylase activation in centrilobular hepatocytes and glycogen formation in 
periportal hepatocytes is dose dependent, and increase with higher doses of APAP and 
as more severe histological damage is apparent. Changes in glycogen metabolism may 
therefore be linked to the cytotoxic effects of APAP metabolism, and be observed as a 
marker of hepatotoxicity (Jepson, 1987). APAP depletes GSH and glycogen by 
similar percentages at each dose, and if NAC is administered with APAP it prevents 
both the early APAP-induced glycogen depletion and toxicity. This suggests that 
glycogen depletion is somehow related to the formation of NAPQI (Hinson, 1983). 
The presence of glycogen may also play a minor role in protection from toxicity 
(Hinson, 1983). 
 
By 24 hours after APAP, confluent hepatocyte necrosis had developed in centrilobular 
zones of most rats and serum aminotransferase levels rose in correlation with the 
severity of necrosis as previously reported (Hessel, 1996). Total serum bilirubin also 
significantly increased from normal in both fed and fasted APAP-treated groups. 
Bilirubin (the breakdown product of heme) is metabolised to a water-soluble molecule 
by glucuronidation (Wang, 2006) and thus would be expected to increase in APAP 
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toxicity as it is in competition with APAP for glucuronidation. Excretion of 
conjugated bilirubin into the bile is also inhibited in APAP toxicity (Davis, 1975).  
 
As was expected, at 24 hours after APAP hepatotoxicity was more prominent in 
fasted rats than fed rats. Fasting is known to increase APAP toxicity in humans 
(Whitcomb, 1994) and rats fasted for 24 hours before dosage (Pessayre, 1979). 
Fasting significantly decreases GSH stores in the liver, reducing its anti-oxidant 
capacity and the ability for the toxic metabolite NAPQI to be detoxified (Walker, 
1982). In addition, fasting increases the half-life of APAP by depressing the rates of 
glucuronidation and sulfation (the non-toxic elimination pathways for APAP), thereby 
increasing the proportion of APAP metabolised by the toxic CYP450 pathway (Price, 
1988, Price, 1987). There was decreased survival of LSECs in areas of parenchymal 
necrosis 24 hours after APAP in fasted rats compared to rats ad libitum fed prior to 
APAP. The decreased resilience of LSECs may have been due to reduction of GSH 
stores during fasting thereby lowering the anti-oxidant and detoxifying capacity of the 
LSECs to NAPQI and other toxins produced during APAP toxicity. In addition, as 
fasting prior to APAP increases the half life of APAP and NAPQI production, the 
insult is further increased on cells that are already more vulnerable to damage. This 
decreased resilience of the LSECs to necrosis may have augmented the amount of 
hepatocyte necrosis in the fasted rats by affecting the viability of the 
microvasculature, enhancing the congestion, hemorrhage, and ischemic damage to 
hepatocytes. It is also possible that HSCs were more vulnerable to damage in fasted 
rats and were not able to release enough VEGF to maintain LSEC viability. 
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In addition to the more severe parenchymal and LSEC toxicity, there was additional 
collagen deposition in fasted APAP-treated rats at 24 hours probably in response to 
the decreased anti-oxidant capacity of the liver (Sener, 2005). Also there was a greater 
presence of infiltrate in the fasted rats in reaction to the increased necrosis. Whether 
inflammatory cells in APAP toxicity promote or abate further damage is still under 
discussion (Ishida, 2006, Jaeschke, 2012b). KCs also appeared to be more activated in 
fasted rats, however KC activation is important for clearing away cellular debris and 
is thought to be protective in APAP-toxicity (Holt, 2010). 
 
The severity and amount of sinusoid dilation in fasted rats at 24 hours after APAP was 
much greater than in the fed rats with severe hepatotoxicity. The cause of the more 
extreme dilation appeared to be due to severe congestion and hemorrhage that 
increased pressure in the sinusoids (as suggested by (Lim, 1995)) combined with 
hepatocyte atrophy. Cells have the ability to atrophy to accommodate changes in 
oxygen and nutrient availability, such as in ischemic environments with decreased 
blood supply, and can decrease their size in response to this (Robbins, 2007). 
Autophagy can accompany this process and large autophagic vacuoles in some of the 
hepatocytes were observed particularly in the fasted group. Autophagy is a protective 
mechanism in APAP overdose, removing damaged mitochondria, stopping 
unessential cell processes, and freeing up nutrients such as sugars, fatty acids and 
amino acids (Igusa, 2012, Ni, 2012) for gluconeogenesis (Ezaki, 2011). Thus, more 
severe sinusoidal dilation in fasted rats was probably due to a combination of lower 
nutrient and antioxidant stores prior to APAP dosage, and increased amounts of 
congestion and hemorrhage which also led to a significant increase the liver weight of 
fasted rats at 24 hours after APAP. Hepatomegaly during the initial stages of APAP 
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toxicity is primarily a result of plasma accumulation, congestion and hemorrhage 
(thus increased blood volume), and increased numbers of inflammatory cells in the 
liver (Walker, 1985).  
 
Regardless of the differences in severity of hepatotoxicity between fed and fasted rats, 
both groups displayed a wide range of response to APAP overdose. Twenty-four 
hours after an equivalent dose of APAP, some rats had developed massive necrosis 
whereas others sustained only mild damage consistent with the extremely variable 
range differences in serum aminotransferases. At 6 hours there was a less noticeable 
range of variability as the hepatotoxicity was not as intense and was still in the 
process of developing. The level of APAP toxicity from a particular dose is known to 
be extremely variable amongst subjects including humans (Whitcomb, 1994) and 
laboratory animals (Foley, 2006, McLean, 1975), however the reasons for this are 
unclear.  
 
Another common feature of APAP toxicity observed in our study was inter and intra 
lobular variability of hepatotoxicity (McLean, 1975). Histological examination of four 
lobes of the liver revealed the amount of hemorrhage and necrosis in each lobe and 
each centrilobular zone of a particular liver could vary from none to severe. Reasons 
for this variability are not understood but could at least partially be due to differences 
in gene expression throughout the liver (Foley, 2006, Irwin, 2005). Consistent with 
the variations in toxicity, the density and zonal distribution of collagen and glycogen 
were variable throughout the liver. 
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In conclusion this study was the first to perform an ultrastructural analysis of LSECs 
using scanning and transmission electron microscopy after extensive centrilobular 
necrosis had occurred in APAP-treated rats, confirming that LSECs are able to remain 
viable and fenestrated in areas of confluent hepatocyte necrosis and ischemia. We also 
observed that HSCs appear to play a major role in physically protecting LSECs in 
areas of hepatocyte necrosis, and that there was extensive formation of extracellular 
matrix between the cells that helped to preserve sinusoid structure where the 
surrounding hepatocytes were dead. 
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5.1    Introduction 
Therapeutic substances that could aid in ameliorating APAP hepatotoxicity are still 
being investigated. LSEC injury, gap formation, and subsequent disruption of the 
microvasculature plays a major role in the severity of hepatotoxicity after APAP 
overdose, occurring prior to hepatocyte necrosis (see Chapter 4). Studies have shown 
that protection of the LSEC and hepatic microcirculation significantly decreases liver 
injury (Ganey, 2007, Ito, 2005, McCuskey, 2006) however the exact mechanism of 
LSEC injury during APAP toxicity remains unclear. 
 
P407 (Pluronic® F-127 or P407) is an LSEC defenestrating agent (Cogger, 2006) that 
may be protective in APAP toxicity by preventing or delaying structural LSEC injury, 
such as the development of gaps that lead to hemorrhage, sinusoid lumen collapse, 
and congestion, and by reducing the amount of APAP and toxic substances from the 
blood reaching the hepatocytes. In addition, it may be capable of interacting with and 
restoring activity of damaged cell membranes (Frey, 2007). Thus P407 might 
ameliorate or prevent microvasculature dysfunction if it were to prevent endothelial 
injury and gap formation after APAP overdose. P407 is a triblock copolymer 
composed of repeating polyoxyethylene and polyoxypropylene units and has 
thermoreversible properties (Dumortier, 2006, Johnston, 2004). At approximately 4 - 
5 °C and below, P407 is a low-viscosity solution, and as the temperature increases 
P407 molecules aggregate into micelles and form a semisolid gel (Zhang, 2002). P407 
is regarded as a non-toxic substance and is already used in pharmaceutical 
preparations (Dumortier, 2006, Li, 1996).  
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P407 has been used in murine studies as an agent that effectively induces pronounced 
hyperlipidemia and hypercholesterolemia without any inherent toxicity (Palmer, 
1997). In fact P407 can be administered chronically to induce atherogenic lesions 
without any other apparent adverse effects for the study of atherosclerosis (Palmer, 
1997). P407 is also safely used to induce hyperlipidemia for the study of 
pharmacokinetics of various drugs during hyperlipidemia (Lee, 2011, Lee, 2012, 
Shayeganpour, 2008). Some of these studies showed that P407 reduces the expression 
of CYP450 enzymes (in particular those of the CYP3A family (Lee, 2011, 
Shayeganpour, 2008) involved in APAP metabolism (Kostrubsky, 1997, Thummel, 
1993) which could be beneficial in APAP overdose by reducing the production of 
toxic metabolites.  
 
It was previously thought that P407 primarily induces hypertriglyceridemia via a 
dose-dependent inhibition of lipoprotein lipase, and hypercholesterolemia by indirect 
effects on hepatic 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase 
activity (Johnston, 2004), and by affecting the activities of various other lipid 
metabolising enzymes (Wasan, 2003). However, it is now known that defenestration 
of the LSEC by P407 also promotes hyperlipidemia by impairing the passage of 
chylomicrons to hepatocytes (Cogger, 2006). The mechanism of P407-induced LSEC 
defenestration in vitro and in vivo is not currently understood. It has recently been 
reported that fenestrations are regulated by lipid rafts in the cell membrane and that 
defenestration can be induced by removal of the non-raft membranes with detergents 
such as Triton X-100 (Svistounov, 2012). P407 has similar properties to Triton X-100 
so might also cause defenestration by the same mechanism. Poloxamers have the 
ability to form tiny pores in membranes that can enable the flux of various cations 
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such as calcium and potassium (Krylova, 2004, Sutachan, 2006) thus the mechanism 
could be related to an effect of P407 on cytoplasmic ion concentrations that could 
increase contraction or dilation of actin filaments around fenestrations. When P407 is 
added to LSECs in vitro it induces profound and acute defenestration of the LSEC 
cytoplasm, and does this by a direct mechanism without influence from other cells 
(Cogger, 2006). In vivo, after intraperitoneal injection, P407 is avidly taken up into 
the liver (Li, 1996). Analysis of porosity using the scanning electron microscope 
showed that P407 significantly defenestrates LSECs (reducing fenestrations by up to 
80 %) from 12 - 36 hours after injection in mice in accordance with a 10 fold increase 
in plasma lipids (Cogger, 2006). P407 does not affect mitochondria or ATP 
production but may work by direct interaction with the cell membrane (Cogger, 
2006). Transmission electron microscopy analysis of murine livers one day after P407 
injection showed that LSECs developed large vacuoles full of lipids and/or P407 
micelles in conjunction with LSEC defenestration and swelling observed on scanning 
electron microscopy, probably in an effort to remove excess lipid and P407 from the 
blood (Warren, 2011).  
 
In addition to LSECs, other liver cells are affected by P407. KCs, become engorged 
with vacuoles full of lipid and/or P407, and are occasionally so swollen they appear to 
completely occlude the sinusoid lumen (Warren, 2011). Hepatocytes, although 
involved in the endocytosis of P407, do not develop steatosis despite the 
hyperlipidemia (Millar, 2005, Warren, 2011), and the morphology of HSCs does not 
change. This could be because LSEC defenestration reduces the access of serum 
lipoproteins to the SoD (and thus the hepatocytes and HSCs).  
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P407 micelles are 20 - 80 nm in diameter being the perfect fit for plugging 
fenestrations that are on average 50 - 150 nm wide in a process equivalent to so-called 
‘fouling’ of ultrafiltration membranes. A fenestration-plugging and/or defenestration 
action by P407 may be beneficial in reducing toxic metabolite production in APAP 
overdose by reducing APAP availability to hepatocytes. One study has shown that the 
passing of APAP from the lumen to the SoD (in the rat) is impeded by a pre-injection 
of P407 (Mitchell, 2010). P407 micelles have been observed throughout the SoD, 
adsorbed to LSECs and between fenestrations on transmission electron microscopy 
(Warren, 2011). 
 
This study aimed to test whether P407, a non-toxic substance already used in 
pharmaceutical preparations that directly targets LSECs, had an ameliorative effect on 
hepatotoxicity during APAP overdose on fed rats, and on fasted rats with more severe 
hepatotoxicity. We pre-treated some rats with P407 to coincide LSEC defenestration 
with APAP administration, and post-treated some rats with P407 after APAP 
administration to observe whether P407 had any potential as a therapeutic substance 
by restoring the activity of damaged cell membranes and ameliorating LSEC injury 
and hepatic microcirculation.  
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5.2    Materials and Methods  
5.2.1    Materials  
0.5 g/ml of P407 (donated by BASF chemicals) in normal saline was prepared by 
mixing gently at 4 °C and kept in liquid form in the fridge or over ice. Animals and 
other chemicals used are identical to those described in section 4.2. 
 
5.2.2    Methods  
 
For P407 pre-treated rats, an intraperitoneal injection of P407 (1 g/kg rat) was 
administered 18 hours before a gavage of APAP (1000 mg/kg rat) which is the dose 
required to defenestrate the LSEC by the time of APAP gavage according to a 
previous study (Cogger, 2006). For P407 post-treated rats, an intraperitoneal injection 
of P407 (1 g/kg rat) was administered 1 hour after a gavage of APAP (1000 mg/kg 
rat). It was determined whether P407 successfully entered the blood by observing and 
testing whether the blood was lipemic (Wout, 1992). Apart from the P407 injection, 
the procedure for surgery, specimen preparation, and analysis used for these 
experiments were identical to those described in section 4.2. 
 
Rats were divided into groups as follows (see fig 5.1). In the ad libitum fed groups 
(fed P407 pre-treated and post-treated groups) 12 rats were ad libitum fed until food 
was removed when 1 g/kg APAP was given. In the fasted rat groups (fasted P407 pre-
treated and post-treated groups) 20 rats were fasted from 24 hours before APAP 
gavage until time of surgery. Ten of those rats were culled at 6 hours after APAP 
gavage (5 from each of the fasted P407 pre- and post-treated groups), and 10 were 
culled at 24 hours after APAP gavage (5 from each of the fasted P407 pre- and post- 
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treated groups). One rat was excluded from the 24 hour fasted P407 post-treated 
group after blood analysis because it was not hyperlipidemic and thus may not have 
properly received the dose of P407 (Wout, 1992), leaving this group with n = 4 rats 
for analysis. Control rats for this experiment were the fed and fasted APAP-treated 
rats from Chapter 4 (labelled in this chapter as APAP controls). 
 
     Fischer Rats 
         (n = 52) 
 
  Fed     Fasted 
          (n = 18)                (n = 34)    
 
 
      
     6 hrs after      6hrs after     
      APAP         APAP   
 24 hrs after    24 hrs after       (n=5, n=5)   (n=5, n=5)  24 hrs after   24 hrs after 
    APAP          APAP                 APAP  APAP 
   (n=6, n=6)       (n=6)                     (n=5, n=4)  (n=5) 
            
 
Figure 5.1 Experimental treatment groups: P407 was injected 18 hours before or 1 
hour after APAP gavage. APAP control rats received APAP and no P407. Surgery 
occurred either 6 or 24 hours after APAP. 
 
 
Apart from the P407 injection, the procedure for surgery and perfusion fixation, 
specimen preparation, and analysis used for these experiments were identical to those 
described in section 4.2. Briefly, after perfusion fixation specimens were collected for 
histology and electron microscopy analysis. Again, average porosity and fenestration 
diameter of LSECs were unable to be measured due to intralobular variability of 
toxicity (fig 5.2). Measurements were taken using Image J of control and P407 rats to 
estimate and compare the size of the sinusoid lumen, SoD, fenestrations, gaps, and 
LSEC cytoplasm in different areas of the liver. Blood samples were also collected. 
Pre- and 
post- treated 
P407
Control  
Pre- and 
post-treated 
P407 Pre- and 
post-treated 
P407 
Control  
Control  
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Renal tissue from one rat was reprocessed from paraffin for transmission electron 
microscopy (as by the procedure described in Chapter 2) as an unknown substance 
was found in the tubules during histological analysis.  
 
 
Figure 5.2 Example of intralobular differences in P407 pre-treated rats  
A) and B) are micrographs taken from different areas of the same section of a P407 
pre-treated rat liver at 24 hours after APAP showing severe differences in toxicity 
across the lobe. In A) there is only very mild centrilobular necrosis (arrows) however 
in B) there is severe hemorrhagic centrilobular necrosis (arrow) and sinusoidal 
dilation in midlobular and periportal zones. C = central venule, P = portal venule. 
Bars = 100 µm. 
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5.3    Results: P407 pre-treated rats 
5.3.1    Macroscopic observations  
 
At 6 and 24 hours after APAP rats mostly appeared quiet and sedated. Two 24 hour 
rats from the fasted group (with very high serum aminotransferase levels) had gross 
hematuria.   
 
5.3.2    Blood analysis  
 
5.3.2.1   Fed P407 pre-treated 24 hour group 
In the 24 hour fed P407 pre-treated group, serum aminotransferases tended to be 
increased however were not significantly different as the data was highly variable 
(table 5.1). Total bilirubin was significantly lower in the P407 pre-treated 24 hour fed 
group, and weight loss was significantly higher than control (table 5.1). 
 
 5.3.2.2    Fasted P407 pre-treated 6 and 24 hour groups 
At 6 hours after APAP the P407 pre-treated rats had significantly lower serum ALT 
and bilirubin than the APAP control rats however the difference was minor (table 
5.1). In the 24 hour fasted P407 pre-treated group, average ALT and AST were 
increased, although not significantly due to variability in the data (table 5.1). There 
were significant increases in serum cholesterol and triglycerides at both 6 and 24 
hours in the P407 pre-treated rats, and significant decreases in hematocrit (table 5.1).  
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Table 5.1 Raw and mean ± S.D. data from ad libitum fed or fasted APAP treated rats 
culled 6 or 24 hrs after APAP and pre-treated with P407 18 hrs before APAP 
 
  Rats raw data   
P407 pre-treated rats Group 1 2 3 4 5 6 Mean ± SD 
APAP 
control 
ALT (U/L) 
6 hr fast 36 20.4 30 31.2 26.6  29±6* 45±7.2 
24 hr fast 2210 14850 11370 29 185  5729±6903 2143±2296 
24 hr fed 164.4 64.8 76.8 153.6 1549 no blood 402±643 171.2±297 
AST (U/L) 
6 hr fast 70.8 76.8 76.8 54 60.2  68±10 81.4±16.4 
24 hr fast 3044 23830 20360 51 277  9512±11612 3008±3473 
24 hr fed 218.4 54 70.8 190.8 3378 no blood 782±1453 155.4±172 
Total Bilirubin (U/L) 
6 hr fast 0 0 0 0 1.4  0.3±0.6* 1±0 
24 hr fast 1 5 4 0 0  2±2.3 2±0.7 
24 hr fed 0 0 0 0 0 no blood 0* 3.4±1.8 
% Weight loss from time of 
fast 
6 hr fast 7 6.9 7.9 6.1 5.2  6.6±1 7.5±1.9 
24 hr fast 10.6 9.2 9.9 10.1 9.6  10±0.5 13±1.7 
% Weight loss 24 hr fed 7.4 no data no data 8.1 4.6 6.6 6.7±1.5* 4.6±0.5 
Total cholesterol (µmol/L) 
6 hr fast 9.6 8.6 12.2 12.9 10.4  10.7±1.8* 1.3±0.1 
24 hr fast 4.6 9.4 14.5 8 15.1  10.3±4.5* 1.1±0.2 
Triglycerides (µmol/L) 
6 hr fast 44.7 31.9 61 67 60  53±14.3* 0.8±0.2 
24 hr fast 11.3 28.5 64 27.7 69.6  40±25.3* 0.7±0.5 
Hematocrit (%) 
6 hr fast 44 46 47 47 47  46±1* 59.5±2.7 
24 hr fast 49 36 39 47 43  43±5* 62±8 
Liver wet weight  % body 
weight 
6 hr fast 3.5 3.3 3.6 3.7 2.9  3.4±0.3 3.3±0.7 
24 hr fast 4.1 5.6 4.8 4 3.7  4.4±0.8 4.3±0.6 
*p<0.05 compared to APAP control         
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5.3.3    Histology 
5.3.3.1    Fed P407 pre-treated 24 hour group 
As was observed in APAP-control rats, toxicity was variable within the P407 pre-
treated fed group (table 5.2). In contrast to APAP-controls, the hepatocytes often 
contained larger sized vacuoles and there was increased inflammation particularly in 
necrotic areas (fig 5.3 A and C). P407 was sometimes observed in the portal venules 
adjacent to both viable and necrotic centrilobular zones (fig 5.3 B). Glycogen was 
present in periportal zones of 3 out of the 6 rats, similar to the APAP controls (fig 5.3 
C), and sinusoidal collagen was mildly increased compared to APAP controls (fig 5.3 
D). 
 
 
Table 5.2 Graded necrosis and sinusoidal collagen, glycogen distribution, and serum 
ALT value for comparison in the P407 pre-treated fed APAP rats 24 hrs after APAP 
 
 
Rat ALT (U/L) Necrosis Collagen Glycogen 
1 164.4 + + 0 
2 no blood 0 + 0 
3 64.8 + + PP 
4 76.8 0 ++ 0 
5 153.6 0 0 PP 
6 1549.2 +++ + PP 
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Figure 5.3 H&E, PAS, and Sirius Red stained sections from Fed P407 pre-treated 
APAP rats 
A) H&E of an area of high toxicity showing CL hemorrhagic necrosis and a high 
amount of infiltrate. There is P407 in the portal venule (P) visible as a grey substance 
and shown magnified in (B). C = central vein. Bar = 100 µm. 
B) Magnified view of the portal venule in (A) showing the P407 entering the 
sinusoids. Bar = 20 µm. 
C) PAS. An area of CL necrosis that is glycogen depleted. There is dense infiltrate 
(arrow) around the central venule and the collapsed reticulin framework around 
necrotic hepatocytes is stained pink. Bar = 100 µm. 
D) Sirius Red counterstained with Fast Green. This section is from a rat with mild 
hepatotoxicity and increased sinusoidal collagen (arrow). Bar = 20 µm. 
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5.3.3.2    Fasted P407 pre-treated 6 hour group 
At 6 hours after APAP histology was mostly normal apart from some patchy 
inflammation and mild amounts of vacuolisation of hepatocytes in centrilobular zones 
(fig 5.4 A). One P407 pre-treated rat displayed mild centrilobular necrosis and severe 
congestion with sinusoidal dilation and large vacuoles in centrilobular hepatocytes 
(fig 5.4 B and table 5.3), a level of damage more severe than found in APAP controls 
at 6 hours. Glycogen was present mainly in a centrilobular and midzonal pattern (fig 
5.4 C and table 5.3) which was in contrast to APAP control rats where glycogen was 
mostly depleted. Sinusoidal collagen increased by a similar amount to APAP controls 
(fig 5.4 D and table 5.3).  
 
Table 5.3 Graded necrosis and sinusoidal collagen, glycogen distribution, and serum 
ALT value for comparison in the P407 pre-treated fasted rats 6 hrs after APAP 
 
Rat ALT (U/L) Necrosis Collagen Glycogen 
1 36 + ++ PP 
2 20.4 0 ++ CL and ML 
3 30 0 ++ CL and ML 
4 31.2 0 ++ Diffuse 
5 26.6 0 ++ CL 
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Figure 5.4 Histology of fasted P407 pre-treated rats at 6 hrs after APAP: H&E, PAS, 
and Sirius Red 
A) H&E. There is vacuolisation of CL hepatocytes and what appears to be a KC 
(arrow) full of vacuoles filling the sinusoid lumen. C = central venule. Bar = 50 µm.  
B) H&E. There is CL congestion and mild sinusoid dilation. P = portal venule. Bar = 
200 µm.  
C) PAS. Glycogen is in a CL pattern and PP hepatocytes are depleted. Bar = 100 µm.  
D) Sirius Red. Sinusoidal collagen is increased. Bar = 200 µm. 
 
 
5.3.3.3    Fasted P407 pre-treated 24 hour group 
At 24 hours after APAP, P407 pre-treated rats displayed the same type of histological 
damage to the liver as the APAP control rats (centrilobular hemorrhagic necrosis, 
congestion, sinusoid dilation, vacuolisation of centrilobular hepatocytes; fig 5.5 A and 
B) with similar inter and intra lobular variability (table 5.4) although in 3 rats the 
hepatotoxicity was more severe than APAP controls. There were also larger vacuoles 
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in hepatocytes, and a greater presence of inflammatory cells particularly in necrotic 
areas (fig 5.5 C) than the APAP controls. Similar to APAP controls there was also 
variability in toxicity within the group (table 5.4). In two of the P407 pre-treated rats, 
the necrosis and congestion was more extreme than the controls. Both of these rats 
displayed macroscopic hematuria, and on examination of renal histology an unknown 
substance was observed in the tubules that may have consisted of P407 (see fig 5.10). 
In contrast, one rat displayed a milder degree of damage than the APAP controls (with 
histology relatively normal apart from some mild congestion and vacuolisation of 
centrilobular hepatocytes) and had normal range LFTs. ALT levels ranged from 
approximately 1 to 370 times the normal average (whereas control APAP rats ranged 
from 3 to 117 times). Similar to APAP controls, glycogen was present in the 
periportal zones of 3 out of the 5 rats (fig 5.5 C, table 5.4). Collagen was increased 
from normal with similar patterns to APAP controls, in the most severely necrotic 
areas there was mild bridging fibrosis (fig 5.5 D, table 5.4).  
 
 
Table 5.4 P407 pre-treated fasted 24 hr group: individual graded centrilobular 
necrosis in four liver lobes, graded sinusoidal collagen, glycogen distribution, and 
ALT values for comparison in each rat 
 
Rat ALT (U/L) 
Grade of Necrosis Per Lobe 
Collagen Glycogen 
Median Right Left  Caudate 
1 2210 ++ +++ +++ ++ + PP 
2 14850 +++ +++ +++ +++ + N 
3 11370 ++ +++ ++ +++ + N 
4 29 0 0 0 0 + PP 
5 184.8 + ++ + + ++ PP 
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Figure 5.5 Histology of fasted P407 pre-treated rats 24 hrs after APAP: H&E, PAS, 
and Sirius Red 
A) H&E. This micrograph shows an area of severe CL hemorrhagic necrosis and 
sinusoid dilation in a P407 pre-treated APAP rat. The PP zone contains heavily 
vacuolated hepatocytes (C = central venule, P = portal venule). Bar = 100 µm. 
B) H&E. A magnified area of sinusoid dilation is displayed in this micrograph of a 
P407 pre-treated APAP rat. Arrows point to intact, collapsing sinusoid lumens 
containing RBCs and leukocytes. LSEC and HSC nuclei are visible in the middle of 
the grossly enlarged SoD with some attachments to cords of atrophied hepatocytes. 
Open arrows point to a neutrophil with a multi lobed nucleus (upper arrow) and a 
monocyte. Bar = 20 µm.  
C) PAS. This micrograph taken from a P407 pre-treated APAP rat with moderate 
hepatotoxicity shows glycogen in a distinct PP pattern with CL hepatocytes glycogen 
deplete. Bar = 200 µm. 
D) Sirius Red. This micrograph shows an area of CL necrosis from a P407 pre-treated 
APAP rat with high hepatotoxicity. Thick collagen bundles appear to be almost 
bridging portal tracts (arrow). Bar = 100 µm. 
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Table 5.5 is a summary of the histological results for centrilobular necrosis, collagen, 
and glycogen in each group. At 6 hours, P407 pre-treatment mildly increased 
sinusoidal collagen however did not change the level of histological necrosis from 
APAP controls. There was glycogen deposition at 6 hours after APAP whereas 
control APAP rats were depleted of glycogen. At 24 hours after APAP, P407 pre-
treatment increased centrilobular necrosis in the fasted rats, whereas it had no effect in 
the fed rats. There was less sinusoidal collagen in the fasted pre-treated rats than 
APAP controls however there was increased sinusdoidal collagen in the fed pre-
treated rats. Glycogen deposition was unaffected by P407 pre-treatment. 
 
 
Table 5.5 Histology summary and comparison table of necrosis, sinusoidal collagen 
deposition, and glycogen deposition in P407 pre-treated rats from fed and fasted 
groups 
 
  Rats raw data   
P407 pre-treated rats Group 1 2 3 4 5 6 Score 
APAP 
control 
score 
Centrilobular 
Necrosis 
6 hr fast + 0 0 0 0  1/5 = 0.2 0/6 = 0 
24 hr fast +++ +++ +++ 0 +  37/25 = 1.4 32/25 = 1.28 
24 hr fed + 0 + 0 0 +++ 5/6 = 0.83 5/6 = 0.83 
Sinusoidal Collagen 
6 hr fast ++ ++ ++ ++ ++  10/5 = 2 10/5 = 2 
24 hr fast + + + + ++  6/5 = 1.2 7/5 = 1.4 
24 hr fed + + + ++ 0 + 6/6 = 1 2/6 = 0.33 
Glycogen Deposition 
6 hr fast PP CL&ML CL&ML Diffuse CL  CL - PP 0 
24 hr fast PP 0 0 PP PP   PP PP 
24 hr fed 0 0 PP 0 PP PP PP PP 
 
Note: The score from the 24 hr fasted group is the sum of all ‘+’s from each lobe 
(table 5.4) divided by the number of lobes analysed. The data shown for rats 1 - 5 in 
the 24 hr fasted group is an average estimate (from the four lobes) of the degree of 
necrosis overall in each rat. 
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5.3.4    Electron microscopy  
5.3.4.1    Fasted P407 pre-treated 6 hour group  
There were gaps in LSECs ranging from approximately 0.5 – 2.5 µm in diameter (fig 
5.6 A) that were larger and more frequent in the rats with the most histological 
damage. Parts of LSEC cytoplasms were swollen (on average from 1 – 2 µm) 
containing large vacuoles and dense bodies and P407 was sometimes observed in the 
SoD (fig 5.6 B). Inflammatory cells such as neutrophils and monocytes were present 
throughout the sinusoids (fig 5.6 C).  
 
One rat displayed greater toxicity than any APAP control rat with congestion and mild 
centrilobular necrosis, although the amount of necrosis was not severe enough to raise 
serum ALT or AST levels (fig 5.6 D-F). There were platelets and RBCs in the SoD in 
areas of sinusoid dilation and hepatocyte atrophy. LSECs and HSCs remained tightly 
associated even though sinusoid lumens were sometimes compressed and oddly 
shaped (fig 5.6 F).  
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Figure 5.6 Micrographs of fasted P407 pre-treated rats 6 hrs after APAP 
A) SEM. The LSEC contains gaps (bold arrow) that are replacing the fenestrations in 
sieve plates (arrow). The hepatocytes contain vacuoles (star; bar = 1 µm). 
B) TEM. An activated LSEC (EC) containing many vacuoles and dense bodies is 
shown in this micrograph. P407 is present in the SoD (arrow) and moving into 
hepatocyte vacuoles. Bar = 2 µm.  
C) TEM. This micrograph shows activated KCs and a monocyte (M) in the sinusoids. 
A dead neutrophil (arrow) has been phagocytosed by a KC (bar = 10 µm). 
D) TEM. In this micrograph, platelets (P) are crossing through a gap in the LSEC 
cytoplasm (arrow) from the lumen (L) to the SoD. The hepatocyte is losing microvilli 
(bar = 2 µm).  
E) TEM. This micrograph shows sinusoid dilation in a rat with high toxicity. The SoD 
is enlarged and contains RBCs and platelets (arrow). Sinusoid lumens (L) are 
collapsing, and the hepatocytes atrophied with many vacuoles (bar = 10 µm). 
F) TEM. A close view of an area similar to (E), highlighting the association of LSEC 
and HSC processes (arrows) where the SoD has expanded and there is total loss of 
hepatocyte microvilli (bar = 2 µm). 
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5.3.4.2    Fed and fasted P407 pre-treated 24 hour groups 
LSEC viability was decreased in comparison to APAP control rats. There was higher 
toxicity and LSEC injury in the fasted group than the fed, consistent with APAP 
control data. There were dead LSECs in areas of moderate toxicity where all or some 
of the surrounding hepatocytes were not dead (fig 5.9 A and 5.8 D). Necrotic LSECs 
were associated with masses of fibrin in the areas of highest toxicity (figs 5.7 A and 
5.8 A-C). In both fed and fasted groups, sinusoid lumens were significantly decreased 
in size in necrotic zones and areas of sinusoidal dilation (fig 5.9 B), and often the 
lumen shape was distorted. The amount of fibrin clots, platelets, and inflammatory 
cells (including neutrophils, lymphocytes, monocytes, and eosinophils) appeared to be 
increased compared to APAP controls consistent with the heightened hepatotoxicity 
in the P407 groups (figs 5.7 A-C and 5.8 A-C) . 
 
In periportal zones and other zones with low toxicity, LSECs were viable and less 
swollen at 24 hours after APAP compared to 6 hours, with swollen areas ranging up 
to 4.5 µm and averaging at 1 µm. There were gaps in LSEC cytoplasms ranging from 
approximately 0.5 - 2 µm (fig 5.7 E), similar to APAP control rats. Overall there was 
more defenestration in rats at 24 hours than at 6 hours after APAP particularly in the 
fed group (fig 5.7 D). However the amount of defenestration was similar to control 
APAP rats and was variable across the liver consistent with the intralobular variability 
of toxicity. Highly activated KCs were found in periportal sinusoids containing large 
amounts of cellular debris and full of vacuoles (fig 5.9 C), sometimes occluding 
sinusoid lumens in the fed group (fig 5.7 F). P407 was present in the SoD and in 
endocytotic vacuoles of LSECs, KCs, and hepatocytes (figs 5.7 E and 5.9 D). 
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Figure 5.7 Micrographs of fed P407 pre-treated rats 24 hrs after APAP 
A) TEM reprocessed from paraffin. An area of high toxicity showing a dead LSEC 
(white arrow) associated with fibrin (arrows). There is hemorrhage of RBCs and the 
hepatocytes (H) are dead (bar = 5 µm). 
B) TEM reprocessed from paraffin. Two cells that appear to be leukocytes (Le), that 
could have been granulocytes as they contain empty vacuoles (V), are amongst 
necrotic hepatocytes. One appears to be squeezing through the hepatocytes and 
adjacent to fibrin (arrow). Bar = 2 µm. 
C) TEM. A portal tract with increased interstitium (open arrow points to an example 
of a collagen bundle) and both granular and agranular leukocytes are making their 
way to the sinusoids. Monocyte = M, eosinophil = E, basophil = B (bar = 10 µm). 
D) SEM. The LSEC (EC) contains less fenestrations than normal (bar = 1 µm). 
E) TEM. An area of mild toxicity. There is P407 in the SoD (bold arrow) and 
hepatocyte vacuoles (V). The double arrows point to a sieve plate in an LSEC and the 
single arrow a gap in the LSEC exposing the underlying HSC process (bar = 2 µm). 
F) TEM. A large activated KC filling a sinusoid lumen containing vacuoles (bold 
arrow) that may include P407. The hepatocytes (H) are mildly steatotic (bar = 2 µm).  
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Figure 5.8 Micrographs of necrotic LSECs from fasted P407 pre-treated rats in areas 
of CL hepatocyte necrosis 
A) TEM. In this micrograph, fibrin is associated with a necrotic LSEC (arrows). The 
sinusoid lumen (L) is collapsed, RBCs have hemorrhaged, and the surrounding 
hepatocytes (H) are necrotic (bar = 5 µm). 
B) SEM. A 3-dimensional representation of the micrograph “A”. The white arrow 
points to a fibrin clot associated with a dead LSEC (EC). There are RBCs (R) in the 
SoD and there appear to be processes (arrows) through the SoD from atrophied 
hepatocytes (H) to the degenerate LSECs (EC) (bar = 10 µm). 
C) TEM. Fibrin (arrows) is associated with a dying LSEC with condensing chromatin 
(white arrow) in a CL zone of hepatocyte necrosis. There is severe hemorrhage and 
the sinusoid lumen is collapsed (bar = 2 µm). 
D) RBCs are flowing to the SoD through a gap in a damaged LSEC cytoplasm 
(arrow). The LSEC and surrounding hepatocytes (H) are pale and necrotic, apart from 
the hepatocyte that is in a process of degeneration marked by a white arrow (bar = 5 
µm). 
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Figure 5.9 Transmission electron micrographs of fasted P407 pre-treated rat 
sinusoids in areas of moderate and low toxicity at 24 hrs after APAP including a 
necrotic LSEC 
A) A dead LSEC with condensed chromatin (arrow) in a CL zone where hepatocytes 
(H) are degenerating but not yet necrotic. Arrows point to the remnants of the LSEC 
cytoplasm. L = sinusoid lumen, R = RBC (bar = 2 µm). 
B) This micrograph displays sinusoid dilation. The sinusoid lumen is compressed and 
the SoD is enlarged. The hepatocytes are atrophied and degenerating and there are 
RBCs in the SoD. The pale hepatocyte is dead and its nucleus has undergone 
karyolysis (bar = 10 µm). 
C) An activated KC in a sinusoid lumen contains large vacuoles (V) full of cellular 
debris. An arrow points to a platelet in the SoD and the adjacent hepatocyte has 
endocytosed two RBCs that are contained in a vacuole (V; bar = 5 µm). 
D) An area of low toxicity showing an autophagic vacuole (AV) in a hepatocyte. The 
sinusoid lumen contains an activated KC and two leukocytes that may be monocytes 
(M), one of which appears to be attached to the KC. The LSEC (EC) in the top left 
hand corner is swollen and has vacuoles that appear to contain P407, as do the 
hepatocytes (arrows; bar = 5 µm). 
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Ultrastructural analysis of the renal cortex and medulla did not reveal any 
nephrotoxicity. The glomeruli were normal and there was no tubular necrosis, 
however there was an unknown globular substance particularly in the distal tubules 
and in the collecting tubules that may have been comprised of P407 (fig 5.9). Refer to 
Appendix 5, A11 for micrographs of APAP control and untreated F344 kidneys. 
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Figure 5.10 Renal histology and electron micrographs from a fasted P407 pre-treated 
rat with hematuria at 24 hrs after APAP  
A) H&E stain showing renal histology is normal in the renal cortex apart from an 
unknown substance (arrows) present in many of the distal tubules. Bar = 100 µm. 
B) Electron micrograph of a section of renal cortex showing the presence of a 
globular substance and some cellular debris in the distal tubules (DT). A peritubular 
capillary (C) contains a RBC (bar = 5 µm). 
C) H&E stained section of a normal glomerulus (G) in the renal cortex. The distal 
tubules (DT) contain an unknown substance (arrows). Bar = 20 µm.  
D) Electron micrograph of a similar section to fig (C). The distal tubule (DT) contains 
a globular substance (arrow), and the glomerulus appears normal (GC = glomerular 
capillary; bar = 10 µm). See fig G for a close view of the unknown substance. 
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E) H&E stained section from the renal medulla showing the same globular substance 
in the collecting tubules (T). An arrow points to a capillary, and an electron 
micrograph of the boxed area is shown in fig (F). Bar = 100 µm.  
F) Electron micrograph showing the lumen of a collecting tubule in the renal medulla. 
A globular substance is present as well as some cellular debris (bar = 5 µm). Refer to 
fig (H) for a closer view. 
G) Magnified view of the globular substance viewed in the tubules of the renal cortex 
(bar = 1 µm). 
H) Magnified view of the globular substance viewed in the tubules of the renal 
medulla (bar = 500 nm). 
 
 
5.3.5    Summary of P407 pre-treated rats 
Pre-treatment with P407 did not protect the liver from APAP toxicity, and damage 
was exacerbated in some rats. Although there was defenestration of LSECs, it was not 
strikingly different to the amount of defenestration in APAP control rats, and gap 
formation was not inhibited. At 6 hours after APAP, livers appeared to have sustained 
damage similar to control APAP rats except in one rat where damage was increased. 
At 24 hours after APAP, fibrin clots and inflammation were increased in the P407 
pre-treated groups compared to controls, and there was an increase in LSEC necrosis. 
The hepatotoxicity and LSEC injury was heightened in fasted rats. Refer to table 5.11, 
section 5.4.5 for a summary of the trends in results including electron microscopy. 
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5.4    Results: P407 post-treated rats 
5.4.1    Macroscopic observations 
At 6 and 24 hours after APAP the rats were sleepy and sedate. One rat from the fasted 
24 hour P407 post-treated group had macroscopic hematuria. 
 
5.4.2    Blood analysis 
 
5.4.2.1    Fed P407 post-treated 24 hour group 
All P407 post-treated blood samples were lipemic. ALT and AST averages were 
lower than controls although not significantly lower. This could have been because of 
variability in the APAP control group and the fact that there was no serum sample 
from one rat with severe hepatotoxicity. Total bilirubin was significantly lower than 
APAP control (table 5.6). These results suggest that there was less hepatotoxicity in 
the P407 post-treated rats, and that the P407 had a protective effect.  
 
5.4.2.2     Fasted P407 post-treated 6 and 24 hour groups 
At 6 and 24 hours after APAP, serum ALT, AST, and bilirubin levels were not 
significantly different to APAP control rats (table 5.6). Triglycerides and cholesterol 
were significantly increased at 24 hours after APAP, but were only mildly increased 
at 6 hours after APAP. Weight loss and hematocrit were significantly lower than 
APAP controls at 24 hours after APAP however there was no difference in average 
liver weight between P407 post-treated and APAP control groups (table 5.6). 
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Table 5.6 Raw and mean ± S.D. data from ad libitum fed or fasted APAP treated rats 
culled 6 or 24 hrs after APAP and post-treated with P407 1 hr after APAP 
 
  Rats raw data   
P407 post-treated rats Group 1 2 3 4 5 6 Mean ± SD 
APAP 
Control 
ALT (U/L) 
6 hr fast 46 47 70 52 162   75±49 45±7.2 
24 hr fast 30 50.4 217 12420     3179±6161 2143±2296 
24 hr fed 31.2 33.6 27.6 36 46.8 38.4 36±6.6 171.2±297 
AST (U/L) 
6 hr fast 75 81 100 156 175  117±45 81.4±16.4 
24 hr fast 84 61.6 270 25479   6474±12671 3008±3473 
24 hr fed 60 62.4 70.8 130.8 61.2 62.4 74.6±28 155.4±172 
Total Bilirubin (U/L) 
6 hr fast 0 1 0 1 2  0.8±0.8 1±0 
24 hr fast 0 4.2 2 6   3.1±2.6 2±0.7 
24 hr fed 1.2 0 1.2 1.2 1.2 0 0.8±0.6* 3.4±1.8 
% Weight loss from time of 
fast 
6 hr fast 5.1 no data no data 5.5 6.9  6±1 7.5±1.9 
24 hr fast 10.4 no data 7.4 10.8   9.5±2* 13±1.7 
% Weight loss 24 hr fed 5.3 6.3 6.9 3.8 4.8 4.4 5.3±1.2 4.6±0.5 
Total cholesterol (µmol/L) 6 hr fast 1.3 1.3 3.8 1.5 1.5 
 2±1 1.3±0.1 
24 hr fast 5.6 10.5 5 8.1   7±2.5* 1.1±0.2 
Triglycerides (µmol/L) 6 hr fast 1.1 1 19.5 1.4 1.1 
 5±8 0.8±0.2 
24 hr fast 26 64.8 16.7 45.4   38±21* 0.7±0.5 
Hematocrit (%) 6 hr fast 62 55 no data 58 56 
 57.6±3 59.5±2.7 
24 hr fast 53 48 54 50   51±3* 62±8 
Liver wet weight  % body 
weight 
6 hr fast 2.4 3.2 2.9 3.2 3.3  3±0.3 3.3±0.7 
24 hr fast 5 3.5 3.7 3.9   4±0.7 4.3±0.6 
*p<0.05 compared to APAP control         
 
 
5.4.3    Histology 
5.4.3.1    Fed P407 post-treated 24 hour group 
The fed P407 post-treated rats sustained much less histological damage than APAP 
controls (table 5.7). Five out of 6 rats did not show any necrosis (fig 5.11 A), with one 
rat displaying only a very mild amount of centrilobular necrosis accompanied by a 
large amount of infiltrate (fig 5.11 B). Occasionally there was vacuolisation of 
centrilobular hepatocytes. There was also a striking difference to APAP controls in 
the distribution of glycogen (table 5.7). The majority of glycogen in the livers was in 
the centrilobular and midzonal hepatocytes (fig 5.11 C), in comparison to APAP 
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control rats where glycogen was mostly depleted or found in the periportal 
hepatocytes. Glycogen in the P407 post-treated group was depleted only in the rat that 
sustained a low degree of histological damage. In 3 rats, sinusoidal collagen was 
mildly increased (fig 5.11 D, table 5.7) in comparison to control APAP rats where 
only 2 out of 6 rats had mildly increased collagen. 
 
Table 5.7  Graded necrosis and sinusoidal collagen, glycogen distribution, and serum 
ALT value for comparison in the P407 post-treated fed APAP rats 24 hrs after APAP 
 
 
Rat ALT (U/L) Necrosis Collagen Glycogen 
1 31.2 0 + CL 
2 33.6 0 0 CL 
3 27.6 0 0 CL 
4 36 0 0 CL 
5 46.8 0 + Diffuse 
6 38.4 + + Deplete 
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Figure 5.11 Histology of P407 post-treated fed rats: H&E, PAS, and Sirius Red 
A) H&E. Normal histology, apart from some mild patchy inflammation (arrows) and 
mild vacuolisation of hepatocytes. Bar = 100 µm. 
B) H&E. An example of the most severe CL toxicity in a fed P407 post-treated APAP 
rat, mild necrosis accompanied by infiltrate (arrow). P = portal, C = central. Bar = 100 
µm. 
C) PAS. There is a distinct pattern of CL glycogen staining with PP hepatocytes 
depleted. Bar = 100 µm.  
D) Sirius Red. There is a mild increase of sinusoidal collagen in this micrograph, 
mainly in CL zones. Arrows point to examples of thick collagen fibres. Bar = 200 µm.  
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5.4.3.2    Fasted P407 post-treated 6 hour group 
At 6 hours after APAP, 4 out of 5 livers were histologically normal (fig 5.12 A). The 
fifth rat sustained damage to two lobes (left lateral lobe and right lobe) including mild 
necrosis, sinusoid dilation, and congestion in some centrilobular zones (fig 5.12 B, 
table 6.5). There was increased glycogen in the P407 post-treated rats compared to the 
APAP control rats, and the zonal distribution of glycogen in the group was variable 
(fig 5.12 C-E, table 5.8). Sinusoidal collagen was increased (fig 5.12 F) although not 
quite as much on average as in APAP control rats (table 5.8). 
 
 
Table 5.8 Graded necrosis and sinusoidal collagen, glycogen distribution, and serum 
ALT value for comparison in the P407 post-treated fasted rats 6 hrs after APAP  
 
 
Rat ALT (U/L) Necrosis Collagen Glycogen 
1 46 0 ++ Diffuse 
2 47 0 ++ Mild/diffuse
3 70 0 + CL 
4 52 0 ++ Diffuse 
5 162 + + PP 
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Figure 5.12 Histology of 6 hr fasted P407 post-treated APAP rats- H&E, PAS, and 
Sirius Red 
A) H&E. An example of normal histology representative of most rats in this group. 
Bar = 200 µm.  
B) H&E. A micrograph from the rat with mild toxicity consisting of congestion, 
sinusoid dilation, and CL necrosis (arrow). P = portal venule. Bar = 100 µm. 
C) PAS. A micrograph showing diffuse glycogen distribution. C = central venule. Bar 
= 100 µm. 
D) PAS. A micrograph from the rat with mild toxicity showing a CL zone with 
sinusoid dilation (arrow). There is glycogen in the PP hepatocytes. Bar = 100 µm. 
E) PAS. A micrograph showing a pattern of CL glycogen and PP glycogen depletion. 
Bar = 100 µm.  
F) Sirius Red stain showing increased sinusoidal collagen (arrow) compared to a 
normal rat (graded ++). Bar = 100 µm. 
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5.4.3.3    Fasted P407 post-treated 24 hour group 
At 24 hours after APAP, 3 rats displayed a mild to moderate level of damage 
including variable amounts of vacuolisation of centrilobular hepatocytes, infiltrate 
around central veins (fig 5.13 A), and some centrilobular sinusoidal dilation and mild 
amounts of necrosis (fig 5.13 E). Swollen LSECs and large KCs full of clear vacuoles 
were visible in the sinusoids (fig 5.13 D) due to the endocytosis of P407.  
 
The remaining rat displayed severe centrilobular hemorrhagic necrosis in two lobes 
reflective of the extremely high ALT and AST level (fig 5.14 A) and mild to moderate 
damage in the other two. Overall, it appears that there was less hepatotoxicity than in 
the APAP control rats however it is difficult to determine because there was a wide 
range of hepatotoxicity from mild to severe in both control and treatment groups. 
 
It appears that there was a significant effect of P407 (or a combined effect of P407 
and APAP) on glycogen metabolism. There was increased glycogen in the P407 post-
treated rats (fig 5.13 B, table 5.9) compared to the APAP control rats. The zonal 
distribution of glycogen was variable (figs 5.13 B-C and 5.14 B, table 5.9). 
 
Sinusoidal collagen was increased from normal (figs 5.13 F and 5.14 C-D, table 5.9), 
and on average, mildly increased compared to APAP controls. There was also intra 
and inter lobular variability of collagen deposition, reflective of the variability of 
toxicity in each lobule.  
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Table 5.9 P407 post-treated fasted 24 hr group: individual graded centrilobular 
necrosis in four liver lobes, graded sinusoidal collagen, glycogen distribution, and 
ALT values for comparison in each rat 
 
 
 
Renal histology was normal in all P407 post-treated rats except for one. The rat with 
severe hepatotoxicity in the 24 hour group had an unknown substance in the collecting 
tubules of the medulla that appeared identical to that described in figure 5.10 in the 
pre-treated rats (fig 5.14 E and F). There was no sign of tubular necrosis. See 
Appendix 5, A11 for a micrograph of an APAP control kidney. 
 
 
 
Rat ALT (U/L) 
Graded necrosis per lobe 
Collagen Glycogen  
Median Right Left lateral Caudate
1 30 + 0 0 0 + diffuse 
2 50.4 0 + 0 + + CL or ML 
3 217 + + + 0 ++ PP 
4 12420 +++ +++ + 0 ++ depleted 
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Figure 5.13 Histology of P407 post-treated fasted rats 1, 2, and 3 (with mild toxicity) 
24 hrs after APAP: H&E, PAS, and Sirius Red 
A) H&E. Mild CL damage, hepatocyte vacuolisation and infiltrate. C = central, P = 
portal. Bar = 100 µm. 
B) PAS. A micrograph from the rat with diffuse glycogen staining. Bar = 100 µm.  
C) PAS. A micrograph from the rat with PP glycogen. Bar = 100 µm.  
D) H&E. Bold arrows point to possible KCs swollen with vacuoles and a swollen 
vacuolated LSEC is marked with a regular arrow. Hepatocytes are showing 
endocytosis of P407 and lipid throughout the sinusoids. Bar = 20 µm.  
E) H&E. An example from a rat with mild toxicity showing sinusoid dilation in a CL 
zone. Bar = 100 µm.  
F) Sirius red. There is increased collagen in a CL zone where there is mild toxicity 
and sinusoid dilation. Bar = 100 µm.  
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Figure 5.14 Liver and kidney histology of the fasted 24 hr post-treated APAP rat with 
extreme hepatotoxicity: H&E, PAS, and Sirius Red 
A) H&E. Severe CL hemorrhagic necrosis and sinusoid dilation. P = portal venule. 
Bar = 100 µm.  
B) PAS. The border of a necrotic area is glycogen deplete, however there are magenta 
stained vacuoles (arrow) in hepatocytes of unknown origin. Bar = 20 µm.   
C) Sirius Red. A necrotic area showing long thick collagen bundles stretching from 
the central venule and portal tracts. P = portal and C = central venule. Bar = 100 µm. 
D) Sirius Red. Increased collagen deposition in a non-necrotic area with collagen 
bundles appearing to radiate from one venule to another. Bar = 200 µm.   
E) H&E. The renal collecting tubules contain a substance that could be a mixture of 
P407, and/or remnants of RBCs and other cellular debris. Bar = 100 µm.   
F) H&E. A magnified view of the boxed area in fig (E). An arrow points to the 
unknown substance in the tubules. Bar = 20 µm.   
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Table 5.10 is a summary of the histological results for centrilobular necrosis, collagen, 
and glycogen in each post-treated group. At 6 hours after APAP, P407 post-treatment 
mildly increased sinusoidal collagen compared to APAP control, whilst decreasing 
level of histological necrosis. There was glycogen deposition at 6 hours after APAP 
whereas control APAP rats were depleted of glycogen. At 24 hours after APAP, P407 
post-treatment decreased centrilobular necrosis in the fasted and fed rats. Sinusoidal 
collagen slightly increased compared to APAP controls in the fasted and fed rats. 
Glycogen deposition was affected by P407 pre-treatment in both fed and fasted 
groups at 24 hours after APAP. In fed P407 post-treated rats, glycogen deposition was 
found in centrilobular regions as well as periportal, and in the fed P407 post-treated 
rats, glycogen distribution was primarily in centrilobular regions whereas the APAP 
control rats expressed glycogen in periportal zones only. 
 
 
Table 5.10 Histology summary and comparison table of necrosis, sinusoidal collagen 
deposition, and glycogen deposition in P407 post-treated rats from fed and fasted 
groups 
 
  Rat raw data   
P407 post-treated rats Group 1 2 3 4 5 6 Score 
APAP 
control 
score 
Centrilobular Necrosis 
6 hr fast 0 0 0 0 +  1/5 = 0.2 0/6 = 0 
24 hr fast 0 + + +++   13/20 = 0.65 32/25 = 1.28 
24 hr fed 0 0 0 0 0 + 1/6 = 0.16 5/6 = 0.83 
Sinusoidal Collagen 
6 hr fast ++ ++ + ++ +  8/5 = 1.6 10/5 = 2 
24 hr fast + + ++ ++   6/4 = 1.5 7/5 = 1.4 
24 hr fed + 0 0 0 + + 3/6 = 0.5 2/6 = 0.33 
Glycogen Deposition 
6 hr fast Diffuse Mild/ diffuse CL Diffuse PP  CL - PP 0 
24 hr fast Diffuse CL or ML PP 0   CL - PP PP 
24 hr fed CL CL CL CL Diffuse 0 CL PP 
 
Note: The score from the 24 hr fasted group is the sum of all ‘+’s from each lobe 
(table 5.9) divided by the number of lobes analysed. The data shown for rats 1 - 4 in 
the 24 hr fasted group is an average estimate (from the four lobes) of the degree of 
necrosis overall in each rat. 
 178
5.4.4    Electron microscopy 
5.4.4.1    Fed P407 post-treated 24 hour group 
There was some defenestration of LSEC in all of the fed post-treated rats 24 hours 
after APAP. The defenestration was variable across the liver lobes such that some 
LSECs were almost completely defenestrated (fig 5.15 B) however other LSECs were 
normally fenestrated (fig 5.15 D). Overall there was more defenestration than found in 
APAP controls and defenestration was also apparent in viable areas of the liver lobe. 
Only occasionally there were gaps. Some LSEC cytoplasms contained vacuoles that 
included P407 micelles (fig 5.15 A and C) as did KCs (fig 5.15 E) as seen in 
histology. The P407 micelles were also present throughout the SoD in many of the 
sinusoids analysed (fig 5.15 A). Occasionally there were neutrophils in sinusoid 
lumens. In the one rat with histological damage, areas of centrilobular necrosis were 
few and thus none were sampled in the randomly cut blocks processed for electron 
microscopy. Therefore, blocks were reprocessed from paraformaldehyde-fixed tissue 
in paraffin for transmission electron microscopy analysis. Large amounts of 
leukocytes were found in and around the central venules (fig 5.16 A), greater than 
seen in an area of mild centrilobular necrosis any APAP control. Extravasation of 
infiltrate through gaps in LSEC cytoplasms was visible (fig 5.16 B). Close to the 
central venule, hepatocytes appeared to be absent. This may have been due to efficient 
clearing of necrotic hepatocytes by the infiltrate, or due extraction of loose necrotic 
cellular debris during reprocessing from paraffin. The LSECs appeared to be viable, 
although fixation was not as clear as glutaraldehyde was not used in the fixation 
process and intricate analysis of LSEC ultrastructure was not possible. Midlobular and 
periportal hepatocytes and LSECs were viable, with some mild vacuolisation of 
hepatocytes close to the necrotic zones (fig 5.16 C). 
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Figure 5.15 Electron micrographs from fed P407 post-treated rats 24 hrs after APAP 
A) TEM. A defenestrated LSEC (EC) contains vacuoles that include P407 micelles 
(arrow). There are also P407 micelles in the SoD (arrow). L = lumen, H = hepatocyte. 
Bar = 1 µm. 
B) A representative SEM of (A). Arrows point to two remaining sieve plates in a 
severely defenestrated LSEC (bar = 1 µm). 
C) TEM. Part of the LSEC (EC) cytoplasm is very swollen with vacuoles containing 
what appear to be P407 micelles (arrows). Bar = 1 µm. 
D) SEM. A normally fenestrated LSEC from a P407 post-treated rat. An arrow points 
to a sieve plate. Bar = 1 µm. 
E) TEM. A KC in a sinusoid lumen with vacuoles that appear to include P407 
(arrows). Above the KC are obliquely cut fenestrations in an LSEC cytoplasm. Bar = 
1 µm. 
F) SEM. A CL area from a P407 post-treated fed rat showing a typical CL zone where 
the hepatocytes and sinusoids look undamaged and viable. There is a central vein 
(CV) with emanating collagen fibres (arrows). Bar = 50 µm. 
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Figure 5.16 Transmission electron micrographs from reprocessed tissue from the fed 
P407 post-treated rat with mild toxicity showing areas of CL necrosis 
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A) An area of CL hepatocyte necrosis. A mass of infiltrate (arrows) is entering the 
liver sinusoids via the central venule (CV). Hepatocytes (H) appear to be missing 
from some areas directly around the CV. L = sinusoid lumen, bar = 20 µm. 
B) A magnified view of the area adjacent to the CV. LSECs (EC) and HSCs appear 
viable. The parenchymal area contains infiltrate appearing to mainly consist of 
monocytes (M), two of which are undergoing extravasation (arrows) and open 
interstitial space where hepatocytes formerly resided. The process of reprocessing 
from paraffin may have extracted the most severely necrotic hepatocyte tissue, 
leaving empty space. Bar = 5 µm. 
C) An adjacent midzonal area to that in micrographs (A) and (B) with intact sinusoids 
and viable hepatocytes with some vacuolisation (V) from where fat appears to have 
been extracted in the dehydration process, lined by fenestrated (arrows) LSECs (EC). 
L = sinusoid lumen, bar = 5 µm. 
 
 
 
5.4.4.2    Fasted P407 post-treated 6 hour group 
In 4 out of 5 rats in this group there was mild toxicity. Many LSEC sieve plates were 
replaced by gaps (approx 0.3 - 3 µm; fig 6.8 A and B), and some parts of the LSEC 
cytoplasm were mildly swollen and contained vacuoles and dense bodies. There 
generally appeared to be more platelets in the sinusoids than found in APAP control 
electron micrographs suggestive of increased endothelial injury. Some neutrophils and 
lymphocytes were present in the sinusoid lumens, and occasionally there was 
vacuolisation of centrilobular hepatocytes. 
 
In the remaining rat with elevated ALT (rat 5) there was evidence of centrilobular 
congestion and hemorrhage, hepatocyte necrosis and sinusoid dilation (consisting of 
RBCs and platelets in the enlarged SoD, atrophy of hepatocytes, and narrowing of the 
sinusoid lumen; fig 5.17 C). There were also platelet aggregates and fibrin clots (fig 
5.17 D) in areas devoid of LSECs (suggestive of LSEC necrosis), and infiltrate in 
amongst necrotic hepatocytes in damaged central zones. This degree of hepatotoxicity 
was greater than found in any APAP control 6 hour rat. 
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Figure 5.17 Electron micrographs from P407 post-treated fasted rats 6 hrs after 
APAP 
A) SEM. A leukocyte (green, possibly a lymphocyte) and KC (red) are in the sinusoid 
lumen. In the furthest left sinusoid of the micrograph, the underside of an LSEC is 
visible with gaps (arrows) in its cytoplasm. H = hepatocytes, bar = 2 µm. 
B) SEM. An LSEC (EC) cytoplasm contains gaps (arrows) replacing many of the 
sieve plates. Hepatocyte microvilli can clearly be seen through the gaps (bar = 1 µm). 
C) TEM. This micrograph displays a CL area of moderate toxicity with a dilated 
sinusoid. LSEC and HSC cytoplasmic processes are tightly associated (arrows), 
hepatocytes are atrophied, losing microvilli (bold arrow), and degenerating with large 
vacuoles (V) and some swollen mitochondria (white arrows). The SoD is enlarged, 
and the sinusoid lumen (L) is collapsing. In the bottom right hand corner a RBC (R) is 
in the SoD (bar = 5 µm). 
D) TEM. This micrograph displays an area of high toxicity. A mass of fibrin (arrows 
point to fibrin strands) and a platelet aggregate (plug/clot) are beside a degenerating 
hepatocyte and RBCs (R). This probably developed in place of a severely damaged 
sinusoid where LSECs became necrotic. A single platelet in the clot is coloured blue 
(bar = 2 µm). 
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5.4.4.3    Fasted P407 post-treated 24 hour group 
In the areas of centrilobular necrosis and hemorrhage in the rat with severely elevated 
ALT, LSECs were dead with condensed chromatin in their nuclei (pyknosis; fig 5.18 
A and C), and the remaining LSEC cytoskeletons surrounded by fibrin maintained the 
sinusoid lumen shape and prevented further hemorrhage (fig 5.18 A-D). There could 
have been viable LSECs in some necrotic areas however none were observed in the 
specimens analysed.  
 
Severe defenestration of LSECs was not observed in our specimens, although there 
was mild defenestration (similar to APAP controls). LSEC cytoplasms contained 
some swollen areas, but these were only mildly swollen (up to 1 – 2 µm), and 
occasionally gaps were present. Vacuoles containing P407 were seen in hepatocytes, 
LSEC, and KCs (fig 5.18 F), and also in neutrophils in necrotic zones (fig 5.18 E). In 
contrast to the fed P407 post-treated rats, no P407 micelles were seen in the SoD on 
the TEM specimens analysed.  
 
Examination of reprocessed kidney tissue on electron microscopy revealed that the 
substance found in the tubules of the rat with severe hepatotoxicity was very similar 
to that described for the P407 pre-treated rats in figure 5.10 with the most severe 
toxicity. In the specimens analysed there was no hemorrhage, although there was 
occasionally some cellular debris suggesting that some tubular cells had degenerated 
or become necrotic. Ultrastructural renal analysis did not provide an explanation for 
the hematuria. 
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Figure 5.18 Electron micrographs of a fasted P407 post-treated rat with severe 
toxicity 24 hrs after APAP 
A) TEM: An area of CL hemorrhagic necrosis where RBCs (R) are infiltrating the 
SoD and congested in the sinusoid lumens (L). The lumen shape is maintained 
although mostly by the remnants of dead LSECs associated with fibrin. Examples of 
RBC in the SoD and lumens (L) are marked R. The hepatocytes (H) are necrotic. Bar 
= 10 µm. 
B) SEM: A three dimensional representation of figure A, a region of CL hemorrhagic 
necrosis. It is difficult to see the LSECs in this micrograph, however fibrin clots 
(arrows) clearly fill the sinusoids between degenerate hepatocytes (H) enhancing 
congestion, vascular stasis, and hypoxia whilst preventing further hemorrhage. Bar = 
10 µm. 
C) TEM: A magnified view of the boxed area in “A” showing hemorrhage, necrotic 
hepatocytes (H), and a necrotic LSEC with a pyknotic nucleus (bold arrow). The 
remnants of the dead LSECs (pointed out by arrows) appear to be associated with 
fibrin, maintaining the sinusoid lumen shape. Bar = 2 µm. 
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D) SEM: A magnified region similar to that in figure B. Surrounding the lumen (L) 
appears to be the cytoskeleton of a dead LSEC entangled with fibrin (arrow). RBCs 
are in the SoD (coloured red) and a dead hepatocyte is marked H. Bar = 5 µm. 
E) TEM. A phagocytic cell (possibly a neutrophil) in a necrotic area that appears to 
have endocytosed P407 micelles (bar = 2 µm). Inset is an enlarged version of the 
boxed area showing the particles (arrow) are approximately 20 nm in diameter, 
similar to the size of P407 micelles (bar = 500 nm). Part of a necrotic hepatocyte (H) 
lies in the bottom corner. 
F) TEM. A sinusoid from a PP zone displaying a striking contrast in toxicity from the 
severe damage of the CL zones. The LSEC is thin and fenestrated (arrow), the 
hepatocytes contain microvilli, and the SoD is of a normal size. A pit cell (P) and an 
activated vacuolated KC are in the sinusoid lumen. Bar = 2 µm. 
 
 
 
5.4.5    Summary of P407 post-treated rats 
Post-treatment of rats with P407 one hour after an overdose of APAP appears to have 
ameliorated toxicity in the fed group, and also defenestrated LSECs. Serum 
aminotransferase levels in all fed rats either fell within the normal range or very close 
to normal and only one rat out of the six displayed a very mild amount of necrosis. 
Whereas in the fasted groups, it is unclear whether P407 post-treatment had any 
protective effect because of the small sample size and extreme ranges of toxicity 
within the group. All fed and fasted P407 post-treated groups displayed different 
patterns of glycogen distribution to APAP controls and thus P407 may have affected 
glycogen metabolism.  
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5.4.6    Table summary of P407 pre- and post-treated rat data trends 
Table 5.11 Summary and trends in the blood, histological, and EM data comparing 
APAP controls to P407 treatment groups. ↓ = decreased compared to control, ↑ = 
increased compared to control, ↓* = statistically significant decrease, ↑* = 
statistically significant increase, nc = no change detected 
 
BLOOD & 
WEIGHT 
6hr fasted 
P407 pre-
treated 
6hr fasted 
P407 post-
treated 
24 hr fasted 
P407 pre-
treated 
24 hr fasted 
P407 post-
treated 
24hr fed 
P407 pre-
treated 
24hr fed 
P407post-
treated 
ALT ↓* ↑ ↑ ↑ ↑ ↓ 
AST ↓ ↑ ↑ ↑ ↑ ↓ 
TBil ↓* ↓ nc ↑ ↓* ↓* 
Triglycerides ↑* ↑ ↑* ↑ ↑ ↑ 
Cholesterol ↑* ↑ ↑* ↑ ↑ ↑ 
Hematocrit ↓* nc ↓* ↓* - - 
Liver wt nc nc nc nc - - 
Body wt loss ↑* ↓ ↓ ↓* ↓ nc 
HISTOLOGY       
CL necrosis ↑ ↑ ↑ ↓ nc ↓ 
Congestion ↑ nc ↑ ↓ nc ↓ 
Infiltrate ↑ nc ↑ nc ↑ ↓ 
Collagen nc ↓ ↓ ↑ ↑ ↑ 
Glycogen ↑ ↑ nc nc nc ↑ 
Glycogen 
distribution 
CL-PP 
(ctrls were 
depleted) 
CL-PP (ctrls 
were 
depleted) 
PP (same as 
ctrl) 
diffuse (ctrls 
had PP) 
PP (same 
as ctrl) 
CL (ctrls 
had PP) 
Renal nc nc 
unknown 
substance in 
tubules 
unknown 
substance in 
tubules 
nc nc 
EM       
LSEC gaps nc nc nc nc nc ↓ 
LSEC swelling ↑ nc nc nc nc ↑ 
Defenestration nc nc nc nc nc ↑ 
LSEC necrosis nc ↑ ↑ ↑ ↑ ↓ 
Fibrin nc ↑ ↑ ↑ ↑ ↓ 
* = p<0.05 compared to APAP controls 
Refer to Appendix 4, table 1 for a table of F344 untreated, APAP treated, and P407 
pre- and post-treated means ± S.D. 
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5.5    Discussion  
 
Post-treatment with P407 protected against the development of APAP hepatotoxicity 
in ad libitum fed rats. At 24 hours after an overdose of APAP, liver histology was 
normal in 5 out of 6 rats. Only one rat displayed very mild amounts of centrilobular 
necrosis without any sign of hemorrhage, congestion, or sinusoid dilation, and thus 
P407 may have had a protective effect on the microvasculature. In addition, sinusoidal 
collagen was decreased in this group indicative of reduced oxidative stress and 
endothelial injury (Toklu, 2006). Electron microscopy of the fed post-treated P407 
rats showed that the amount of LSEC gap formation induced by APAP toxicity was 
decreased correlating with the histological findings of decreased microvasculature 
injury. It also revealed that the LSECs had noticeably less fenestrations per cell and 
increased LSEC swelling. These are normal side-effects of P407 at about 24 hours 
after administration (Cogger, 2006, Warren, 2011) and not a result of APAP injury. 
LSEC swelling is primarily a result of increased endocytosis in order to remove 
excess serum lipids induced by P407, and P407 particles (Johnston, 2004, Warren, 
2011) although the mechanism for defenestration by P407 is not yet understood (see 
section 5.1). 
 
By defenestrating LSECs, P407 has been shown to reduce the availability of 
hepatocytes to APAP in fed rats (Mitchell, 2010) and may have slowed or reduced the 
production of NAPQI in this group. Micelles of P407 were clearly present in some of 
the sinusoids in contact with LSECs and hepatocyte microvilli in the SoD and may 
have played a protective role. Poloxamers are able to adsorb to cell membranes and 
have restorative effects on damaged areas of the membrane (Frey, 2007), therefore the 
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P407 may have ameliorated damaged cell membranes and protected hepatocytes and 
LSECs from exposure to toxins in the blood. 
 
There was no sign of inflammation in the 5 out of 6 fed P407 post-treated rats with 
normal histology. However there was more infiltrate in the remaining rat in areas of 
centrilobular necrosis than in control APAP rats with more severe necrosis. This could 
be explained by a P407-mediated stimulation of immune response to injury as P407 
promotes increases in both cell-mediated and humoral immune response (Dumortier, 
2006, Johnston, 2009). As the areas of necrosis in this P407 post-treated rat were not 
wide-spread and were mild in severity, the increased infiltrate could have had an 
ameliorative effect on hepatotoxicity and did not appear to exacerbate it. 
 
Glycogen was present in the centrilobular hepatocytes of 5 out of 6 rats in this group 
with normal histology. APAP toxicity is not associated with centrilobular glycogen 
deposition, and it was not observed in any of the APAP control rats. During APAP 
toxicity, glycogen is initially depleted, and then replenished in periportal hepatocytes 
just prior to the onset of centrilobular necrosis (Corcoran, 1988, Jepson, 1987). APAP 
depletes GSH and glycogen by similar percentages at each dose, and if NAC (a GSH 
precursor) is administered with APAP it prevents both the early APAP-induced 
glycogen depletion and toxicity (Hinson, 1983). Thus it is likely that glycogen 
depletion and subsequent replenishment in periportal zones is related to the formation 
of NAPQI. The fact that fed P407 post-treated rats had normal histology and 
expressed centrilobular glycogen suggests that there was decreased NAPQI formation 
in this group. Centrilobular glycogen is the last to be depleted during a fast due to a 
higher expression of glycogen storing enzymes in centrilobular hepatocytes (see 
 189
Chapter 1 section 1.3). Thus the depletion of periportal glycogen and remaining 
centrilobular glycogen in the post-treated rats could have been a normal metabolic 
adaption in the rats due to fasting from the time of APAP overdose. The presence of 
glycogen in centrilobular hepatocytes may have also played a minor role in protection 
from APAP toxicity by increasing uridine 5'-diphospho-glucuronic acid (UDPGA) 
levels within hepatocytes and increasing glucuronidation of APAP (Hinson, 1983).  
 
In contrast, pre-treatment with P407 in fed rats did not protect against the 
development of hepatotoxicity 24 hours after APAP overdose. Aminotransferase 
levels were raised compared to controls (although not significantly) and exacerbated 
histological injury was apparent in some rats. P407 is able to occlude blood vessels 
(Raymond, 2004), and was observed on histology plugging and occluding some of the 
portal venules of fed P407 pre-treated rats. It is unclear whether this had any effect on 
the microvasculature by exacerbating congestion and ischemia. Ultrastructural 
analysis revealed that centrilobular LSECs from fed P407 pre-treated rats had more 
severe injury than APAP controls, and were often dead in areas of hepatocyte necrosis 
whereas they survived in such areas of APAP control livers. In addition, more 
frequent fibrin clots were observed in comparison to control APAP rats which may 
have in turn intensified congestion and ischemic necrosis. The hemostatic 
(coagulative) system augments hepatotoxicity in APAP overdose and sinusoidal fibrin 
deposition can disrupt blood flow, resulting in localized hypoxia and hepatocellular 
necrosis (Ganey, 2007). P407 has been shown to enhance the rate of assembly of 
fibrin, and inhibit fibrinolysis in vitro (Carr, 1996) which could further exacerbate 
hemostasis and liver injury in APAP toxicity. Periportal LSEC injury was not 
exacerbated, and periportal LSEC morphology at 24 hours in P407 pre-treated rats 
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was normal apart from some increased endocytosis and swelling of the LSEC 
cytoplasm secondary to the continuing clearance of P407 and excess serum lipid 
(Johnston, 2004, Warren, 2011). It is likely that periportal LSECs were spared from 
necrosis due to an increased antioxidant capacity (GSH availability) in the periportal 
zone (Smith, 1979) and less NAPQI production as CYP450 enzymes are not as highly 
expressed in the periportal zone (Gooding, 1978). 
 
The fed P407 pre-treated group also showed a significant increase in sinusoidal 
collagen compared to control APAP fed rats, associated with increased oxidative 
stress (Toklu, 2006). P407 is able to induce oxidative stress in vivo by an indirect 
mechanism that increases the oxidation of LDL and other serum lipids resulting in 
malondialdehyde production (Johnston, 2007), and could have increased oxidative 
stress in this group via this mechanism. 
 
Inflammatory cells were increased in fed P407 pre-treated rats, particularly in areas of 
hepatocyte necrosis. P407 has been reported to promote increases in both cell-
mediated and humoral immune response (Dumortier, 2006). A single intraperitoneal 
injection of P407 can increase cell adhesion molecules (CAMs) including endothelial-
leukocyte adhesion molecule (E-selectin), vascular CAM, and intercellular CAM 
(Johnston, 2009). These molecules expressed on endothelial cells are involved in 
leukocyte recruitment and adhesion, and their upregulation may have contributed to 
the increased amount of infiltrate present in the P407 pre-treated rats. Whether 
inflammatory cells have any detrimental effect in APAP toxicity remains 
controversial, although it is possible that an increased amount of infiltrate could 
exacerbate toxicity through excessive release of inflammatory mediators leading to 
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heightened induction of iNOS and enhancement of peroxynitrite formation (Jaeschke, 
2005). Exacerbated oxidative stress would in turn increase collagen formation and 
LSEC injury, and could explain the increased sinusoidal collagen and LSEC damage 
in the fed P407 pre-treated group. 
 
The reason why post-treatment with P407 after APAP was protective and pre-
treatment before APAP was not protective is unclear. When the P407-induced 
changes in LSEC morphology such as defenestration and swelling occurred at the 
time of APAP overdose (in the pre-treated group where rats were given P407 18 hours 
before APAP overdose) they were not protective. However when these same P407-
induced changes in LSEC morphology occurred later in APAP toxicity (when rats 
were post-treated with P407 1 hour after APAP) they could have had a protective 
effect by promoting amelioration of earlier APAP microvascular injury and 
decreasing gap formation.  
 
Two time points were investigated in fasted rats treated with P407 and APAP. 
Analysis showed that P407 pre- or post-treatment did not protect the liver from early 
microvasculature injury at 6 hours after APAP, and that P407 pre- or post-treatment 
did not protect the liver from centrilobular hemorrhagic necrosis 24 hours after APAP. 
Fasting increases the hepatotoxicity of APAP overdose primarily because GSH stores, 
crucial to the detoxification of NAPQI, are depleted to about 50 % of their original 
amount by fasting (see Chapter 1, section 1.3.1). LSECs (and hepatocytes) are more 
vulnerable to injury in an environment with a lowered antioxidant capacity.  
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At 6 hours after APAP in fasted rats, P407 pre-treated liver function tests revealed a 
significant decrease in aminotransferase levels, suggestive of a hepatoprotective 
effect, however the decrease was small. In addition, there was significantly less 
weight loss in the pre-treated group at 6 hours compared to APAP controls, which 
again points to a protective effect. In contrast, P407 post-treated aminotransferase 
levels were raised (although not significantly) indicative of increased hepatocyte 
injury. In both 6 hour groups, histology was mostly normal apart from some mild 
centrilobular vacuolisation and focal necrosis. One rat from each group sustained a 
greater degree of injury than was observed in the APAP control group with 
centrilobular sinusoid dilation and hemorrhage, and some mild necrosis in the post-
treated rat. In both pre- and post-treated groups, glycogen was present in centrilobular 
hepatocytes of the rats without histological damage. Centrilobular glycogen is not 
normally observed during APAP toxicity and was not found in any of the APAP 
controls. P407 does not have any influence on blood glucose or insulin levels (which 
could stimulate glycogen production) (Johnston, 2008), however, the effects of P407 
on glycogen synthase and phosphorylation of glucose to glucose-6-phosphate have 
not been studied. Poloxamers have the ability to form tiny pores in membranes that 
can enable the flux of various cations such as calcium and potassium (Krylova, 2004, 
Sutachan, 2006), and it is therefore possible that in this way P407 may indirectly 
inhibit or stimulate enzymes that participate in glycolysis and gluconeogenesis as they 
are sensitive to cytoplasmic concentrations of different ions. As glycogen depletion 
and periportal replenishment is a sign of the progression of APAP toxicity, it is also 
possible that the hepatocytes of these rats were protected by P407 and that the 
centrilobular glycogen expression was a normal result of the initial periportal 
glycogen depletion in fasting.  
 193
Pre-treatment with P407 did not reduce the expression of sinusoidal collagen at 6 
hours after APAP, and post-treatment only reduced sinusoidal collagen in one rat thus 
P407 did not reduce oxidative stress. Electron microscopy revealed that P407 also did 
not prevent APAP-induced LSEC gap formation injury in either group. In the post-
treated group there was an increased amount of platelets in the sinusoids at 6 hours 
after APAP. Platelets are recruited in response to endothelial injury and could have 
been increased as a result of exacerbated LSEC injury. One P407 post-treated rat 
displayed severe congestion with fibrin clots, hemorrhage, and LSEC necrosis, a level 
of damage greater than found in any APAP control rat at 6 hours after APAP, 
suggesting that LSEC injury was increased by P407 in this group, correlating with the 
LFT data. This degree of injury was not apparent in the pre-treated groups. 
Interestingly, P407 pre-treated rats did not display LSEC defenestration as was 
expected at 24 hours after P407 administration. This could have been due to an 
unknown effect of APAP toxicity inhibiting the mechanism of P407 defenestration. 
Also in the pre-treated group there was P407-induced LSEC swelling secondary to the 
uptake of excess lipid in response to the hyperlipidemia induced by P407 (Warren, 
2011) and LSECs were more swollen and vacuolated than in the control group. 
Hematocrit was significantly decreased secondary to the severe hyperlipidemia 
induced by P407 that increased the plasma fraction of the blood samples. Overall, 
these results at 6 hours after APAP show that pre- or post-treatment with P407 did not 
protect the liver from early APAP-induced microvasculature injury in fasted rats and 
did not coat and protect LSECs from gap formation injury.  
 
At the second time-point, 24 hours after APAP, livers of fasted rats were also not 
protected by P407 pre- or post-treatment. Hematocrit was significantly decreased in 
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both these P407 groups secondary to the severe hyperlipidemia induced by P407 that 
increased the plasma fraction of the blood samples. In the fasted P407 pre-treated 
group, average aminotransferase levels were increased (although not significantly) 
compared to APAP controls correlating with histological findings of exacerbated 
injury in some P407 rats with more severe necrosis than controls. Sinusoidal collagen 
was decreased which was in this case reflective of the greater amount of hemorrhagic 
necrosis in the group as collagen was not upregulated in severely necrotic areas in any 
APAP or P407 groups. The presence of inflammatory cells was also increased in 
fasted P407 pre-treated rats at 24 hours after APAP particularly in areas of hepatocyte 
necrosis, which could have been a direct effect of P407 (Dumortier, 2006, Johnston, 
2009). A higher amount of infiltrate could have added to the APAP toxicity by 
increasing the release of inflammatory mediators leading to heightened induction of 
iNOS and enhancement of peroxynitrite formation (Jaeschke, 2005). Electron 
microscopy revealed LSECs from the fasted pre-treated group at 24 hours after APAP 
were dead in centrilobular zones where hepatocytes were only mildly injured and not 
necrotic. This level of LSEC injury was not observed in the fasted APAP controls 
suggesting that pre-treatment with P407 made the LSECs more susceptible to injury. 
In addition, fibrin clots were more frequently observed in the fasted pre-treated rats 
compared to APAP controls, a sign that there was increased hemorrhage due to 
exacerbated endothelial injury. 
 
In the fasted P407 post-treated rats at 24 hours after APAP overdose, there was 
extreme variability in the toxicity making it harder to define whether P407 protected 
from or exacerbated APAP toxicity. Overall, histological necrosis was decreased in 
comparison to controls with low toxicity in 3 out of 4 rats, however average 
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aminotransferase levels in the group were increased (although not significantly) as the 
fourth rat sustained severe injury in the form of centrilobular hemorrhagic necrosis, 
dead LSECs in areas of hepatocyte necrosis, and macroscopic hematuria. In contrast, 
2 rats in the group sustained less damage than the APAP controls with normal range 
serum aminotransferase levels and glycogen in centrilobular hepatocytes, and a third 
displayed low range APAP toxicity. In comparison to the fed post-treated rats, the 
fasted P407 post-treated rats were not as defenestrated at 24 hours after APAP. 
Fasting opens fenestrations wider than in the fed state (see results of Chapter 3) 
possibly to maximise the availability of nutrients in the blood to hepatocytes. The 
difference in fenestration size between fed and fasted rats may be due to alterations in 
the levels of serum proteins in the fasted state such as endothelin, VEGF, calcium, 
serotonin, and noradrenaline, however the exact mechanism is unknown. It is possible 
that the mechanism that dilates fenestrations in fasting may somehow override the 
defenestrating effect of P407 allowing more APAP (and any other toxins in 
circulation) to reach the hepatocytes resulting in an increased production of NAPQI. 
This effect of fenestration dilation could potentially override the protective 
mechanism of P407 post-treatment found in the fed state.  
 
The cause of hematuria in the three P407 pre- and post-treated fasted rats with severe 
hepatotoxicity was investigated by renal histological and ultrastructural analysis as 
APAP nephrotoxicity is well recognized in addition to its hepatotoxicity (McMurtry, 
1978). Analysis did not reveal any tubular necrosis or hemorrhage. It is possible the 
bleeding that caused the hematuria occurred in the bladder instead of the kidneys, or 
that there was some glomerular bleeding in other areas of the kidney that were not 
sampled for analysis. The P407/APAP combination could have caused some minor 
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tubular degeneration or necrosis as cellular debris was occasionally found in some of 
the tubules. There was also a globular substance discovered in the tubules of the renal 
cortex and medulla that was not present in the other rats with lower hepatotoxicity or 
in any of the APAP controls. This substance may have been comprised of P407 as its 
structure resembled that of micelles. Whether this substance had effect on renal 
function or promoting the hematuria is unknown. It has previously been shown that 
P407 can cause alterations of the murine glomerular filtration rate in a time-dependent 
manner (Li, 1996, Pec, 1992), and could contribute to increasing the toxicity of APAP 
by decreasing its rate of elimination. One suggested mechanism of action is that at 
some point during its elimination, P407 may accumulate in the glomeruli and thus 
plug fenestrations in glomerular endothelial cells (Li, 1996). Although this was not 
observed in our analysis it may have occurred at other time-points, and a decrease in 
the filtration rate could have subsequently exacerbated the hepatotoxicity, particularly 
in fed and fasted P407 pre-treated groups. 
 
In summary, P407 post-treatment one hour after APAP had a protective effect in rats 
ad libitum fed prior to APAP overdose, reducing hepatocyte necrosis, hemorrhage, 
and LSEC injury compared to APAP controls. P407’s defenestrating mechanism 
could have helped to ameliorate microvascular dysfunction by reducing the number of 
gaps and fenestrations, thereby reducing the amount of APAP and other toxins from 
reaching the hepatocytes. By accumulating in the SoD it could have also formed a 
physical protective barrier and helped to prevent and restore membrane damage. 
However P407 post-treatment in the fasted state did not protect LSECs from early 
injury, and results later in the course of toxicity were inconclusive with one of the rats 
in the group developing very severe hepatotoxicity and others appearing to be 
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protected at 24 hours after APAP. Some animals are more vulnerable to APAP 
toxicity than others because of genetic polymorphisms in metabolic and drug-
transporter enzymes (Au, 2011, Heinloth, 2004) and idiosyncratic adverse drug 
reactions are not uncommon (Boelsterli, 2007, Fontana, 2008). Thus it is possible that 
the dose of P407 administered was enough to protect some of the rats in the group 
from toxicity but not others. Pre-treatment with P407 did not protect the LSECs from 
the toxic effects of APAP in the fed or fasted state early or late in the course of 
toxicity. At 6 hours after APAP, pre-treatment with P407 may have had a mild 
hepatocyte protective effect, as aminotransferase levels were reduced, however it did 
not appear to protect LSECs from injury. It appears that by 24 hours after APAP 
overdose, pre-treatment with P407 aggravated hepatotoxicity and LSEC injury caused 
by APAP overdose in some of the rats in both the fed and fasted groups. Reasons for 
this may include a P407-induced inflammatory recruitment, exacerbated oxidative 
stress via P407-induced lipid oxidation, promotion of hemostasis by P407 inhibition 
of fibrinolysis and enhanced fibrin assembly rate, occlusion of the microvasculature 
and venules by P407 micelles increasing ischemia, and alteration of renal function by 
P407 which could have indirectly increased APAP hepatotoxicity.  
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Chapter 6: 
The Ultrastructure of Isolated Liver 
Sinusoidal Endothelial Cells from Young 
and Old F344 Rats 
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6.1    Introduction 
Recently old age in many species, including humans, has been found to be associated 
with marked ultrastructural changes of the LSEC called pseudocapillarisation (Ito, 
2007, Le Couteur, 2001, Stacchiotti, 2008, Warren, 2005). These changes include 
defenestration with a reduction of porosity of approximately 50 % associated with 
increased thickness of the endothelium and altered expression of various antigens 
including von Willebrand factor, caveolin-1 and ICAM-1 (Le Couteur, 2008). Age-
related defenestration of the LSEC is secondary both to a reduction in frequency and 
diameter of fenestrations (Le Couteur, 2008) and has been shown to impede the 
transfer of lipoproteins from blood to hepatocytes (Hilmer, 2005). This provides a 
novel risk factor for age-related vascular disease (Le Couteur, 2007, Le Couteur, 
2002). Pseudocapillarisation has also been implicated in increasing susceptibility to 
drug reactions in ageing and altering the rate of drug metabolism (Le Couteur, 1998, 
McLean, 2003). There is evidence to suggest that thickening and defenestration of the 
LSEC, in addition to increased collagen deposition in the SoD, impedes drug delivery 
to hepatocytes (Mitchell, 2011), and reduces the rate of oxygen diffusion from the 
blood crucial for oxidative metabolism (Le Couteur, 1998) thereby slowing drug 
elimination in the elderly. 
 
Therefore it is important that an effective method to study the ageing LSEC be 
discovered in order to test new substances that might modulate and reverse LSEC 
defenestration and thickening. The study of LSECs from old animals in vitro would 
be an ideal method to test the effects of potential therapeutic substances directly on 
LSECs without the influence of other biological factors and without having to 
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administer the substance to an animal. This would allow preliminary data to be 
obtained on how the substance modulates old LSEC morphology before in vivo 
studies are carried out.  
 
Whether the pseudocapillarisation is maintained in LSECs that have been isolated and 
cultured from old livers is unknown. If pseudocapillarisation is maintained in isolated 
LSECs it would suggest that this aging change is either irreversible and/or a primary 
endothelial change. Furthermore, it would indicate that isolated LSECs are suitable 
for the study of aging. 
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6.2    Materials and methods 
 
6.2.1    Animals and general information 
Young mature adult (aged 6 - 10 months, weight 380 - 440 g) and old adult (aged 24 - 
26 months, weight 390 - 490 g) male Fisher 344 rats were imported from the National 
Institute of Aging (Bethesda, MD), maintained on a 12 hour light / dark cycle and 
given free access to water and standard rat chow. The study was approved by the 
Sydney South West Area Health Service Animal Welfare Committee. Sterility was 
kept when weighing out materials for cell culture by using a cell culture fume hood 
and filtering solutions through a 2 µm filter to exclude bacteria. 
 
6.2.2    Surgery and LSEC isolation method using a 2-step Percoll gradient 
Rats (n = 4 young, n = 4 old) were anesthetised via an intraperitoneal injection of 0.2 
ml/100 g rat ketamine/xylazil (as described in Chapter 2). LSECs were isolated as 
described (Cogger, 2006, Cogger, 2004). After laparotomy, the portal vein was 
cannulated with an 18 G cannula and held in place with a suture. 100 µl of heparin 
was injected into the IVC to prevent any clots during perfusion. Following this the 
IVC was severed to allow adequate drainage of perfusate during perfusion (preventing 
any build up of pressure). Approximately 50 ml of Hank’s balanced salt solution 
(HBSS) without calcium at 37 ºC was perfused through the liver at a flow rate of 
approximately 10 ml per minute to remove the blood from the sinusoids (the liver 
turned from a dark reddish brown to a consistent tan colour). Immediately following 
this, livers were perfused with 50 - 100 ml collagenase A (0.05 % collagenase in 
HBSS with calcium, and 5 % fetal calf serum to neutralise non-specific proteases) at 
approximately 5 ml per minute (until the liver became soft). The liver was then 
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carefully removed using the portal vein as an anchor, rinsed with saline, and placed in 
a sterile petri dish. Glisson’s capsule and major vessels were removed using sterile 
forceps, eventually leaving a paste-like substance (containing the liver cells). 
Collagenase B (0.05 % collagenase in HBSS with calcium, 5 % fetal calf serum and 
0.001 % DNase) was added to the petri dish and mixed around to further break up the 
liver, then placed in an incubator (5 % CO2 at 37 ºC) for 10 min. The remaining cell 
suspension was filtered through nylon gauze (100 µm mesh) to remove any 
undigested tissue then centrifuged in a falcon tube at 100 g for 5 min at 20 ºC forcing 
most of the hepatocytes into a pellet at the bottom of the tube. The supernatant 
(containing a mixture of sinusoidal liver cells) was removed and centrifuged at 350 g 
for 10 min, forcing LSECs into a pellet. The pellet was then resuspended in 50 ml 
PBS and centrifuged for 10 min at 350 g. The resulting pellet was resuspended in 20 
ml PBS. Two 2-step Percoll (Stock Percoll = 90 % Percoll in PBS) gradients were 
made with 15 ml 50 % stock Percoll (in PBS) on the bottom layer, and 20 ml 25 % 
stock Percoll (in PBS) on the layer above. 10 ml of the cell suspension was carefully 
added on top of each of the Percoll gradients and centrifuged for 20 min at 900 g. The 
resulting intermediate zone enriched in LSECs was carefully removed and diluted 
with an equal volume of PBS, then centrifuged again at 900 g for 10 min. The pellet 
was resuspended in 10 ml complete Roswell Park Memorial Institute (complete 
RPMI-1640) medium (0.02 g/100 ml L-glutamine, 2 % heat inactivated fetal calf 
serum, 1 ml/100 ml of 100 U/ml penicillin, and 100 µg/ml streptomycin, in RPMI-
1640 medium). The cell suspension was then pipetted into uncoated sterile dishes and 
incubated for 10 min (37 ºC, 5 % CO2) to allow the selective attachment of Kupffer 
cells to plastic wells, enhancing LSEC purity. LSECs were then collected by firmly 
washing the dishes with complete RPMI-1640 to maximize the yield.  
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After a Trypan blue stain (450 µL Trypan blue, 50 µL cell suspension) allowing 
subsequent counting of the cells using a hemocytometer, LSECs were cultivated at 0.8 
 106 LSEC per ml in 24-multiwell plates on collagen-coated Thermanox coverslips 
for scanning electron microscopy. Specifically, 13 mm diameter Thermanox 
coverslips were coated with 10 L calf type 1 collagen. LSECs were cultured for 18 
hours (37 ºC / 5 % CO2) in 1 ml complete RPMI-1640 per well. The media did not 
contain vascular endothelial growth factor. Cells were rinsed in warm PBS and given 
fresh medium after 2 hours in culture. 
 
6.2.3    Specimen preparation for scanning EM  
Scanning electron microscopy on the cultured LSECs was performed as described 
(Cogger, 2006, Cogger, 2004). After 18 hours in culture, LSECs were fixed for 
scanning electron microscopy in 2.5 % glutaraldehyde in 0.1 M Cac (0.1 M sodium 
cacodylate buffer with 1 % sucrose pH 7.4) buffer for 1 hour then washed in 0.1 M 
Cac buffer. Filtered 1 % Tannic acid in 0.1 M Cac buffer (pH 7.4) was then added to 
cells on coverslips for 1 hour and rinsed thoroughly in 0.1 M Cac buffer. Cells on 
coverslips were then osmicated (1 % OsO4 / 0.1 M Cac buffer pH 7.4 for 1 hour), 
washed in 0.1 M Cac buffer and dehydrated in an ethanol gradient from 50 to 100 % 
EtOH (5 min each), and incubated for 2 min in hexamethyldisilazane. After the 
hexamethyldisilazane was removed from the wells, coverslips were left to air-dry in a 
fume hood. Coverslips were then mounted on stubs using double-sided tape, coated 
with platinum in a sputter coater (as described in Chapter 2), and examined using a 
Jeol 6380 Scanning Electron Microscope.  
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6.2.4    Analysis 
At least 30 images per animal from at least 10 cells were taken of the LSEC 
cytoplasm at a magnification of 15000  for measurement of fenestration diameter 
and LSEC porosity. Measurements of fenestration size, number and density were 
carried out using Image J (as described in Chapter 2, section 2.4.5.4). Fenestrations 
were defined as open pores with diameters < 300 nm. Gaps were defined as pores 
with diameters > 300 nm, and large gaps were defined as diameters > 500 nm. 
Diameter was defined as the major length of each fenestration or gap. Porosity was 
defined as the sum area of fenestrations / total area of the cell in the micrograph. The 
results are expressed as mean ± S.E.M. and comparison of the two age groups was 
performed using the Student’s t-test. The frequency distribution of the fenestration 
diameters was compared using 2. Differences were considered significant when p < 
0.05. 
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6.3    Results 
The average diameter of the fenestrations was decreased in old age from 194  1 nm 
(n = 13467 fenestrations, 4 rats) to 185  1 nm (n = 21,521 fenestrations, n = 4 rats, p 
< 0.0001). The graph of the distribution frequency of the diameters of fenestrations 
(fig 6.1) showed a slight shift to the left in old age (p < 0.001). However there was no 
change in the overall porosity between young and old (8.5  0.4 % versus 8.6  0.3 %, 
respectively).  
 
%
Fenestration diameter (nm)
Young
Old
%
 
 
Figure 6.1 Frequency distribution graph of the fenestration diameter in LSECs 
isolated from young and old rats. There is a slight shift to the left in old age 
concomitant with a significant reduction in average diameter. 
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Figure 6.2 shows examples of isolated cells from young and old rats and highly 
magnified areas used for analysis. An increase in fused fenestrations, that is adjacent 
fenestrations that appear to have lost some of the intervening cytoplasm (fig 6.3), was 
increased from 0.4  0.05 per m2 in young LSECs to 0.8  0.01 per m2 in old age 
(p < 0.0001). In addition, mesh-like structures reminiscent of vesiculo-vacuolar 
organelles (Dvorak, 2001), pored domes (Koriyama, 1992, Ohata, 1984), and 
trabecular meshworks (Taira, 1994) were noted frequently in both young and old 
LSEC cytoplasm and sometimes on the LSEC nucleus (fig 6.3), and gaps in the 
cytoplasm were common, suggesting that the ultrastructure of LSECs is influenced by 
their isolation and culture. The presence of gaps greater than 500 nm in diameter was 
mildly increased in old age (11 ± 2 large gaps per cell in the old versus 8 ± 1.5 large 
gaps per cell in the young). In addition, structures that have previously been described 
as fenestration forming centres (Braet, 1998), and more recently described in detail 
using three dimensional structured illumination microscopy (Svistounov, 2012), were 
occasionally observed (fig 6.3). 
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Figure 6.2 Electron micrographs of isolated young and old LSECs 
A) LSECs from a young rat in culture. There are intercellular junctions between the 
LSECs (arrow) and the nuclei (N) are distinguishable from the cytoplasms (bar = 10 
µm). 
B) Higher magnification of the LSEC cytoplasm from a young rat showing numerous 
fenestrations clustered into sieve plates (bar = 1 µm). 
C) An LSEC from an old rat showing the nucleus (N) and gaps in the cytoplasm 
(arrow; bar = 10 µm). 
D) Higher magnification of the LSEC cytoplasm from an old rat. Similar to the young 
rat, there are numerous fenestrations clustered into sieve plates (bar = 1 µm). 
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Figure 6.3 Scanning electron micrographs of unusual fenestration structures 
A) Fused fenestrations (white arrow) and mesh-like sieve plates (black arrows) were 
observed in both young and old cells (bar = 1 µm). 
B) Higher magnification of a mesh-like sieve plate showing what appears to be two 
layers of fenestrations (white and black arrows) in the LSEC cytoplasm in a sieve 
plate formation. Bar = 1 µm. 
C) A micrograph showing examples of “fenestration forming centres” (white arrows; 
bar = 1 µm). 
D) An LSEC nuclear region (N) containing structures resembling pored domes, 
vesiculo-vacuolar organelles, or trabecular meshworks (bar = 1 µm). 
 
 
 
 
 
 
 
 
 
N 
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6.4    Discussion 
LSECs occupy a critical and strategic position in the hepatic sinusoid because they 
facilitate the perm-selective and bi-directional transfer of substrates between blood 
and hepatocytes (Fraser, 1995, Le Couteur, 2005, Oda, 2003). The extreme 
vascularity of the liver generates a huge surface area for LSEC interactions with blood 
cells and particulate substrates for endocytosis. These features underpin many 
important physiological roles for the LSEC including their sieve, scavenger and 
immunological functions (Elvevold, 2008). 
 
Old age has been reported to be associated with reduced porosity in mice (Ito, 2007, 
Stacchiotti, 2008, Warren, 2005), rats (Jamieson, 2007, Le Couteur, 2001), baboons 
(Cogger, 2003), and humans (McLean, 2003). Overall, these studies performed in 
intact liver tissue have shown a reduction in porosity, however results for fenestration 
diameter were inconsistent, with different trends in fenestration diameter in old age 
reported in different species (Le Couteur, 2008). In the F344 rat, two in vivo studies 
have shown a trend towards reduction in fenestration diameter with age (Jamieson, 
2007, Le Couteur, 2001) however a more recent study (completed after our 
experiments) using the hybrid F344/BN F1 rat reported no difference in fenestration 
diameter of young and old rats (Simon-Santamaria, 2010). The hybrid rat type is 
considered to be a healthier model of ageing with less disease and greater longevity, 
and thus could explain the different result, particularly as rats in the “old” groups were 
of the same age (from 24 – 26 months old) in all three studies.  
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In isolated and cultured LSECs we found a reduction in fenestration diameter of about 
5 %, which is consistent with the in vivo reports in F344 rats. However, we could not 
detect any reduction in overall porosity in isolated LSECs from old livers. There are 
several plausible reasons for this inconsistency. First, the isolation and culture method 
might select only the most viable cells, so that defenestrated old cells are lost during 
isolation and culture. Second, it is possible that the actin disruption that occurs with 
cell isolation might cause an artefactual hyperfenestration (Cogger, 2009), thus 
diminishing the capacity to detect any aging changes. Finally, it is possible that some 
of the age-related changes in LSEC ultrastructure are maintained by in vivo factors 
such as cytokines derived from other hepatic cells or blood. On the other hand, LSECs 
derived from thioacetamide-induced cirrhotic livers were defenestrated both in intact 
livers and isolated LSECs. This result suggests that these thioacetamide-induced 
changes are intrinsic to LSECs and not related to the in vivo microenvironment (Mori, 
1993).  
 
Consistent with our results, the study by Simon-Santamaria et al found no significant 
difference in the porosity of LSECs isolated from old and young rats however in 
contrast they found no difference in fenestration diameter (Simon-Santamaria, 2010). 
This study used hybrid rats and cultured the LSECs for 2 hours with fetal calf serum-
free medium, however our study used inbred F344 rats and LSECs were cultured for 
18 hours with fetal calf serum in the medium. These differences in methodologies 
could explain the inconsistent results, demonstrating that minor differences in 
methodology produce different conclusions. 
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The diameter of fenestrations from normal LSECs has a Gaussian distribution, 
skewed to the right by the presence of some larger pores (Wisse, 1983, Wisse, 1985). 
Larger pores (greater than 300 nm diameter) are known as gaps (Wisse, 1985). Gaps 
represent large deficits in the liver endothelium probably caused by loss of, or fusion 
of all the fenestrations in the liver sieve plates (Montesano, 1978, Shin, 1997, Wisse, 
1985). Gaps seem to occur as a result of cellular injury, technical issues related to 
high pressure perfusion (Fraser, 1980, Wisse, 1983, Wisse, 1985), hypoxia (Frenzel, 
1977), fixation or pathological states (Wright, 1983). The absence of large 
chylomicrons in the space of Disse has been proposed as evidence that gaps do not 
normally occur in vivo (Wisse, 1985). We found numerous gaps in isolated LSECs 
suggesting that gaps may be an artefact of the isolation process and cell culture 
method. Old age was associated with a shift to the left of the frequency distribution 
graph for fenestration diameter up to 300 nm, together with no change in gap 
formation between 300 – 500 nm, and a slight increase in very large gaps greater than 
500 nm. Consistent with this finding, a more recent study observed gaps with a 
diameter greater than 300 nm in LSECs isolated from young and old rats and no 
significant difference in gap formation between the groups (Simon-Santamaria, 2010), 
although they did not analyse data for gaps greater than 500 nm. The age-related 
increase in large gaps observed in our study suggests that old age is associated with 
some reduction in the resilience of old LSECs to withstand the isolation process. 
 
Factors innate to the isolation and culture process appear to influence the morphology 
of LSECs, including the extracellular matrix components used in the culture. Type 1 
collagen was used in these experiments and although collagen remains the most 
important factor in LSEC culture (March, 2009), the use of different extracellular 
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components could influence the results (McGuire, 1992). However, it should be noted 
that recent studies show that fenestrations are better preserved when collagen is used 
compared to either Matrigel (Yokomori, 2009) or fibronectin (Martinez, 2008). 
Unusual fenestration structures were observed in both young and old LSECs. We 
noted fused fenestrations, which were more frequent in old LSECs. Fenestrations with 
irregular shaped margins or fusing fenestrations have previously been described in rat 
liver tissue (Young-Chul, 1997) but their significance and pathogenesis are unknown. 
Certainly they have the appearance of an artefact where part of the intervening 
cytoplasm has been lost during the fixation process however it is uncertain whether or 
not these structures are artefactual. We also noted the appearance of complex, 
multilayered sieve plates in both old and young isolated LSECs similar in structure to 
vesiculo-vacuolar organelles seen in capillaries of other tissues (Dvorak, 2001), and 
pored domes (Ohata, 1984), fenestrations in labyrinths (Braet, 2009), or trabecular 
meshworks (Taira, 1994) previously described in the liver in vivo (and consistent with 
the mesh-like sieve plates described by Simon-Santamaria et al in isolated LSECs). 
 
In conclusion, old age is associated with marked ultrastructural changes in the liver 
sinusoidal endothelium that have been called pseudocapillarisation. Whether such 
changes are maintained in LSECs that have been isolated and cultured was unknown. 
In this study, it was found that LSECs isolated from old livers retain some but not all 
of the ultrastructural changes that have been documented in vivo and in intact liver 
samples. Specifically there was a reduction in fenestration diameter with old age, yet 
fenestration porosity was the same in LSECs isolated from young and old livers. The 
result suggests that reduced fenestration diameter in old age is either irreversible or 
intrinsic to the LSEC.   
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Chapter 7: 
General Discussion 
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The majority of liver studies focus on the hepatocyte however the cells of the hepatic 
sinusoid are also crucial to liver function. The work of this thesis supports the vital 
role of the LSEC in the liver during health, toxicity, and ageing, and its important 
influence on hepatocyte function. 
 
The LSEC forms a protective barrier between the blood and the hepatocytes that is 
modulated by changes in the size and number of fenestrations. In Chapter 3 I found 
that fasting significantly increased the size of fenestrations by approximately 10 % 
without a change in porosity. When the dietary nutrient supply is ceased, the liver 
plays a crucial role in maintaining homeostasis of energy metabolism and blood 
nutrient levels. Dilation of LSEC fenestrations could increase the exchange of 
nutrients between the hepatocytes and blood. For example it could enhance the 
delivery of hepatocyte-produced VLDL and glucose to other organs, and improve 
delivery of substrates from the blood to hepatocytes for the production and storage of 
glucose and other nutrients. Further study could investigate the correlation of 
fenestration dilation with changes in serum levels of various cytokines and hormones 
in the fasted state that are known to influence fenestrations (such as VEGF, endothelin 
1, noradrenaline, and serotonin). It would also be of interest to investigate whether 
uptake of larger sized lipoproteins occurs with fasting by injecting radio-labelled 
lipoproteins into the portal vein and measuring the proportion that are trapped (hence 
passed into the SoD) in the fed and fasted liver. In addition, an investigation of 
whether the rate of hormone (such as insulin and glucagon) and drug delivery to 
hepatocytes is altered in the fasted state could be done by performing a multiple 
indicator dilution test. If drug delivery is increased in fasting it could have significant 
implications for drug metabolism and clearance, and could be related to the increase 
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in toxicity associated with fasting in some drugs (in particular the exacerbation of 
APAP-induced toxicity in Chapter 4 by fasting). It would also be of interest to 
determine whether fenestrations are dilated more in the periportal than the 
centrilobular zone as has been reported in the fed state. This could be done by 
measuring fenestration size and porosity in zones 1 and 3 of the liver to show whether 
the LSEC maintains a phenotype zonation in both the fed and fasted state similar to 
hepatocyte metabolic zonation. 
 
In Chapter 4 I found evidence, in support of findings of previous studies, that 
ultrastructural changes in LSECs influence hepatocyte pathology and repair during 
drug toxicity. In APAP overdose, LSEC injury can have crucial implications for the 
degree of hepatocyte damage. Gap formation in the LSEC cytoplasm can exacerbate 
hepatocyte damage (already initiated by NAPQI) by facilitating direct hepatocyte 
contact with harmful substances in the blood. The congestion that occurs as a result of 
microvascular dysfunction can cause ischemic hepatocyte necrosis. LSECs are able to 
recover from their initial APAP injury and enable liver repair and hepatocyte 
rejuvenation. In the current study I found that at 24 hours after APAP overdose, 
LSECs and HSCs formed a tight complex with basement membrane formation and 
reduction of sinusoid lumen size in areas of severe hepatocyte necrosis. Fenestrations 
were still present in LSECs supportive of their viability. The survival of LSECs and 
the maintenance of basic microvasculature structure in areas of hepatocyte necrosis 
could be crucial to giving hepatocytes a scaffold and nutrient supply by which to 
regenerate after severe injury. Further investigation of how the sinusoids regenerate 
from their initial APAP injury could be done by ultrastructural analysis at more time 
points of APAP toxicity, from the earliest signs of LSEC injury to the time of liver 
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regeneration and recovery from centrilobular hemorrhagic necrosis up to 3 - 4 days 
after APAP. A serum analysis of APAP and LSEC-related hormone (such as VEGF 
and hepatocyte growth factor) concentration could be performed at each time point to 
help elucidate the physiological basis for the ultrastructural changes.  
 
As was expected, more hepatotoxicity was observed in rats fasted before APAP 
overdose along with decreased resilience of LSECs in hepatocyte necrotic zones. 
Certainly fenestration dilation would increase the speed of delivery of APAP to 
hepatocytes which could result in more NAPQI formation. A multiple indicator 
dilution test could be performed to observe any differences in APAP uptake between 
fed and fasted rats that could have been caused by fasting-induced fenestration 
dilation. Serum analysis of APAP levels could also be performed to examine whether 
there is a difference in drug clearance of APAP in fasting that could be due to changes 
in LSEC phenotype. To date studies have only focused on the fasting-related changes 
in hepatocytes that influence the hepatotoxicity of APAP. 
 
In Chapter 5 I tested the therapeutic value of P407, a substance known to modulate 
LSEC morphology, in APAP toxicity. P407 was protective to hepatocyte injury and 
prevented hemorrhage in rats that were fed prior to APAP and given P407 1 hour after 
APAP overdose. Further study could be performed to investigate the mechanism of 
P407 protection. Initially this could be done in vitro by administering APAP to 
isolated LSECs and treating them with P407 to observe the direct effect of P407 on 
LSECs after APAP exposure and injury. P407 post-treatment was not effective at 
preventing necrosis and hemorrhage in the rats fasted before APAP overdose. This 
could have been due to a fasting-related morphological or hormonal change that 
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prevented the protective effect of P407. Alternatively the dose of P407 may not have 
been high enough to protect liver cells that were more vulnerable in fasting. 
Exacerbated hepatotoxicity in rats treated with P407 18 hours before APAP was 
associated with increased LSEC necrosis in areas where hepatocytes were viable. 
Investigation of whether P407 is toxic to LSECs when administered before a dose of 
APAP could also be performed in vitro.  
 
Age-related changes to the sinusoids, known as pseudocapillarisation, have a 
significant effect on drug and lipid metabolism. LSEC defenestration reduces the 
clearance of drugs and lipoproteins from the blood, making people of old age more 
vulnerable to adverse drug effects and dyslipidemia (that can lead to atherosclerotic 
plaque formation). In vitro analysis of old LSECs could be an effective method of 
testing substances that may reverse age-related changes in LSEC morphology. In 
Chapter 6 I found that in vitro, the old LSEC retained some but not all of its age-
related changes. There was a decrease in fenestration size however porosity was not 
decreased as it is in vivo. Further studies could be performed to observe whether 
alterations to the cell culture medium, or changes in the time from LSEC isolation to 
fixation, would enable LSECs to retain all of the age-related changes needed for the 
study of the ageing LSEC in vitro. 
 
In summary, the LSEC is crucial to the maintenance of many important liver 
functions. Modulation of the LSEC phenotype during fasting appears to be crucial to 
nutrient exchange in the liver and homeostasis. Injury to the LSEC during drug 
toxicity and its altered phenotype in ageing has a significant impact on the function 
and health of the liver. Survival of the LSEC during severe hepatocyte toxicity is vital 
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for the regeneration of the liver. Therefore therapeutic substances that directly target 
the LSEC have the potential to improve liver function and viability during disease and 
hepatotoxicity, and enhance drug and lipid clearance in ageing. 
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Appendix 1: Embedding protocols 
 
A) Spurr’s resin embedding protocol for TEM specimens 
1. After primary fixation in EM fixative, wash specimens in fixative buffer for 5 min 
2. Incubate in 2 % Osmium tetroxide in 0.1 M Na Cacodylate for 30 min, and wash in 
0.1 M Na Cacodylate (pH 7.4) for 5 min, then distilled water for 2  5 min 
3. For an en bloc uranyl acetate stain, incubate specimens in 2 % aqueous uranyl 
acetate for 20 min and wash in distilled water for 5 min, otherwise proceed straight to 
step 4 
4. Dehydrate the specimens in a series of ethanols - 50 %, 70 %, 90 %, 95 %, 100 % 
EtOH for at least 5 to 10 min each, then another 2  100 % in EtOH for 10 min each 
5. Incubate in acetone 2  10 min 
6. Incubate in 50 % acetone 50 % Spurr’s resin for 30 min 
7. Incubate in Spurr’s resin 2  30 mins and 1  60 min before placing specimens into 
BEEM® capsules filled with Spurr’s resin 
8. Set the Resin in an oven at 75 - 80 ºC overnight (until hard). Specimens are now 
ready for sectioning on an ultratome 
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B) Paraffin embedding protocol for histological specimens 
1. Following primary fixation in formaldehyde, washing in fixative buffer, and 
placing of specimens in cassettes, dehydrate the specimens in a series of ethanols (70 
%, 95 %  2, 100 %  3) for at least 1 hour each wash 
2. Incubate specimens in xylene, 3  1 hour 
3. Incubate specimens in hot paraffin wax - first incubation in paraffin wax for 2 
hours, second in fresh paraffin wax for at least 1 hour 
4. Pour fresh hot paraffin wax onto the specimens, and set them on a cold plate until 
the paraffin becomes hard, ready for sectioning 
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Appendix 2: Staining protocols for histology 
 
A) Hematoxylin and Eosin: stains RBCs red, cytoplasm pink, nuclei blue 
1. Firmly stick 4 µm thick paraffin-embedded sections on slides at 60 ºC 
2. Incubate sections in xylene for 2  1 min 
3. Dehydrate sections in 100 % ethanol, 2  1 min, and wash in water for 1 min 
4. Incubate sections in Harris Haematoxylin for 4 to 5 min then wash in water 1 min 
5. Dip sections into acid alcohol for approx 15 sec, then wash in water for 30 sec 
6. Incubate sections in Scott’s Blue for 1 min then wash in water for 30 sec 
7. Incubate sections in Eosin for 1 min 
8. Dehydrate sections in 100 % EtOH for 3  1 min 
9. Incubate in xylene for 2  1 min 
10. Coverslip sections with coverglass and mountant and view under the microscope 
  
B) Periodic Acid Schiff: stains glycogen and reticular fibres pink/magenta 
1. Firmly stick 4 µm thick paraffin-embedded sections on slides at 60 ºC 
2. Incubate sections in xylene for 2  1 min, then 100 % EtOH for 2  1 min 
3. Hydrate sections in water for 1 min before incubation in Periodic acid for 10 min 
4. Wash in water for 30 sec before incubation in Schiff’s reagent for 10 min 
5. Wash in water for 30 sec before incubation in Harris Hematoxylin for 2 min 
6. Wash in water 30 sec, incubate in Scott’s Blue 30 sec, wash in water 30 sec 
7.  Dehydrate in 100 % EtOH 2  1 min, incubate in xylene 2  1 min 
8. Coverslip sections with mountant and coverglass before viewing on the microscope 
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C) Sirius Red: stains collagen (I, II, III, and V) red, Fast Green FCF counterstain 
stains cells green  
1. Firmly stick 4 µm thick paraffin-embedded sections on slides at 60 ºC 
2. Incubate sections in xylene 2  1 min, before rehydrating in 100 % EtOH 2  1 
min, 95 % EtOH 1 min, 70 % EtOH 1 min, then water 2  1 min 
3. Incubate in 0.1 % Sirius Red for 1 hour 
4. Rinse sections in running water for 10 min 
5. To counterstain, incubate sections in 0.1 % Fast Green FCF for 5 min, and rinse 
briefly in water (up to 1 min), otherwise go straight to step 6. The dehydration steps 
after counterstaining must be very brief, only 1 - 2 dunks per section, as the dye will 
run out of the specimens very easily 
6. Dehydrate in 100 % EtOH 2  1 min (or 1 - 2 dunks if counterstained), and 
incubate in xylene 2  1 min (or 1 - 2 dunks if counterstained) 
7. Coverslip sections with mountant and coverglass before viewing on the microscope 
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Appendix 3: Staining protocols for TEM 
 
A) Toluidine blue stain 
Toluidine blue is made with 200 ml dH2O, 2 g Toluidine Blue powder, and 2 g borax, 
stirred on heat (simmered just under boiling) for 1 hour, poured through Whatman’s 
filter paper no.1 whilst warm into a fresh bottle. Filter the solution twice to remove all 
traces of precipitates. 
 
1. Place 0.5 µm thick sections on a drop of water on a glass slide 
2. Place slide on a heat pad (at 80 - 100 ºC) to evaporate the water in order to firmly 
stick sections to the slide 
3. Add a drop of toluidine blue onto the sections, and heat on the heat pad until a 
shiny film appears around the drop (approximately 2 - 5 sec) 
4. Rinse with dH2O and dry on the heat pad before viewing the sections on a 
microscope 
 
B) Ultrathin sections for transmission EM were stained as follows 
1. 80 nm sections on grids were placed in a drop of uranyl acetate (taken from the top 
of the solution in the bottle to avoid precipitate) for 3 min  
2. Rinsed in dH2O for 5 sec and dried briefly on filter paper 
 
3. Grids were placed in a drop of lead citrate for 3 min, exposure to oxygen and CO2 
were minimised by placing a lid over the Petri dish containing the grids, and not 
breathing directly onto the grids 
4. Rinsed in dH2O for 5 sec and dried briefly on filter paper 
 
5. Specimens are ready for viewing on the TEM 
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Appendix 4: Summary of the data from Chapters 4 and 5 
Table 1 Means ± S.D. of untreated control ad libitum fed and 48 hour fasted rats, fed 
and fasted APAP treated rats, and fed and fasted P407 pre and post treated rats. 6 hr 
= rats culled 6 hours after APAP, 24 hr = rats culled 24 hours after APAP.  
 
  Group 
Untreated 
control 
rats fed & 
fasted 
Treatment 
Group 
APAP 
treated 
P407 pre 
treated 
P407 post 
treated 
ALT (U/L) 
  6hr fast  45±7.2 29±6* 75±49 
fast 40±3.6 24hr fast  2143±2296 5729±6903 3179±6161 
fed 36.8±3 24hr fed  171.2±297 402±643 36±6.6 
AST (U/L) 
  6hr fast  81.4±16.4 68±10 117±45 
fast 70.7±9.1 24hr fast  3008±3473 9512±11612 6474±12671 
fed 52.4±4 24hr fed  155.4±172 782±1453 74.6±28 
Total Bilirubin (U/L) 
  6hr fast  1±0 0.3±0.6* 0.8±0.8 
fast 1±0 24hr fast  2±0.7*† 2±2.3 3.1±2.6 
fed 1±0 24hr fed  3.4±1.8* 0* 0.8±0.6* 
% Weight loss from time of 
fast 
  6hr fast  7.5±1.9 6.6±1 6±1 
fast 7±1.6 24hr fast  13±1.7*† 10±0.5 9.5±2* 
% Weight loss fed 0 24hr fed  4.6±0.5 6.7±1.5* 5.3±1.2 
Total cholesterol (µmol/L) 
  6hr fast  1.3±0.1 10.7±1.8* 2±1 
fast 1.5±0.1 24hr fast  1.1±0.2*† 10.3±4.5* 7±2.5* 
Triglycerides (µmol/L) 
  6hr fast  0.8±0.2 53±14.3* 5±8 
fast 0.4±0.1 24hr fast  0.7±0.5 40±25.3* 38±21* 
Urea 
  6hr fast  4.2±2.1 no data no data 
fast 4.6±0.3 24hr fast  7.7±2.1*† no data no data 
Creatinine 
  6hr fast  21±7.5 no data no data 
fast 24.3±1.5 24hr fast  36.8±11.6*† no data no data 
Hematocrit (%) 
  6hr fast  59.5±2.7 46±1* 57.6±3 
fast 52.7±2.1 24hr fast  62±8† 43±5* 51±3* 
Liver wet weight  % body 
weight 
  6hr fast  3.3±0.7 3.4±0.3 3±0.3 
fast 2.5±0.2 24hr fast  4.3±0.6*† 4.4±0.8 4±0.7 
Centrilobular Necrosis 
  6hr fast  0/5 = 0 1/5 = 0.2 1/5 = 0.2 
fast 0 24hr fast  32/25 = 1.28 37/25 = 1.4 13/20 = 0.65 
fed 0 24hr fed  5/6 = 0.83 5/6 = 0.83 1/6 = 0.16 
Sinusoidal Collagen 
  6hr fast  10/5 = 2 10/5 = 2 8/5 = 1.6 
fast 0 24hr fast  7/5 = 1.4 6/5 = 1.2 6/4 = 1.5 
fed 0 24hr fed  2/6 = 0.33 6/6 = 1 3/6 = 0.5 
Glycogen Deposition 
  6hr fast  0 CL no trend 
fast CL 24hr fast  PP PP no trend 
fed Diffuse 24hr fed  PP PP CL 
APAP treated group: *p<0.05 compared to 6 hour rats, †p<0.05 compared to untreated control rats. 
P407 pre and post treated groups: *p<0.05 compared to APAP control. 
Data for centrilobular necrosis and sinusoidal collagen are scores from the sum of ‘+’s in each group divided by the number of 
rats per group, or lobes analysed for necrosis in the 24 hour fasted groups. 
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Appendix 5: Micrographs not included in thesis chapters 
 
All micrographs are from F344 rats used in experiments for this thesis (unless 
otherwise specified) 
 
 
 
A1: Portal tract (TEM) 
HA = hepatic arterioles, PV = portal venules, BD = bile duct, ECM = extra cellular 
matrix (portal interstitium), F = fibroblasts, LPH = limiting plate of hepatocytes. Bar 
= 10 µm 
 
BD 
HA 
ECM 
F 
F 
PV 
PV 
HA 
LPH 
 271
 
 
A2: Eosinophil (TEM from a reprocessed specimen) showing typical rod shaped 
granules (from a P407 pre-treated liver in Chapter 5). Top picture bar = 2 µm, bottom 
bar = 500 nm. 
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 A3: Direct communication between cells of the hepatic sinusoids (arrows). Top 
picture bars = 2 µm, bottom picture bars = 1 µm. 
 
 
 
 
 
 
 
 
 
 273
 
 
A4: H & E stained sections from old rats (24 - 26 months old, Chapter 6). The top 
picture shows what looks to be lipid engorged HSCs, typical of ageing (bar = 100 
µm). The bottom picture shows patchy inflammation in an ageing rat (bar = 200 µm).  
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A5: Sirius red stained section of a male 9 month old mouse with Werner’s 
syndrome. There is mildly increased collagen, associated with age-related 
pseudocapillarisation. The bottom picture (bar = 20 µm) displays an enlarged area 
from the top right hand corner of the top picture (bar = 100 µm). Refer to (Massip, 
2010) for mice used. 
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A6: Sinusoids from mice with Werner’s syndrome aged 7-9 months showing an 
age-related increase in numbers of fat engorged HSCs associated with mild 
pseudocapillarisation. Refer to (Massip, 2010) for mice used. Bars = 5 µm.  
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A7: A sinusoid with age-related pseudocapillarisation from a male mouse with 
Werner’s syndrome aged 7 months. There is mild LSEC swelling and 
defenestration, some basement membrane formation (arrows) and increased collagen 
fibrils (C). There appears to be accumulation of lipofuscin and/or ferritin-like electron 
dense particles in the LSEC cytoplasm. Bottom micrograph is an enlarged version of 
the boxed area in the top micrograph. Refer to (Massip, 2010) for mice used. Top 
picture bar = 2 µm, bottom bar = 1 µm. 
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A8: A plasma cell ((P), effector B-cell) in a sinusoid lumen of a Werner 
Syndrome mouse showing abundant ER. There are large knife marks through the 
section however it is rare to spot a plasma cell so I have included this micrograph. H = 
hepatocyte, HSC = hepatic stellate cell. Refer to (Massip, 2010) for mice used. Bar = 
5 µm. 
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A9: Fibrin (TEM, from a reprocessed specimen from Chapter 4). The white 
arrows point to fibrin tactoids with typical periodicity observed by tilting the 
transmission electron microscope stage to an appropriate angle. This micrograph was 
taken from a rat liver severely affected by APAP toxicity. Bar = 500 nm. 
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A10: Glomerular endothelial cells (a reprocessed TEM specimen from Chapter 
5). Close view of a glomerulus. The glomerular endothelial cells contain fenestrations 
(arrows) without diaphragms however have an underlying basement membrane (B) 
separating them from podocyte foot processes (F). The podocyte cell body (P) and 
foot processes (F) reside along the underside of the basement membrane in the urinary 
space (U).
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A11: Control untreated and APAP-treated rat renal histology 
A) Renal cortex from a normal untreated F344 rat. Black arrow points to a distal 
convoluted tubule and the white arrow indicates a proximal convoluted tubule. H & E 
stain. G = glomerulus. Bar = 20 µm. 
B) Renal cortex from an F344 APAP treated rat 24 hours after APAP overdose. The 
glomerulus and surrounding tubules are histologically normal. The arrow points to 
Bowman’s capsule stained red by a Sirius Red stain. Fast Green was used as a counter 
stain to stain the cells green. PT = the start of the proximal tubule. Bar = 20 µm. 
C) Renal medulla from an untreated normal F344 rat. The thin loops of Henle and 
collecting ducts are clear and histologically normal. H & E stain. Bar = 100 µm. 
D) The renal medulla from an APAP-treated rat is histologically normal. The 
collecting tubules and thin loops of Henle of the medulla (M) are open and clear and 
do not contain any substances. No tubular necrosis was observed. Sirius Red/Fast 
Green FCF stain. Bar = 100 µm. 
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